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Adult central nervous system neurons regenerate poorly after injury. One reason for this 
regenerative failure is that a developmental change occurs where essential growth-molecules 
become excluded from axons with maturation. In this thesis, two strategies were employed in order 
to improve axon regeneration: 1) restoring the axonal transport of growth-molecules in mature 
axons via manipulation of transport machinery; 2) reverting mature neurons to an earlier 
developmental state where growth-molecules are abundant in the axon.  
 
 
In order to restore axon transport of growth-molecules, protrudin - a membrane-associated 
protein involved in directional membrane trafficking, was studied. Phosphorylated protrudin 
preferentially binds Rab11, a small GTPase involved in axon transport of growth receptors. This 
association is required for neurite outgrowth and for anterograde movement of this complex. We 
found that endogenous protrudin is excluded from mature axons similar to other growth-related 
machinery and cargo. It was hypothesised that introducing a phosphomimetic form of protrudin to 
mature cortical neurons, could increase the phospho-protrudin/Rab11 interaction resulting in 
improved anterograde transport of growth-molecules and enhanced axon regeneration. We found 
that overexpression of two constitutively phosphorylated forms and also wild-type protrudin 
increased the proportion of regenerating axons after in vitro laser axotomy. Furthermore, 
overexpression of wild-type and phospho-protrudin in the retina resulted in enhanced axon 
regeneration in a mouse model of optic nerve crush 2 weeks after injury. Live-cell imaging 
experiments revealed that this increased regenerative ability is accompanied with increased 
transport of Rab11 endosomes as well as growth receptors into the axon. Importantly, by further 
studying protrudin’s mechanisms of action, we identified novel players in the process of axon 
regeneration, including an exciting new role for the endoplasmic reticulum. In summary, protrudin 
is a promising intervention which improves axon regeneration in vitro and in vivo and due to its 
participation in multiple molecular pathways, new targets for aiding and understanding axon 
regeneration could be uncovered. 
 
Another approach to aid axon regeneration is to rejuvenate mature neurons. We 
hypothesised that overexpressing different combinations of transcription factors that are 
developmentally down-regulated could bring neurons to an earlier developmental stage. Four 
maturity markers were identified – doublecortin as an early maturity marker and 68-kDa 
neurofilament, calcitonin, tubulin-4a as late maturity markers. Some transcription factors showed 
promising results in rejuvenating primary cortical neurons. Further studies are needed to identify 
correct combinations of transcription factors to achieve maximum effect and to examine the effects 
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1. The burden of spinal cord injury and glaucoma   
 
Injuries to the central nervous system (CNS) can often lead to permanent disability and 
reduced quality of life for the affected individuals and their families. Spinal cord injury (SCI), 
for example, is a devastating condition which affects more than 50 000 people in the UK and 
Ireland (What is spinal cord injury?|Spinal Research, 2018). SCI results from damage to the 
nerve cells connecting the brain and the spinal cord to the rest of the body’s organs, limbs and 
muscles. Full or partial paralysis is the most common outcome of SCI; however, the condition 
is also associated with a high risk of developing secondary symptoms such as urinary 
incontinence, depression, sleep disturbance, chronic pain and in some severe cases, 
respiratory failure. Currently there are several treatments on the market which ameliorate 
some of the symptoms of this complex condition, but no cure exists to repair the damaged 
nerves.  
 
Glaucoma is another condition which features sustained damage to the optic nerve –
the nerve which transmits visual information from the eye to the brain in order to process an 
image. The highest risk for developing glaucoma is increased intraocular pressure (IOP) due 
to ineffective drainage of intraocular fluid. When persistent, IOP results in neuronal cell loss 
from the retina, optic nerve damage and vision impairment. Glaucoma is the second leading 
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cause of blindness around the world and currently there is no treatment for protecting the 
cells of the retina or for repairing the damaged nerves (Glaucoma Facts and Stat |Glaucoma 
Research Foundation, 2018). The limited number and quality of treatments for both SCI and 
glaucoma emphasise the pressing need to understand more about the biology of CNS neurons 
and their loss of regenerative ability with ageing in order to design innovative therapies and 
to improve the quality of life of patients and their families.  
 
2. Regeneration in the adult mammalian central nervous system 
 
Axons of immature CNS and adult peripheral nervous system (PNS) neurons readily 
regenerate after injury (Nicholls and Saunders, 1996; Huebner and Strittmatter, 2009). In 
contrast, mammalian CNS axons lose their regenerative capabilities with maturity (Bradke and 
Marín, 2014). For centuries, many scientists believed that adult CNS neurons simply do not 
regenerate after injury (Illis, 2011). Ramon y Cajal first described the swollen ends of injured 
axons as “dystrophic endballs” which are incapable of regeneration (Ramon y Cajal, 1928). 
Seminal studies over the past few decades, however, have challenged this long-standing 
dogma. In a series of pioneering experiments, Aguayo and colleagues showed that injured 
adult spinal cord or brain axons are, in fact, capable of regenerating through a peripheral nerve 
graft where the extracellular environment is more growth-permissive (Richardson, 
McGuinness and Aguayo, 1980; David and Aguayo, 1981; Benfey and Aguayo, 1982). These 
findings demonstrated for the first time that adult mammalian CNS neurons retain some 
intrinsic ability for regeneration and identified the non-permissive CNS extracellular 
environment as a key determinant of the CNS regenerative failure. 
 
2.1 Extrinsic Factors  
 
2.1.1 Chondroitin sulphate proteoglycans 
Several extracellular processes have been associated with the regenerative failure in 
adult CNS axons. Firstly, after injury to the CNS axons, a complex cascade of molecular and 
cellular events is triggered leading to the formation of a glial scar. The glial scar is a dynamic 
structure with different cell types (astrocytes, oligodendrocytes, immune cells) arriving at 
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different times and performing a variety of functions attempting to repair the damaged axons 
(Fawcett and Asher, 1999). While initially these cells are protective and aiding repair, sustained 
activation results in the secretion of numerous inhibitory molecules which oppose 
regeneration and remyelination. For example, reactive astrocytes secrete extracellular matrix 
molecules such as chondroitin sulphate proteoglycans (CSPGs) after injury which are 
restrictive to growth (Shen et al., 2009; Fisher et al., 2011). CSPGs contain a single protein core 
to which glycosaminoglycan (GAG) chains are attached. Treatment with chondroitinase ABC 
(ChABC), an enzyme which severs the GAG chains of the proteoglycans or with arylsulfatase B 
(ARSB), an enzyme which changes the sulfation pattern of GAGs to a more permissive one, 
result in improved regeneration after optic nerve crush (Pearson et al., 2018). ChABC 
treatment also leads to improved regeneration proximal to the lesion site and sprouting which 
are accompanied by partial functional recovery after spinal cord injury (Moon et al., 2001; 
Bradbury et al., 2002; Barritt et al., 2006). 
2.1.2 Myelin-derived inhibitors 
Other inhibitory molecules present in the extracellular milieu after injury originate 
from the myelin debri around the injury site. Some examples include NoGo (neurite outgrowth 
inhibitor), myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein 
(OMgp)(Yiu and He, 2006). The use of antibodies sequestering NoGo-A, genetic ablation of 
the NoGo gene, or interfering with its receptor NR1, have all been useful methods of 
improving the regenerative response and in aiding functional recovery after injury mostly by 
increasing neuronal sprouting and plasticity (GrandPré, Li and Strittmatter, 2002; Kim et al., 
2003, 2004; Liebscher et al., 2005; Freund et al., 2006). In 2011, anti-NoGo antibodies 
successfully passed Phase I clinical trials in paraplegic and tetraplegic patients with acute 
injuries and Phase II is now underway to examine the efficacy of this therapy (Zörner and 
Schwab, 2010). Furthermore, treatment combining anti-NoGo antibodies and chABC has been 
shown to be more effective than single treatments in stimulating sprouting and functional 
recovery after spinal cord injury in rats, suggesting that a combinational approach might be 
the way forward (Zhao et al., 2013). Interfering with MAG has not resulted in axon 
regeneration in the corticospinal tract (CST) up to date in animal models (Bartsch et al., 1995). 
In a recent study, transgenic mice lacking NoGo, MAG and OMgp were examined for 
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synergistic effects compared to single treatments. A modest effect was observed on sprouting 
but no improved spinal axon regeneration or functional recovery was recorded suggesting that 
while these inhibitors might have a role in sprouting, they are not the main players in the 
regenerative failure in CNS axons (Lee et al., 2010).  
2.1.3 Growth factors signalling  
One further obstacle to axon regeneration after injury is the supply of growth factors 
and their receptors to injured cells. Growth factors such as nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF) and Neurotrophin-3 have all been associated with aiding 
neuronal survival, neurite outgrowth, plasticity and neurotransmission in development and 
after injury in the PNS (Jones et al., 2001). In the CNS, the expression of several of these factors 
decreases with maturation and their upregulation after injury is very limited which could 
further complicate the process of axon regeneration (Schwab and Bartholdi, 1996). Recent 
attempts focused at delivering these growth factors to the injury site in spinal cord injury and 
optic nerve crush models - indeed many of them showed promising results in aiding sprouting 
and axon regeneration (Tuszynski et al., 1996; Menei et al., 1998; Zhang et al., 2000; Blesch 
and Tuszynski, 2003; Blesch et al., 2004; Wong et al., 2014). 
Many of the studies described above, do indeed show promising results in aiding 
neuronal sprouting and plasticity as well as in improving functional recovery. Some of them 
even report enhanced axon regeneration near the lesion site. In most cases, however, the 
axons grow proximal to the lesion site and very rarely through the injury. Also, the extent of 
growth seen in these animal models would be negligible if translated to the human situation. 
These observations suggest that rendering the environment more permissive for growth is 
one step forward in the right direction – however, in order to observe true, long-range, 





2.2 Intrinsic Factors 
In addition to the non-permissive extracellular environment after injury, intrinsic neuronal 
factors also play an important role in axon regeneration (He and Jin, 2016; Tedeschi and 
Bradke, 2017). Aguayo and colleagues showed that only a subset of neurons is capable of re-
growing through a peripheral nerve graft whereas others such as descending CST axons have 
lost this ability even if the environment is permissive (Aguayo, David and Bray, 1981; 
Richardson, Issa and Aguayo, 1984). This discovery opened a new avenue for boosting 
regeneration – modulating the intrinsic ability of adult neurons to re-grow after injury.  
2.2.1 PTEN and PI3K pathways 
One approach includes stimulating pathways, essential for neuronal growth and survival. 
For example, PTEN (phosphatase and tensin homologue), an inhibitor of the mammalian 
target of rapamycin (mTOR) pathway was initially identified as a negative regulator axon 
growth as it opposes the actions of phosphoinositide 3-kinase (PI3K). The PI3K pathway is an 
essential cellular pathway involved in cell survival, metabolism and growth processes (Fig. 
1.1).  Knocking down PTEN resulted in robust long-range retinal ganglion cell (RGC) 
regeneration after optic nerve crush (Park et al., 2008). In addition, deletion of PTEN improved 
sprouting of uninjured axons and aided regeneration at short distances past the lesion site of 
some injured CST neurons in vivo – this effect was attributed to upregulation of mTOR pathway 
(Liu et al., 2010). The mTOR pathway is highly active during early development but is 
diminished with maturation in the CNS and PNS. Its activation, however seemed to specifically 
be involved in CNS and not PNS regeneration as blocking the pathway by rapamycin reduced 
the regenerative potential of immature cortical neurons but not that of adult PNS neurons 
(Huang et al., 2017). The effect of PTEN deletion was further enhanced by a combination with 
another deletion – suppressor of cytokine signalling 3 (SOCS3), a negative regulator of Janus 
kinase/signal transducers and activators of transcription (JAK/STAT) pathway. A combination 
of two separate intracellular pathways activation - mTOR and JAK/STAT, resulted in an additive 
effect on RGC survival and a robust long-range retinal ganglion cell regeneration after optic 
nerve crush (Smith et al., 2009; Sun et al., 2011). PTEN, however also acts as tumour 
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Figure 1.1 A schematic diagram to illustrate the PI3 Kinase Signalling Pathway. Insulin or growth factors from 
outside the cell bind to receptor tyrosine kinases and activate them which in turn, activate PI3K. PI3K then 
converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 
acts as an effector which triggers numerous downstream intracellular cascades, one of which is the activation 
of Protein Kinase B (or also known as AKT) and subsequently of mTOR ultimately leading to cellular events which 
support cell survival, proliferation and growth.  
 
 
Other strategies, however, such as manipulating PI3K instead could prove to be more 
effective in the clinic in the future. PI3K activation has so far been achieved through 
potentiating the insulin growth factor 1 receptor (IGF1R) which is upstream of PI3K signalling. 
IGF1 expression peaks during development and falls gradually during adult life (Wrigley, Arafa 
and Tropea, 2017). Combinational viral delivery of the IGF1 receptor (IGF1R) and osteopontin 
– an enhancer of neuronal response to IGF1R activation, results in improved axon 
regeneration in RGCs after optic nerve crush (Duan et al., 2015) and in sprouting, short-range 
axon regeneration and some functional recovery in CST neurons after T10 spinal cord hemi-
section (Liu et al., 2017). These findings highlighted the potential of modulating neuronal 
intrinsic pathways in order to promote some therapeutically relevant functional recovery after 
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spinal cord injury. Despite that, long-range axon regeneration of the CST was not achieved and 
most of the functional recovery observed was due to sprouting.  
2.2.2 Other intracellular pathways 
Recently, another intracellular signalling molecule – Cacna2d2, a gene encoding for 
voltage-gate calcium channel units, has been shown to restrict axon growth and regeneration. 
In fact, using a pharmacologically available antagonist – pregabalin, to block this channel 
resulted in improved regeneration in adult mice after spinal cord injury (Tedeschi et al., 2016). 
Improving adult neuronal sensitivity to growth factors such as BDNF by overexpressing its 
receptor - the TrkB receptor has also proved to be beneficial for axon growth and regeneration 
and revealed new pathways involved – such as the ERK/MAPK pathway (Hollis et al., 2009). 
Other intracellular pathways involved are the RhoA/ROCK pathway. Ras homolog gene family, 
member A (RhoA) is a small GTPase which is downstream of many pathways activated by 
extracellular inhibitory factors such as MAG, OMgp and CSPGs (Hu and Selzer, 2017). 
Inactivation of RhoA by C3 transferase enzyme was first shown to improve axon regeneration 
of the optic nerve and neuronal survival after an optic nerve crush (Lehmann et al., 1999; Koch 
et al., 2014). Inhibition of RhoA with C3 transferase or with a pharmacological inhibitor was 
later showed to result in increased axon regeneration and sprouting as well as in improved 
motor behaviour in mice with partial spinal cord injury (Dergham et al., 2002). These effects, 
however seem to result from benefits in sprouting and survival instead of long-range 
regeneration to initial muscle targets (Tuszynski and Steward, 2012). Many other intercellular 
molecules such as cyclic AMP, GSK3 and others have been targeted to improve axon growth, 
regeneration and survival after injury (Qiu et al., 2002; Leibinger et al., 2017) . No intracellular 
manipulations to date however, have resulted in long-range axon regeneration of injured CNS 
axons back to their original target cells to form functional synapses. 
So far, one of the most robust axon regeneration improvements observed in vivo has been 
in the peripheral nervous system where overexpression of activated growth-promoting 
receptor - integrin alpha9 - resulted in robust regeneration (more than 25mm in length) and 
in functional recovery after dorsal root crush (Cheah et al., 2016). This study was the first of 
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its kind to highlight the importance of transport and trafficking of growth-promoting 
molecules such as integrins to the tip of regenerating neurons as another intrinsic process key 
for regeneration in addition to the activation of intracellular signalling cascades. Intracellular 
trafficking and transport and their involvement in axon regeneration are discussed in detail in 
Section 3.  
2.3 Gene expression changes and epigenetics 
While targeting individual intracellular pathways or molecules did show some 
promising effects in aiding axon sprouting and short-range regeneration past the lesion site, 
all studies described so far, highlight the importance of targeting a global set of intracellular 
events in order to trigger more robust axon growth. PNS neurons upregulate a particular set 
of genes after injury in order to enable axon regeneration – a response that is only partially 
present in the CNS (Neumann and Woolf, 1999; Plunet, Kwon and Tetzlaff, 2002; Hoffman, 
2010).  Recent efforts have been concentrated on altering intrinsic factors on a more global 
level by neutralising inhibitory transcription factors such as KLF4 or by overexpressing 
developmentally down-regulated and growth-associated transcription factors such as ATF3 
and KLF7 – all leading to increased expression of pro-regenerative genes and enhanced 
regeneration (Seijffers, Mills and Woolf, 2007; Moore et al., 2009; Blackmore et al., 2012a; 
Fagoe et al., 2015; Wang et al., 2015). A detailed review of the most recent studies in which 
transcription factors are used as a tool to target multiple growth-related genes at once is 
provided in Chapter 6. Despite the promising initial results that these studies yielded, there 
seemed to be other mechanisms in the CNS such as epigenetic changes which do not allow 
for PNS-like regeneration to be observed (Trakhtenberg and Goldberg, 2012; Venkatesh et al., 
2016; Wang et al., 2017). PCAF, for example, is a histone acetyltransferase which associates 
with the promoters of known pro-regenerative genes and drives their expression (Puttagunta 
et al., 2014). PCAF is highly active in PNS neurons after injury to induce axon growth and its 
overexpression in CNS non-regenerative neurons is sufficient to promote axon regeneration 
after spinal cord injury (Puttagunta et al., 2014). Other epigenetic factors and their use to 
improve axon regeneration are reviewed in Chapter 6, Section 1.  
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In addition, many of the studies mentioned above show that numerous aspects 
of neuro-regeneration recapitulate development and that both processes share similar 
molecular players (Harel and Strittmatter, 2006; Hilton and Bradke, 2017). In this sense, 
understanding the transition from early to late neuronal development might be essential to 
identifying factors contributing to the regenerative failure of mature neurons.   
2.4 Regeneration Capacity Declines with Maturation  
Research over the past few decades has shown that the regenerative abilities of 
immature and mature neurons can be very different, with young neurons readily regenerating 
after injury and mature neurons failing to re-grow their injured axons (Nicholls and Saunders, 
1996). Regeneration of some adult CNS axons which have lost their regenerative ability could 
be partially improved by grafting embryonic spinal cord or PNS tissue which provide more 
permissive environment (Vidal-Sanz et al., 1987; Mori et al., 1997). Despite that, even in 
neurons capable of regeneration such as those of the PNS, the regenerative response is 
delayed and less effective in aged compared to younger animals (Verdú et al., 2000).   
2.4.1 In vitro studies  
In the CNS, the effects of maturation are even more pronounced with strongly 
diminished regenerative ability in mature neurons. As adult CNS regeneration rarely occurs in 
vivo, some in vitro models could prove valuable to test different strategies to improve axon 
regeneration (Bradke, Fawcett and Spira, 2012). Recently, Koseki and colleagues showed that 
the maturational state of cultured rat cortical neurons negatively correlates with their 
regenerative abilities whereby less than 10% of neurons aged 23-30 DIV (days in vitro) 
regenerate compared to 70% of 3-5 DIV neurons (Koseki et al., 2017). This failure of 
regeneration in mature CNS neurons was attributed to an intrinsic change because when 
young neurons were cultured in an aged environment (24-day-old cultures), they retained 
their regenerative ability. Another change that accompanied the regenerative failure was 
exclusion of Rab11-positive endosomes from axons but not from dendrites in aged neurons, 
implicating axonal transport as a possible mechanism by which maturation can affect 
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regeneration (Koseki et al., 2017). The maturational change in cultured primary cortical 
neurons was further confirmed by RNA sequencing studies which showed extensive changes 
in gene expression with upregulation of genes involved in synapse formation and function, 
and downregulation of genes important for growth and development (Koseki et al., 2017). 
Other in vitro studies showed that retinal ganglion cells (RGCs) show similar age-
dependent decline - RGCs lose their regenerative ability shortly after birth and have reduced 
growth potential when cultured in vitro whether grown on neonatal (unmyelinated) or adult 
(myelinated) optic nerve sections (Goldberg et al., 2002). In contrast, dorsal root ganglion 
(DRG) neurons isolated from the PNS retain their intrinsic ability to grow on either of these 
substrates suggesting that they have a preserved intrinsic ability to regrow (Shewan, Berry 
and Cohen, 1995). Furthermore, embryonic RGCs were better regenerators compared to adult 
RGCs when grown on laminin and injured (Verma et al., 2005). This was not the case for PNS 
neurons where the majority of injured axons formed a growth cone and regenerated 
irrespective of their maturational stage (Verma et al., 2005).  
 
2.4.2 In vivo studies  
Ageing and maturation are complex processes which can affect the regenerative 
abilities of axons through different pathways, hence studying their effects in vivo has proven 
to be rather challenging. The lack of true regeneration in aged animals also complicates this 
study. Early studies showed that the developmental decline in regenerative ability is triggered 
by intracellular events rather than ageing of the environment or influences from surrounding 
glia. For example, the majority of neonatally-derived retinal axons lose their ability to re-
innervate their target brain region (the tectum) even when presented with an embryonic 
target or when oligodendrocyte inhibitory proteins are neutralised (Chen, Jhaveri and 
Schneider, 1995). On the contrary, embryonic retinal explants are capable of extending long 
axons to immature or mature tectum (Chen, Jhaveri and Schneider, 1995). Similar 
observations were made in entorhinal-hippocampal slices where “old” entorhinal axons are 
not able to project to “old” or “young” hippocampal areas whereas more immature entorhinal 
axons are able to extend connections to any target (Li, Field and Raisman, 1995). These studies 
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were seminal in establishing that the critical factor for the maturational decline in 
regenerative ability is the age of the projecting neurons. 
Recent studies in Caenorhabditis elegans (C. elegans) showed similar results to the 
ones Koseki and colleagues obtained in vitro with 65% of GABA motor neurons 
regenerating after single-neuron laser axotomy in young adult worms (1 day post the final 
larval stage) compared to only 28% of aged neurons (5 days post the final larval stage) 
regenerating (Byrne et al., 2014). The current study was also able to attribute this decline 
specifically to the intrinsic ability of aging neurons to regenerate rather than to secondary 
processes occurring in the ageing organism or to the length of the worm’s lifespan (discussed 
by Belin, Norsworthy and He, 2014). Further studies in C. elegans where laser axotomy was 
performed on various neuronal cell types at different stages of development, revealed that 
regenerative ability is highly dependent on neuronal cell type, developmental stage and 
signalling from molecules in the surrounding environment (Wu et al., 2007). 
The regenerative ability with maturation was also studied in more complex organisms. 
Opossums, for example, are marsupials which are born immature and complete their nervous 
system development after birth. Their spinal cord neurons are capable of axon regeneration 
until they are 9–12 postnatal days old for cervical segments, and 17 days old in lumbar 
segments (Varga et al., 1995). This critical period of developmental regenerative decline 
coincides with upregulation of myelination and the secretion of myelin inhibitors in the 
extracellular environment as well as with downregulation of cAMP and other growth-
associated pathways (Mladinic and Wintzer, 2002; Mladinic, 2007; Mladinic et al., 2010).  In 
this sense, the opossum CNS provides a model where axon regeneration declines both 
temporally and spatially.  
 
In mammals, an early study of the effects of neuronal maturation on regeneration was 
carried out in organotypic slice cultures of auditory gerbil neurons where P7 cultures showed 
robust regeneration which was not observed in P12 cultures (Hafidi, Lanjun and Sanes, 1999). 
In hamsters, injured as infants there was a greater axon regeneration and functional recovery 
of hindlimb function after lesion to the medullary pyramidal tract compared to animals injured 
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as adults (Kalil T., 1979; Keifer and Kalil, 1991). Examining the regenerative potential in chicks 
shows that maturation results in 55% reduction in regeneration potential of spinal cord 
neurons and in 90% reduction in hindbrain neurons (Blackmore and Letourneau, 2006). 
Furthermore, transplanting embryonic neurons into the adult spinal cord allows for robust 
axon growth whereas adult neurons do not grow well even when plated on permissive 
substrates again highlighting the importance of the intrinsic ability of axons to grow in axon 
regeneration (Blackmore and Letourneau, 2006). 
 
The most comprehensive study so far about the effects of ageing of regeneration used 
a model for regeneration in adult CNS neurons in vivo.  As mentioned above, in previous 
reports PTEN deletion was shown to promote axon regeneration in retinal ganglion cells 
and corticospinal tract neurons after injury in young adult mice (Park et al., 2008; Liu et al., 
2010).  Geoffroy and colleagues recently expanded on these findings and examined the 
effects of ageing on the efficacy of PTEN deletion to promote axon regeneration in CST 
neurons (Geoffroy et al., 2016). Ageing did not reduce the positive effects of the PTEN deletion 
on improving the intrinsic neuronal ability to regenerate proximally to the spinal cord injury. 
In contrast, ageing greatly reduced the axonal regeneration normally seen in young adult 
animals distal to the injury and resulted in increased inflammatory markers expression at the 
injury site (Geoffroy et al., 2016).  This study suggests that the ability of injured axons to 
regenerate at long distances diminishes with ageing.  
 
In summary, it has been long known that younger neurons have enhanced 
regenerative abilities compared to their older counterparts (Ramon y Cajal, 1928). Despite the 
enormous advancement in our understanding of the extrinsic and intrinsic processes that 
contribute to the regenerative failure with maturation, most studies to date which aimed at 
manipulating these factors only achieved modest axon regeneration and insignificant 
functional recovery. Improving axonal transport of various growth and regeneration-related 
molecules in adult neurons has recently come to the forefront of regeneration research as a 
strategy to improve delivery of receptors to newly formed growth cones in order to achieve 




3. Axon Transport in Development and Regeneration  
 
3.1 What is Axon Transport?  
The transport of molecules, organelles and other cellular components along the axon 
is required for proper functioning of the cell. The great length of axons (some can reach up to 
1m in length) requires tight spatial and temporal regulation of axonal transport. Long-range 
axon transport and trafficking is mediated by motor proteins which move along microtubule 
tracts which enable high velocity movement. Microtubules in axons have homogenous 
organisation with all minus ends pointing towards the cell body and all plus ends pointing 
towards the tip of the axons. In contrast, in dendrites mixed polarity microtubule structures 
are present (Yau et al., 2016; Tas et al., 2017). There are two types of active transport in axons 
at all times – retrograde (towards the cells body and the minus end of microtubules) mediated 
by dyneins and anterograde transport (towards the tip of growing neurites and the plus end 
of microtubules) mediated by kinesins (Fig. 1.2). In addition, transport involving the actin 
cytoskeleton and myosin motors allows for slower, more flexible transport beyond the rigid 
skeleton of the microtubule network. Proteins and cellular components are usually enclosed 
in membrane structures which connect to the correct motor proteins via adaptor proteins.  
3.2 Control of membrane axon transport – ARF6 and Rab11 
Research from the past few decades revealed that two small GTPases – Ras-related in 
brain (Rab, in particular Rab11) and ADP ribosylation factor (ARF, in particular ARF6), play key 
roles in controlling the transport of recycling endosomes along the axon (Salminen and Novick, 
1987; D’Souza-Schorey and Chavrier, 2006; Stenmark, 2009). These small G proteins alternate 
between a GDP- and a GTP-bound state which regulates their binding to various adaptor 
proteins (Bos, Rehmann and Wittinghofer, 2007). The GDP-GTP cycle is highly regulated by 
guanine nucleotide exchange factors (GEFs) which release GDP to be replaced by GTP and by 
GTPase-activating proteins (GAPs) which stimulate hydrolysis of GTP to GDP.  The spatial and 
temporal availability of GEFs and GAPs regulate the rate of GTP-to-GDP cycling in Rab11 and 




Figure 1.2 A schematic diagram to illustrate the bidirectional movement of recycling endosomes along 
microtubule tracts in the axon. Motor proteins such as dyneins and kinesins associate with adaptor proteins 
such as FIP3 and protrudin which in turn interact with Rab11-tagged recycling endosomes carrying various cargo 
molecules such as integrins and other growth-associated receptors. The activational state of Rab11 is thought 
to influence which type of adaptor proteins it associates with. Dyneins transport cargo towards the minus end 
of microtubules, i.e. towards the cell body – this movement is also referred to as retrograde transport. Kinesins 
such as KIF5 transport cargo towards the positive end of microtubules i.e. to the tip of processes, also referred 








Previous studies show that Rab11 is involved in exocytosis as well as in the insertion 
of various proteins in the plasma membrane. For example, Rab11 is essential for the 
membrane recycling of receptors such as the transferrin receptor (Ullrich et al., 1996; Ren et 
al., 1998), β2 adrenergic receptor (Parent et al., 2009), AMPA receptors (Park et al., 2004; 
Correia et al., 2008; Esteves da Silva et al., 2015), toll-like receptors (Husebye et al., 2010), 
fibroblast growth factor receptor 4 (Haugsten et al., 2014), tropomyosin receptor kinase B 
(TrkB) (Lazo et al., 2013; Sui et al., 2015; Song et al., 2015) and the integrin receptor (Powelka 
et al., 2004; Caswell et al., 2008; Eva et al., 2010). Interestingly, Rab11 and ARF6 both regulate 
the vesicular transport of integrins – growth-associated receptors which are involved in axon 
guidance, extension and migration. ARF6, similarly to Rab11 cycles between an active (GTP-
bound) and an inactive form (GDP-bound form) whereby the active form in the axon favours 
retrograde axonal transport and the inactive form supports anterograde transport (Eva et al., 
2012). In summary, Rab11 and ARF6 act in co-ordination along the axon and control 
membrane-dependent recycling and exocytosis with their activation states and adaptor 
binding being key to these processes (Welz, Wellbourne-Wood and Kerkhoff, 2014).  
 
3.3 Developmental decline in regeneration-associated axon transport  
 
It has been widely known that axon transport is essential for successful regeneration 
after injury and many groups have focused their efforts in understanding the differences in 
axon transport in regenerating vs. non-regenerating neurons and in immature vs. mature 
axons. 
 
During development, neurons are fully equipped with the growth machinery they 
need to extend long axons, reach their target cells and form functional connections. Once 
these connections have been established, the elongation capacity of 
neurons declines dramatically. One reason why adult CNS axons have poor regenerative 
capabilities might be that a developmental change occurs where essential growth molecules 
are no longer transported to the tip of axons given they are no longer needed there. Instead, 
the transport of synapse-associated cargoes becomes priority over the transport of growth-
associated molecules (Bonanomi et al., 2008; Tedeschi et al., 2016). Axon transport has been 
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shown to change with maturation and there are also stark differences between transport in 
the adult PNS and in the CNS which might be responsible for the differential regenerative 
abilities of these neurons.  
Early studies have shown that PNS and CNS axonal transport of some essential 
cytoskeletal proteins in rats declines with age – between 1 and 6 months of age (McQuarrie, 
Brady and Lasek, 1989). Recently, Milde and colleagues (2015) were able to identify some 
specific developmental changes in both CNS and PNS axon transport using single-
axon fluorescence live imaging of acute tissue explants of mice aged between 1.5 and 24 
months. They observed two major periods of axonal transport decline of two specific cargoes 
– a neuronal survival factor NMNAT2 and mitochondria. Initial decline in axonal transport was 
observed for both cargoes in PNS and CNS neurons between 1.5 and 6 months of age and a 
later drop in the number of particles transported along the axon was observed in sciatic 
and optic nerve but not in hippocampal axons at 24 months (Gilley et al., 2012; Milde et al., 
2015). Interestingly, peripheral nerve crush induced an increase in the axonal transport of 
mature axons in an ageing environment (24-month-old mice) – there were more 
anterogradely moving particles containing NMNAT2 and mitochondria at rates similar to 
young mice. Retrograde transport was unaffected (Milde et al., 2015). These studies support 
previous findings that a balance between a retrograde and an anterograde transport is needed 
for axon growth and extension, whereas predominant retrograde movement is restrictive to 
growth (Hollenbeck and Bray, 1987; Hollenbeck, 1993). These findings further highlight that 
enhanced anterograde transport is need for axon regeneration after peripheral nerve injury. 
One reason for the change in axonal transport with maturation in CNS neurons 
could be that the axon initial segment (AIS) forms. The AIS acts as a molecular barrier which 
can enable or restrict the transport of specific cargos along the axon (Song et al., 2009; 
Rasband, 2010) . For example, in multipolar hippocampal neurons, cargo specific to 
the somatodendritic compartment is excluded from axons by the AIS, which at the same time 
selectively permits axon-specific cargo to pass through to the distal axon (Song et al., 
2009). Our group has shown that an activator of ARF6 – EFA6 is localised within the AIS where 
it regulates directional transport in the axon (Eva et al., 2017). Interfering with EFA6 resulted 
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in enhanced anterograde transport of growth-associated molecules in the axon which in turn 
results in improved regeneration after laser axotomy in primary cortical neurons (Eva et al., 
2017). This finding suggests that molecules in the AIS could be targeted in order to improve 
axonal transport of growth-related molecules. A similar mechanism has recently 
been described in sensory DRG neurons whereby microtubule-associated protein 2 – MAP2 
has a strict somatodendritic and proximal axon distribution in vitro and in vivo regardless of 
age of the neurons (Gumy et al., 2017). This distribution plays a role in the balance between 
two motor adaptor proteins – KIF5 and KIF1 which in turn regulates the entry of specific axonal 
cargo into axons as well as axonal growth (Gumy et al., 2017).  
 Cytoskeletal re-arrangement and the proper formation of a growth cone are some of 
the requirements for successful axon regeneration (Bradke, Fawcett and Spira, 2012). Early 
studies identified that the transport of cytoskeletal proteins such as growth-associated protein 
43 – GAP43, is rapidly upregulated in the optic nerve in the CNS of neonatal rabbits after injury 
to aid regeneration – an effect which declined steadily in the adult (Skene and Willard, 1981). 
In contrast, the transport of GAP43, was highly upregulated in the readily regenerating 
neurons of hypoglossal nerve in the PNS in the adult (Skene and Willard, 1981). This 
upregulation in GAP43 in regenerating immature and adult PNS axons after injury was also 
shown to be co-ordinated with an increase in the transport of other cytoskeletal elements 
such as beta tubulin (Hoffman et al., 1983). In the adult, the trafficking of cytoskeletal 
elements along the axon was also shown to slow down during maturation of motor neurons 
and retinal ganglion cells (Hoffman et al., 1983; McQuarrie, Brady and Lasek, 1989). 
Furthermore, enhanced regeneration after a conditioning lesion in the PNS or axon growth of 
RGCs into a peripheral graft both resulted in enhanced axon transport of cytoskeletal elements 
such as microtubules and neurofilaments (McQuarrie and Grafstein, 1982; Oblinger and Lasek, 
1988; McKerracher, Vidal-Sanz and Aguayo, 1990; McQuarrie and Jacob, 1991). Recently, the 
axon transport of other regeneration-associated molecules such as 14-3-3 proteins and the 
RhoA inhibitor – RhoGDI, as well as membranous structures such as lysosomes, synaptophysin 
and APP vesicles was also found to be upregulated in the central branch of DRG neurons upon 
a peripheral branch conditioning lesion (Mar et al., 2014). This study suggests that global axon 




In summary, the experiments described above point towards a global decline in the 
axonal transport with maturation, and to an increase in trafficking of growth-associated 
molecules and cellular components during enhanced regeneration in immature and adult PNS 
neurons. Some of the most pronounced changes in the distribution and the axon transport of 
growth and regeneration-associated proteins, organelles and mRNAs in adult CNS neurons are 
described below. These changes could be in the epicentre of the regenerative failure observed 
in mature neurons and restoring axon transport of these components could prove a valuable 
tool to aid targeted axon regeneration.  





The distribution of surface receptors along the axon and their insertion into the growth 
cone membrane triggers a cascade of molecular and cellular events which result in the 
cytoskeletal re-arrangement and the improved axon transport that are necessary for 
enhancing axon regeneration. Integrins are large family of cell surface receptors, which are 
essential for neuronal survival, growth cone formation and axon elongation in the developing 
CNS and in the PNS after injury (Nieuwenhuis et al., 2018). In PNS neurons, integrins are found 
abundant in axons, dendrites and growth cones and they are transported in recycling 
endosomes to a similar extent in the retrograde and in the anterograde direction along axons 
(Eva et al., 2010, 2012). Overexpression of alpha9 integrin showed increased neurite 
outgrowth in sensory DRG neurons in vitro and in vivo and had a modest effect on axon 
regeneration and functional outcome on sensory axons after rhizotomy and spinal cord injury 
(Andrews et al., 2009). Interestingly, AAV-mediated expression of activated α9-integrin in the 
dorsal root ganglion promoted long-range axon regeneration of sensory neurons into the non-
permissive environment of the spinal cord as well as functional recovery after a dorsal root 
crush (Cheah et al., 2016). This effect was likely observed as anterograde transport of integrins 
into PNS axons is possible, but this strategy would likely fail in descending CNS axons because 




In contrast to the PNS, integrins become excluded from CNS axons both in vitro and in 
vivo as neurons mature resulting in decreased axonal regeneration (Andrews et al., 2009, 
2016; Franssen et al., 2015). In CNS axons, there is a developmental change in the transport 
of integrins such that retrograde trafficking increases in cortical neurons in vitro as observed 
by live cell imaging of integrins at 3 DIV (35%) and 10 DIV (57%) (Franssen et al., 2015). This 
change in the direction of axonal transport coincides with the exclusion of integrins from the 
mature axon and with decreased regenerative ability (Franssen et al., 2015; Koseki et al., 
2017). Allowing more integrins to enter the axon by either interfering with the AIS or changing 
the direction of integrin transport from predominantly retrograde to anterograde resulted in 
increased neurite outgrowth and improved regenerative ability in primary cortical neurons in 
vitro (Franssen et al., 2015; Eva et al., 2017; Koseki et al., 2017). It is yet to be tested whether 
increasing integrin amount in CNS axons in vivo can promote neurite outgrowth and axon 
regeneration similar to previous studies in the PNS (Cheah et al., 2016).   
 
3.3.1.2 Rab11 endosomes 
 
The absence of integrins from mature CNS axons is accompanied by absence of their 
carriers – Rab11-positive endosomes too. Previous reports show that Rab11 vesicles are 
excluded selectively from axons but not dendrites both in vitro (Franssen et al., 2015; Koseki 
et al., 2017) and in vivo (Sheehan et al., 1996). In another report, the failure of regeneration 
in mature CNS neurons coincided with the time point of exclusion of Rab11-positive vesicles 
from axons (Koseki et al., 2017). Similar to integrin transport, Rab11-positive vesicles are also 
trafficked predominantly retrogradely in mature axons – a phenomenon localised to the axon 
but not dendrites where bidirectional movement was observed (Koseki et al., 2017). Restoring 
Rab11 to axons by overexpressing it in mature cortical neurons in vitro resulted in improved 
regeneration which was accompanied in with an increase in the amount of axonal integrins 
(Koseki et al., 2017). Interestingly, this phenomenon was also observed in human ESC-derived 
dopaminergic neurons. Rab11-tagged endosomes are known to transport a variety of growth-
promoting receptors as discussed above which are important during the developmental stage 
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of neuronal maturation. Their absence of the mature axon could instead be reflecting a change 
in the requirements for recycling within the axon.  
 
3.3.1.3 TrkB and IGFR1  
 
The availability of growth factors and growth factor receptors after injury is also an 
essential requirement for successful regeneration. Growth receptor activation at the growth 
cone is associated with enabling an array of downstream intracellular pathways involved in 
growth and survival, but also with sensing the environment and sending retrograde signals to 
the cell body to alter gene expression, transport and cell function (Bhattacharyya et al., 1997; 
Cosker, Courchesne and Segal, 2008). Two growth receptors, in particular, are well-studied in 
this regard - tropomyosin receptor kinase B (TrkB) and insulin-growth factor receptor 1 
(IGFR1) which are activated by two growth factors – brain-derived neurotrophic factor (BDNF) 
and insulin growth factor (IGF), respectively (Lu and Tuszynski, 2008; Hollis et al., 2009a; Hollis 
et al., 2009b; Duan et al., 2015; Liu et al., 2017).   
 
Both IGFR1 and TrkB receptors play an important role in developmental axon growth and 
survival. IGFR1 activation acting through the PI3K pathway has recently been implicated in the 
axon specification and initial growth in hippocampal neurons (Sosa et al., 2006; Dupraz et al., 
2009). This effect was preceded by IGFR1 accumulation in the newly forming axonal process 
by means of selective transport – a critical step for axon outgrowth. Furthermore, IGFR1 
signalling is required in the initial axonal outgrowth of retinal ganglion cells in vitro (Dupraz et 
al., 2013) and of CST neurons in vivo (Özdinler and Macklis, 2006). Similarly, neuron-specific 
mouse knockout of TrkB displayed reduced survival and attenuated axon growth both in vitro 
and in vivo (Gates, Tai and Macklis, 2000).  
 
Intracellularly, the IGFR1 and TrkB undergo dynamic recycling and were both shown to co-
localise with Rab11-positive recycling endosomes (Romanelli et al., 2007; Ascano et al., 2009; 
Huang et al., 2013; Lazo et al., 2013). These observations suggest that similarly to integrins 
and Rab11, IGFR1 and TrkB might be present at very low levels in the mature axon which could 
in addition contribute to the regenerative failure. Indeed, IGFR1 and TrkB were shown to be 
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excluded from the mature axon in CST neurons of the spinal cord (Hollis et al., 2009a; Hollis 
et al., 2009b). TrkB was also excluded from axons of rubrospinal neurons (Kwon et al., 2004).  
 
Given their effects on axon growth, overexpression of IGF1 or TrkB in mature neurons was 
expected to improve axon growth after injury. Applying IGFR1, however, to the injured CST 
only improved neuronal survival but did not aid axon regeneration (Hollis et al., 2009a). When 
IGFR1 activation is combined with osteopontin (a potent growth activator which interacts with 
integrins), enhanced sprouting as well as partial functional recovery in two different models 
of CST injury was observed (Liu et al., 2017). This effect was further strengthened by electrical 
stimulation highlighting the therapeutic relevance of proper receptor functioning and 
distribution in the axon as well as of rehabilitation through electrical stimulation as key for 
improving function after injury. Knockout of the TrkB receptor significantly reduced the 
amount of regeneration whereas the use of TrkB agonists promoted structural and functional 
repair of peripheral nerves after injury (English et al., 2013). Strikingly, CST neurons show 
abundant TrkB receptor distribution in their soma and dendrites. CST axons, however, had 
very little TrkB present which correlated closely with their inability to regenerate after injury 
(Lu, Blesch and Tuszynski, 2001). In contrast, motor neurons contained axonal TrkB and were, 
therefore, able to regenerate past the lesion. These findings point towards a key role for  
axonal TrkB in stimulating axon growth after injury (Lu, Blesch and Tuszynski, 2001). It is no 
surprise then that when overexpressed TrkB improved the regeneration capacity 
of corticospinal neurons after a CST lesion (Hollis et al., 2009b). Importantly, abundance of 
BDNF at the growth cone stimulated enhanced anterograde transport of the TrkB receptor 
suggesting that signalling at the distal axon can enhance growth-promoting mechanisms by a 
feedforward mechanism (Cheng et al., 2011). 
 
In summary, essential growth-associated receptors (integrins, IGFR1 and TrkB) as well as 
their trafficking machinery (Rab11), seem to be evolutionary removed from the fully-grown 
mature axon and to adopt a more somatodendritic distribution. Their absence from 
developed axons could contribute to the regenerative failure after injury and their transport 




3.3.2 Developmental decline in the axon transport of organelles 
The axon transport of organelles is another cellular process which also varies 
noticeably with maturation and that could further contribute to reduced regenerative ability 
in mature axons after injury. 
3.3.2.1 Mitochondria 
The dynamics and direction of mitochondrial axonal transport as well as their 
morphology change dramatically with CNS maturation. Early on in development, 
mitochondria adopt shortened morphology to aid their highly mobile nature and bidirectional 
movement along the axon (Chang and Reynolds, 2006). While functionally similar, in the 
mature, synaptically active neuron, mitochondria acquire an elongated form and their axonal 
movement slows down (Chang and Reynolds, 2006). This study, however, together with many 
others measured the bulk mitochondrial transport down the axon. Only recently with the 
advance of imaging technology, the specifics of individual mitochondrion axonal movement 
could be studied. Tracking individual mitochondrial particles, Lewis and colleagues observed 
that in immature cortical neurons (3-7 DIV) mitochondria are very mobile whereas in more 
mature neurons (10+ DIV), up to 95% of all axonal mitochondria become stationary by 28 DIV 
(Lewis et al., 2016). This change in mitochondrial dynamics coincides with their localisation to 
the pre-synapse and with reduced regenerative ability. The authors also examined the 
transport of mitochondria in anaesthetised or awake, behaving animals using two-photon 
imaging. More than 90% of mitochondria in distal axons of cortical neurons were shown to be 
of stationary nature (Lewis et al., 2016). Furthermore, a recent study identified one reason 
why mitochondria are less mobile in mature neurons - they become docked to the axon by a 
protein called syntaphilin (Kang et al., 2008). Interestingly, syntaphilin knockout mice showed 
increased mitochondrial dynamics in the distal axon which resulted in improved axon 
regeneration after a sciatic nerve crush (Zhou et al., 2016). Enhancing mitochondrial mobility 
by overexpression of Armcx1 – a mitochondrial-related protein involved in axon regeneration, 
again resulted in improved axon growth in vitro and in enhanced axon regeneration in vivo 
after optic nerve crush (Cartoni et al., 2016). Taking into account that the unmet energy 
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demands after axonal injury are speculatively one reason why mature axons do not 
regenerate well, improving anterograde axonal transport of functional mitochondria could be 
key for regeneration.  
3.3.2.2 Proteasome  
The ubiquitin-proteasome system (UPS) is essential for the clearance of damaged and 
misfolded proteins. Similar to mitochondria, the axonal transport of proteasomes seems to be 
affected by the process of neuronal maturation. Proteasome activity drastically declines 
during normal ageing in the brain (Keller, Huang and Markesbery, 2000). Furthermore, 
impairments in UPS have been shown to result in protein aggregation and deficits in axonal 
transport (Otero et al., 2018). In hippocampal neurons, at very early stages of development 
(1 DIV) there is a bidirectional movement of proteasomes along neurites (Hsu et al., 2015). 
After axon specification at 3 DIV, however, there is an enhanced retrograde movement of 
proteasomes in the axon. Anterograde transport, on the other hand, remains unaffected 
suggesting that retrograde transport increases with axon length and development (Hsu et al., 
2015). In a different study, 10 DIV hippocampal neurons were shown to exhibit fast axonal 
transport when associated with membranous vesicles and certain motor proteins (Otero et 
al., 2014). The majority of proteasomal transport, however, was found to be random and 
diffuse which only small proportion being long-range active transport (Otero et al., 2014).  
 
 In regenerative PNS neurons, ligation of the sciatic nerve causes proteasome 
accumulation both at the proximal and distal site of the ligation, with the proximal being 
predominant (Otero et al., 2014). This study points out that anterograde axonal transport of 
proteasomes plays a crucial role in the regenerative response mounted by PNS neurons. 
Importantly, a conditioning lesion further enhanced the amount of proteasomal machinery 
both in vivo and in vitro suggesting that improved regeneration is associated the delivery of 
more proteasomes into the axons of regenerating neurons (Verma et al., 2005). This form of 
active anterograde axonal transport of proteasomes upon injury and even during 
development was not observed in adult CNS neurons (Verma et al., 2005). Furthermore, 
blockade of UPS by lactacystin or N-acetyl-Nor-Leu-Leu-Al resulted in reduced ability of 
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injured axons to form a growth cone and therefore, impaired regeneration (Verma et al., 
2005).  
 
 The most current view on the role of the proteasome after injury is that the oxidative 
stress caused by the injury damages axonal proteasomes resulting in the accumulation 
of ubiquitinated proteins which in turn is deleterious to axon regeneration (Gong et al., 2016). 
Taking into account that the dynamic balance between local protein synthesis 
and protein degradation is essential for axon regeneration after injury (Gumy, Tan and 
Fawcett, 2010), axonal redistribution of proteasomes with development and upon injury 
might play a crucial role in defining the regenerative response of an adult neuron.  
 
3.3.2.3 Autophagosome  
Autophagy plays a crucial role in the recycling of dysfunctional organelles and 
aggregated proteins (Kulkarni, Chen and Maday, 2018). In neurons, the majority of autophagy 
takes place in the soma. Therefore, retrograde axonal transport of autophagosomes (double-
membranous structures enwrapping cellular components targeted for degradation) from the 
distal axon to the cell body is essential for neuronal homeostasis in both PNS and CNS axons 
(Hollenbeck, 1993; Maday, Wallace and Holzbaur, 2012; Maday and Holzbaur, 2014). Defective 
transport of autophagosomes has previously been associated with a number of 
neurodegenerative diseases such as Alzheimer’s disease, Huntington’s disease and 
amyotrophic lateral sclerosis (ALS) (Fu, Nirschl and Holzbaur, 2014). Fusion of 
autophagosomes with late endosomes in the distal axons triggers the recruitment of dynein 
motors which in turn transport the whole complex retrogradely (Cai et al., 2010; Cheng et al., 
2015). During this trafficking event, autophagosomes fuse with lysosomes to form auto-
lysosomes. The lysosomal acidic environment ensures that the cellular contents are degraded 
and recycled for further use. In order to ensure continuous retrograde transport 
of autophagosomes, a scaffold protein - JIP1,  interacts with the autophagosome adaptor – 
LC3 to simultaneously activate dyneins and dephosphorylate kinesins (Fu, Nirschl and 
Holzbaur, 2014). This study reveals for the first time some of the tightly regulated mechanism 
behind distributing autophagosomes to the correct cellular compartments in 
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neurons. Interestingly, autophagosomal axon transport dynamics are not altered in a 
neurodegenerative model of protein aggregation in DRG neurons which possibly suggests that 
post-mitotic mature neurons are less efficient at upregulating this process after insult (Maday, 
Wallace and Holzbaur, 2012). 
 
In the contest of injury, some autophagy markers were previously shown to 
be upregulated in vivo after peripheral and central nerve injury (Hou et al., 2013; Liu et al., 
2015; Bisicchia et al., 2017). In a recent study, activation of autophagy by the addition of a 
specific autophagy-inducing peptide – Tat-Bec or two other autophagy-inducing agents 
– rapamycin or spermidine in 1 DIV cortical neurons, enhanced axon growth and 
counteracted the negative influence of myelin when neurons were grown on a myelin 
substrate (He et al.,2016). This increase in neurite outgrowth was accompanied by increased 
microtubule stabilisation due to the degradation of microtubule-severing protein SCG10 as a 
result of increased autophagy. Microtubule stabilisation had previously been reported to be 
involved in axon regeneration as low doses of microtubule-stabilising drugs such as taxol, 
epothilone B or epothilone D result not only in attenuated fibrosis after injury, but also in 
improved axon growth and regeneration as well as in functional recovery (Erturk et al., 2007; 
Hellal et al., 2011; Ruschel et al., 2015; Ruschel and Bradke, 2018). Furthermore, 
administration of the Tat-Bec peptide to a mouse model of spinal cord injury reduced the 
retraction of corticospinal neurons after injury and promoted the regeneration of another 
type of descending axons (serotonergic neurons) which resulted in mild functional recovery 
(He et al., 2016). The majority of autophagosomes in this system were found in the axon, so 
the inability of this treatment to promote regeneration of CST neurons after injury, might be 
a result of differential axonal transport, distribution and clearance.   
 
Controversial to these findings, in a different study suppression of autophagy (by 
silencing ATG7 – autophagy-related gene 7) resulted in an increased neurite outgrowth in 
primary cortical neurons (Ban et al., 2013). These discrepancies could be due to the duration 
and the timing of autophagy induction as well as differential targeting and transport of auto-
phagosomes in CNS and PNS axons. For example, autophagy biogenesis was 4 times slower in 
the distal axon of hippocampal neurons compared to DRG neurons  – a possible contributing 
factor for the differential regenerative ability of these two types of neurons (Maday and 
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Holzbaur, 2016). Interestingly, neuronal autophagy was found to be constitutively active unlike 
in other cell types where it is induced by starvation suggesting that it plays a role in balancing 
the protein synthesis and degradation (Maday and Holzbaur, 2016). 
Autophagosomes have also been reported to contain BDNF/TrkB signalling elements which 
are transported back from the distal axon to the cell soma in order to enhance survival and 
prevent neurodegeneration as well as to promote neuronal complexity in hippocampal 
neurons (Kononenko et al., 2017). 
 
Autophagosomes were also thought to interact with other membranous structures 
such as recycling endosomes and lysosomes near the growth cone (Farías et al., 2017). Taking 
into account that some lysosomes were found to lack an acidic environment near the growth 
cone (Farías et al., 2017). These findings suggest that autophagosomes might not necessarily 
only have a degradative function in the axon but might also be involved in the recycling of 
materials and membranes at the growth cone – an essential process during the remodelling 
of the growth cone and initiation of axon regeneration. Further studies are needed to clarify 
whether there is a developmental change in the transport and distribution of 
autophagosomes and their derivatives along axons with differential regenerative capacity.  
 
 
3.3.3 Developmental decline in the axon transport of mRNAs 
Over past several decades local axonal translation has been implicated as key for 
axonal growth and regeneration (Gumy, Tan and Fawcett, 2010). In order for neurons to 
produce a timely response to injury or any external cues, their axons need to have 
a continuous supply of mRNAs which can then be translated in a swift manner to produce the 
proteins needed for an appropriate response (Twiss et al., 2000; Zheng et al., 2001; Holt and 
Schuman, 2013; Terenzio et al., 2018). Furthermore, additional evidence such as the quick 
formation of a growth cone in some regenerative axons in vivo (quicker than protein synthesis 
in the cell body and transport to the site of injury) (Pan et al., 2003), the formation of growth 
cones in axons which have been disconnected from the cell body (Shaw and Bray, 1977; Verma 
et al., 2005) and the presence of various translational machinery and mRNAs in the axon 
(Bleher and Martin, 2001; Jung, Yoon and Holt, 2012), point towards an essential role of this 
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process in the initiation of axon regeneration. Indeed, blockade of protein synthesis with 
inhibitors (anisomycin or cycloheximide) resulted in reduced ability of normally regenerative 
neurons such as embryonic sensory neurons to re-grow their axons but had little effect on 
weak regenerators such as adult RGC neurons after in vitro injury (Verma et al., 2005). Many 
mRNAs have been detected in axons so far and their importance in growth cone formation 
and turning as well as in axon elongation and regeneration has been elucidated. For 
example, the axonal abundance and translation of beta-actin mRNA is required for successful 
axon regeneration of DRG neurons after in vitro axotomy as suppression of this mRNA 
by RNAi resulted in failure of growth cone regeneration (Vogelaar et al., 2009). Other 
mRNAs such as importins, vimentin, STAT3A and KIF3C mRNAs are also essential for successful 
axon regeneration (Gumy, Tan and Fawcett, 2010; Gumy et al., 2013). 
mRNAs are produced in the nucleus where they bind to RNA-binding proteins (RBPs). 
RBPs are then packaged in glanular-like particles to be transported along the microtubule 
tracts to distant locations in the axon (Xing and Bassell, 2013). A recent study revealed some 
of the main molecular players in this process in retinal ganglion cells – mRNA-containing 
particles associated with Rab7-positive late endosomes which transported them and docked 
them to mitochondria (Cioni et al., 2019).  Late endosomes then acted like hotspots for de 
novo protein synthesis of mitochondrial proteins. This process was highly reliant on targeted 
transport along the axon and when Rab7 was mutated, protein synthesis in the axon was 
impaired resulting in mitochondrial defects and reduced cell viability (Cioni et al., 2019). The 
study further supports the hypothesis that constitutive, targeted transport of mRNAs for local 
axonal protein synthesis is essential for survival, and possibly for regeneration.  
 
Several studies recently provided evidence that the transport, distribution and 
function of mRNAs along the axons might differ in immature vs. mature neurons. Embryonic 
and adult DRG neurons which importantly have different regenerative capabilities, display the 
presence of different repertoires of mRNAs in their axons. One mRNA in particular – tubulin-
beta3 (Tubb3) – encoding an essential-for-regeneration cytoskeletal protein was shown to be 
only present and locally translated in axons of immature DRG neurons (Gumy et al., 2011). 
Tubb3’s abundance and function in mature DRG neurons is entirely dependent on 
anterograde transport of the protein to growing axons (Gumy et al., 2011). Furthermore, 
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higher abundance of ribosomal components and translational machinery before and after 
injury was observed in DRG neurons compared to RGCs both in vivo and in vitro suggesting 
that regenerative DRGs have increased capacity for local protein synthesis (Verma et al., 
2005). Anterograde transport of specific mRNA transcripts encoding cytoskeletal proteins was 
shown to be elevated after NGF or BDNF treatment in DRG neurons suggesting that axonal 
transport can be altered by signalling from external factors (Willis et al., 2007). Another 
example is the enhanced anterograde transport of an ion channel involved in pain sensing 
(Trpv1) mRNA upon inflammatory response in the periphery (Tohda et al., 
2001).  Interestingly, some mRNAs such as Creb mRNAs are specifically enriched in a particular 
type of neurons – sensory peripheral neurons but not in central neurons (Cox et al., 2008).   
 
Apart from very a specific spatial distribution throughout the cell, mRNAs also undergo 
temporal control. In an attempt to unravel the differences in mRNA transcripts over 
time, Zivraj and colleagues performed laser capture microdissection of growth cones 
in Xenopus either during their immature, growing state or in their synaptically-mature state 
(Zivraj et al., 2010). They found that mRNA transcripts could be specifically target to the soma, 
the axon or the growth cone itself suggesting that there are active targeting mechanisms 
taking place. Moreover, they showed that some mRNAs such as EphB4 (ephrin B4 receptor) 
that are enriched at the growth cone in mature neurons, are actually abundant in both 
younger and older somas suggesting that there is a developmental regulation of these 
transcripts’ transport down the axon (Zivraj et al., 2010). Recently, mRNAs from mature and 
regenerating hippocampal neuron axons were isolated and 866 mRNAs were found to 
differentially distributed upon injury (Taylor et al., 2009). This study also identified major 
differences in the mRNA transcripts present in regenerating axons after injury in the PNS and 
in the CNS  (Taylor et al., 2009). A key question remains: Does injury reactivate a 
developmental growth programme in the neuron instructed by changes in gene expression or 
does it simply cause changes in mRNAs axonal transport? In summary, the transport of mRNAs 
down the axon is a dynamic process with changes with development and after injury – tight 




3.4 The virtuous cycle of axon growth  
Over the past few decades, it has become clear that intrinsic mechanisms play an 
essential role in the regenerative failure observed in mature CNS neurons. As described above, 
a developmental change in CNS neurons exists whereby there is a reduced abundance and 
transport of growth-promoting molecules, organelles and mRNAs as well underactive 
signalling pathways accompanied by altered gene expression as a result of epigenetic 
modifications.  We recently described the concept of the “virtuous cycle of axon growth” in a  
review paper elaborating on the possible mechanisms behind low regenerative CNS ability 
(Petrova and Eva, 2018). We speculated that at all times in neurons, there exists a cycle 
whereby changes in gene expression could activate growth-promoting pathways but also 
improve axonal transport of regeneration-associated cargo. Once this cargo reaches the 
growth cone, its interaction with the extracellular environment is enabled which in turn, 
results in retrograde signalling to the soma. These signals can then lead to a further 
enhancement of the growth-promoting program by amplification of transcription, translation 
and axon transport – a cycle which promotes virtuous axon growth (Fig. 1.3). We also 
proposed that this cycle of events could be targeted at any one point in order to enhance axon 
growth and regeneration after injury.  
In this thesis, “the virtuous cycle of axon growth” is targeted at the level of anterograde 
axon transport of growth-promoting cargo to the tip of axons by activating the transport 
machinery involved in the process – in this case the adaptor protein protrudin (discussed 
below). A second strategy is to trigger gene expression changes in the nucleus with the use of 
transcription factors which could lead to enhanced regenerative program activation 
(discussed in detail in Chapter 6). Both strategies show promising results for enhancing axon 





Figure 1.3 The “virtuous cycle of axon growth”. A schematic diagram illustrating the cycle of events within a 
neuron which can enable growth and regeneration. For example, increasing the transport of growth-associated 
receptors in recycling endosomes facilitates their insertion in the growth cone, ligand binding and intracellular 
signalling cascades. Activated growth cone receptors triggers retrograde signalling in signalling endosomes to 
the cell body. A response is then evoked in the cell body resulting in gene expression changes and protein 
translation favouring a growth-promoting program. Retrograde signals from growth factor receptors can also 









4. Protrudin – the linker 
 
4.1 The protrudin protein and its domains 
 
Protrudin, encoded by the ZFYVE27 gene is a member of the ZFYVE family of zinc-
binding proteins. Protrudin is a peripheral membrane protein which contains several binding 
domains. The protein contains a Rab11-binding domain (RBD), 2 hydrophobic domains (TM-1 
and TM-2), FFAT motif important for ER localisation, a coiled-coiled domain (CC) and a FYVE 
domain (a phosphoinositide-binding domain) (Fig. 1.4A). The protrudin protein is membrane-
bound and could be found in endosomes, the endoplasmic reticulum (ER) or the plasma 
membrane. It has also been shown that the protrudin protein oligomerises in order to perform 
some of its main functions such as to aid neurite outgrowth (Pantakani et al., 2011). 
Figure 1.4 Figure summarising key features of the protrudin protein.  A. Schematic diagram of the human 
protrudin protein domains. B. Schematic diagram showing the molecular pathway through which protrudin is 
phosphorylated in PC12 cells upon the addition of nerve-growth factor. Phosphorylation through the MAPK/ERK 
pathway leads to enhanced interaction of protrudin with Rab11-GDP specifically. C. Protrudin acts as a linker 
between motor proteins (kinesin 1) and Rab11-GDP-tagged endosomes carrying growth-associated molecules 
such as integrins and other growth receptors anterogradely towards the tip of neurites (modified from Welz, 
Wellbourne-Wood and Kerkhoff, 2014). 
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4.2 Protrudin’s role in endoplasmic reticulum shaping and morphology  
 
 
Protrudin is a membrane-bound molecule and possesses three transmembrane, 
hydrophobic domains (TM-1, TM-2 and TM-3) which allow its interaction with the lipid layer 
in cellular membranes. Two of protrudin’s transmembrane domains are located close together 
(amino acids 67-87 and 89-109 in the human gene) and the third one (amino acids 180-214 
with a Pro200 hairpin residue) suggesting that the protein forms hairpin structures in the 
membrane (Chang, Lee and Blackstone, 2013). Protrudin is a resident ER protein (Gil et al., 
2012) and was also found to localise with other tubular ER markers such as calnexin, REEP5 
and atlastin proteins but not with sheet ER markers such as CLIMP-63 (Chang, Lee and 
Blackstone, 2013). Interestingly, deletion of all three transmembrane domains (∆TM1-3) but 
not TM1 and TM2 or TM3 on its own results in translocation of the protrudin protein from the 
ER structures to the cytoplasm. Furthermore, depletion of protrudin by siRNA results in 
altered ER morphology with predominant sheet-like rather than tubular appearance – this 
phenotype was rescued by expressing siRNA-resistant wild-type protrudin but not a protrudin 
construct lacking the three transmembrane regions (Chang, Lee and Blackstone, 2013) once 
again emphasising the role of protrudin in ER morphology and shaping.  
 
Another domain important for the interaction of protrudin with ER protein - VAP-A is 
the FFAT motif which represents two phenylalanine amino acids in an acidic tract. The FFAT 
domain (amino acid sequence of EFFDAXE, where X is any amino acid) is originally thought to 
act as an ER-targeting signal and is also found in other proteins which play a role in the transfer 
of lipids between the ER and other organelles such as the Golgi apparatus (Kawano et al., 
2006). The interaction between protrudin and VAP-A was initially identified in a proteomics 
study (Saita et al., 2009) and was shown to be facilitated specifically by protrudin’s FFAT 
domain as when the domain is fully deleted or mutated (D294A) at a residue important for 








4.3 Protrudin binding to phospholipids   
 
As a member of the ZFYVE-family of membrane-binding proteins, protrudin contains a 
FYVE (Fab 1, YOTB, Vac 1, and EEA1) domain. However, unlike other proteins which contain a 
typical FYVE domain specifically binding phosphatidylinositol 3-phosphates (PtdIns(3)P), 
protrudin’s FYVE domain preferentially binds phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2), phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2), and 
phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) (Gil et al., 2012). Also contrary to 
typical FYVE domains which are localised to endosomes, protrudin’s FYVE domain was found 
to be localised at the plasma membrane. Two cationic residues were shown to be particularly 
important for protrudin’s specificity to vesicles containing the lipids listed above – lysine 367 
and arginine 369 (Gil et al., 2012). When mutated to aspartic acid, they result in the protrudin 
protein being removed from the plasma membrane. In addition, 3-phosphorylated 
phosphatidylinositol phosphates (PtdIns(3,4)P2, PtdIns(3,4,5)P3) were specifically shown to be 
involved in protrudin’s recruitment to the plasma membrane, whereas PtdIns(4,5)P2 played a 
role in its localisation to endosomes (Gil et al., 2012). Interestingly, full deletion of the FYVE 
domain resulted in protrudin’s localisation to the ER suggesting that this process is driven by 
protein interaction rather than lipid interaction.  
 
In summary, the presence of all of the above domains in the protrudin protein suggests 
that protrudin’s physiological function most likely revolves around the process of membrane 
trafficking and recycling.   
 
 
4.4 Protrudin and spastin in disease 
 
A protrudin mutation (p.G191V) was recently identified in a single German family with 
a high incidence of autosomal dominant hereditary spastic paraplegia (HSP), a condition 
characterised by a progressive distal axonopathy (Mannan et al., 2006). Interestingly, another 
protein - spastin (a microtubule-severing protein) which is also a binding partner of protrudin 
is the most commonly mutated protein in HSP (Martignoni, Riano and Rugarli, 2008) . The 
mutation of protrudin identified in HSP (p.G191V) is located near the third transmembrane 
domain and was functionally studied by creating the same mutant protrudin in the form of a 
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DNA construct and introducing it to HeLa cells. In that case, the missense mutation caused 
abnormal interaction with spastin and protrudin’s localisation to abnormal tubular structures 
around the cell (Mannan et al., 2006). The overexpression of the same construct in PC12 cells, 
did not however, compromise protrudin’s effects on neurite outgrowth upon NGF treatment 
(Zhang et al., 2012). In addition, injection of mutant protrudin into zebrafish embryos resulted 
in altered distribution and some defects in the yolk sac expansion but there was no effect on 
developmental axon growth in this model or in PC12 cells (Zhang et al., 2012). Mutant 
protrudin was also not found to alter protrudin’s preferential binding to Rab11-GDP and its 
ability to induce neurite outgrowth when overexpressed in HeLa cells. These findings 
suggested that the mutation does not result in a loss of function of the protein (Martignoni, 
Riano and Rugarli, 2008). The same mutation was also previously identified as a single 
nucleotide polymorphism present in the general population which is not pathogenic 
(Martignoni, Riano and Rugarli, 2008). Therefore, protrudin’s involvement in human HSP is yet 
to be elucidated.  
 
In a recent paper, a novel role for protrudin as a central network protein involved in 
ALS disease pathogenesis was identified (Dervishi et al., 2018). In this study, ingenuity 
pathway analysis was performed on genes whose mutations have previously been identified 
as causative or disease-modifying in ALS and their known binding partners in mammalian CNS 
neurons. 1105 proteins were identified from this screen which allowed for the discovery of 
upstream regulators.  Protrudin was identified as a key upstream regulation of this network 
and was found to be aberrantly upregulated in the soma of Betz cells from ALS patient brains 
(Dervishi et al., 2018). In these cells, protrudin accumulated in the cytoplasm and was no 
longer associated with the ER, which the authors speculate could contribute to ER dysfunction 
and ER stress which is one of the main causes for neuronal cell death in ALS motor neurons 
(Dervishi et al., 2018). In summary, this paper suggests that protrudin might be a core protein 
linking dysfunctional ER dynamics and protein trafficking and could be a potential target for 







4.5 Protrudin’s role in neurite outgrowth and directional trafficking 
 
Endogenous protrudin readily interact with endogenous Rab11 in PC12 cells and the 
two proteins colocalise 6 hours post nerve growth factor (NGF) treatment in the tip of growing 
neurites (Shirane and Nakayama, 2006). Although protrudin contains a Rab11-binding 
domain, this domain is not conserved for binding to Rab11-GTP (guanosine triphosphate). On 
the contrary, it contains amino acid sequences very similar to GDI-α and GDI-ß, both of which 
readily interact with Rab11-GDP (guanosine diphosphate).  Immunoprecipitation experiments 
using mutant forms of Rab11 such as Q70L (GTP-bound form due to interrupted GTPase 
activity) and S25N (GTP-binding deficient) revealed that although protrudin binds to wild-type 
Rab11, it preferentially binds to Rab11-GDP demonstrated by enhance interaction with S25N 
mutant (Shirane and Nakayama, 2006). Furthermore, this interaction was potentiated by the 
addition of NGF or by constitutively activating the mitogen-activated protein kinase (MAPK) 
pathway, suggesting the phosphorylation of protrudin is essential for its interaction with 
Rab11-GDP (Fig. 1.4B, 1.4C). Indeed, when putative MAPK phosphorylation sites on the 
protrudin molecule were mutated so they could not be phosphorylated the interaction 
between Rab11-GDP and protrudin was markedly reduced (Shirane and Nakayama, 2006). 
These findings suggest a role of protrudin in directional membrane trafficking in growing 
processes.  
 
One of protrudin’s functions in the cell is to aid neurite outgrowth. When FLAG-
protrudin is overexpressed in HeLa cells, 5-30% of cells form growing protrusions highly 
resembling ruffling lamellipodia (Shirane and Nakayama, 2006)s.  Furthermore, when 
exogenous protrudin is applied to rat hippocampal neurons at 1 DIV, the neurons extend 
longer neurites 48 hours post transfection. As mentioned above, when NGF is applied to PC12 
cells, it results in phosphorylation of protrudin, which in turn leads to increased interaction 
with Rab11-GDP and protrudin’s redistribution from the somatodendritic compartment to the 
tip of growing neurites, carrying important cargos such as NgCaM (a cell adhesion molecule) 
with it (Fig. 1.4C) (Shirane and Nakayama, 2006). Downregulation of protrudin expression by 
RNAi in either cortical neuronal cultures or PC12 cells prevents the extension of long neurites 
(Shirane and Nakayama, 2006). This suppression could be rescued by administering the wild-
type form of the protein but not a mutant form where the Rab11-binding domain is deleted 
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suggesting that the interaction between protrudin and Rab11-GDP is essential for neurite 
extension. Interestingly, FKBP38 (a member of the immunophilin protein family) acts as an 
inhibitor of protrudin phosphorylation and hyperphosphorylation of protrudin in FKBP38-/- 
mice resulted in abnormal extension of nerve fibres (Shirane et al., 2008). 
 
Transport mechanisms of cargo are tightly regulated in order to ensure proper 
functioning of the cells and successful neurite outgrowth. In the above experiments, the 
protrudin-Rab11 complex was shown to move anterogradely towards the tip of growing 
neurites suggesting that protrudin might be interacting with proteins from the kinesin family. 
Indeed, recent proteomics studies have identified KIF5A, a member of the Kinesin 1 family of 
motor proteins which is also involved in anterograde transport of membrane-associated 
vesicles, as another binding partner of protrudin (Matsuzaki et al., 2011). Rab11, KIF5 and 
protrudin have all been shown to colocalise at the tip of growing processes in HeLa cells. 
Matsuzaki et al., 2011 showed that protrudin actually serves as an adaptor protein which links 
KIF5A to Rab11-bound recycling endosomes and that proper functioning of the KIF5-
Protrudin-Rab11-GDP complex results in displacement of cargo molecules to the tip of 
growing neurites. Suppressing KIF5 in HeLa cells using shRNA approach, inhibit the protrusion-
forming functions of protrudin suggesting the KIF5 is necessary for protrudin’s function in 
neurite outgrowth (Matsuzaki et al., 2011). A mutant form of protrudin that lacks amino acids 
324–344 and does not bind to KIF5A, did not promote the binding of Rab11-GDP to KIF5A and 
resulted in reduced neurite outgrowth. Furthermore, this inhibition results in the 
accumulation of protrudin and Rab11 but also of other proteins involved in the complex such 
as reticulon 3, VAP-A, VAP-B and Surf4 in the soma of cultured hippocampal neurons 
(Matsuzaki et al., 2011). These experiments suggest that protrudin docks Rab11-associated 
vesicles transporting all sorts of molecules along neurites to anterograde motor proteins (in 
this case, KIF5) in order to ensure their transport to the tip of growing process and to aid 
neurite outgrowth.  
Furthermore, protrudin’s effect on neurite outgrowth seems to be facilitated not only 
by directional trafficking but also by several other processes. Some of the domain mutants 
mentioned above have been shown to affect neurite outgrowth. For example, if FFAT mutants 
(either missing the whole domain or the D294A mutant) are overexpressed in HeLa cells, the 
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percentage of cells extending neurites is significantly reduced compared to the overexpressing 
the wild-type (Saita et al., 2009). Similarly, if VAP-A is depleted by shRNA in PC12 cells, 
protrudin-induced neurite outgrowth is suppressed and this also resulted in failure of 
protrudin translocation from the somatodendritic compartment normally seen upon NGF 
addition (Saita et al., 2009). These studies suggest that VAP-A has an effect on protrudins 
localisation and that the VAP-A protrudin interaction is necessary for neurite outgrowth. In 
addition, mutations in the FYVE domain at two critical residues (K367 and R369) or deletion 
of the whole FYVE domain which result in decreased affinity for lipids, prevent the 
enhancement of neurite outgrowth normally seen with wild-type protrudin in primary 
hippocampal neurons (Gil et al., 2012). In another report, however, after a series of rescue 
experiments with different mutants of protrudin, the N-terminus of protrudin was pointed out 
as essential for its neurite outgrowth properties and not the FYVE domain (Zhang et al., 2012). 
This discrepancy leaves the involvement of the FYVE domain in protrudin’s neurite outgrowth 
function still elusive.  
 
Another important interaction of protrudin which is further required for its properties 
on neurite outgrowth is its interaction with the microtubule-severing protein – spastin. Co-
expression of spastin and protrudin had an even more pronounced effect on driving neurite 
outgrowth, than protrudin on its own (Zhang et al., 2012). While protrudin alone or protrudin 
and spastin overexpression rescued neurite outgrowth upon NGF treatment in PC12 cells 
which have been depleted of the two proteins, spastin was unable to do so. These 
experiments suggest that spastin might help promote protrudin-driven neurite outgrowth in 
the cells. 
 
 In summary, the protrudin protein plays an important role in membrane transport and 
trafficking as well as in neurite outgrowth in several cellular models. In this thesis, the 
interaction of protrudin with Rab11-positive endosomes is studied as a novel mechanism to 
enhance regenerative ability of CNS axons by delivering growth molecules to the distal axon. 
Phosphorylated protrudin has been shown to be particularly important for the anterograde 




II.  Aims and Hypothesis 
 
Hypothesis  
Constitutive phosphorylation of protrudin will result in increased association with 
Rab11-GDP which in turn will increase anterograde axon transport. When applied to primary 
cortical neurons, this system will result in more growth-associated cargo being transported to 




1. To investigate protrudin’s localisation in developing neurons and upon injury  
2. To create constitutively activated phosphomimetic forms of protrudin by altering 
amino acids at six putative ERK-phosphorylation sites.  
3. To investigate the effects of constitutively active protrudin on Rab11-mediated 
transport into axons, and whether these can serve to improve axon regeneration after 
injury in primary cortical neurons in vitro and in an in vivo model of optic nerve crush  
4. To investigate the neuroprotective effects of protrudin in a chronic model of glaucoma 
in rats 
5. To investigate the mechanisms of protrudin action on axon regeneration 
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1. Plasmids, antibodies and reagents 
 
1.1 Plasmid constructs 
 Protrudin constructs (in pmCherry-C1 and pEGFP-C1 vectors) were a kind donation 
by Dr Evan Reid, Cambridge Institute for Medical Research. The control GFP plasmid was pHR-
sinUbEM-GFP with GFP under SFFV promoter and Emerald under ubiquitin promoter. The 
control mCherry plasmid was pmCherry-C1 empty plasmid vector. CMV-Rab11-GFP construct 
was kind donation from Dr Jim Norman, Beatson Institute, Cancer Research UK. CMV-integrin-
alpha9-GFP constructs were purchased from Addgene, deposited by Dean Sheppard 
(University of California, San Francisco, CA). Viral vector plasmid backbones (AAV2-sCAG-GFP) 
and CRISPR-backbone plasmid (pAAV-SYN-SaCas9-hU6-sgRNA) were a kind donation by Prof. 
Joost Verhaagen, The Netherlands Institute for Neuroscience. CRISPR sgRNA sequences 
against rat protrudin were designed by Bart Nieuwenhuis, Cambridge Centre for Brain Repair 
(Table 2.1). 4 unique 29-mer shRNA constructs (Table 2.1) against rat protrudin in retroviral 




              Name Sequence 
     Protrudin-1 sgRNA  GATGCAGTCTTCGGATCGGGAC 
Protrudin-2 sgRNA GGTACAGGGCTTGTCTGCAGCG 
Protrudin-3 sgRNA GGGCGGATGAGCCCCAAGCAGG 
TG713727A (shRNA_A) GTGTGCCTCCTGTAATCAGACCTTGAGCA 
TG713727B (shRNA_B) TACCACAGCGTGCGGCAGGAAGACCTGCA 
TG713727C (shRNA_C) TTCAACCTGGTTCTGTCCTACAAGAGGCT 
TG713727D (shRNA_D) CAACATCTTGTTCCTCACTCTGAATGAGG 
 
Table 2.1 A table showing the target shgRNA sequences in CRISPR constructs (Protrudin-1 sgRNA, Protrudin-2 
sgRNA, Protrudin-3 sgRNA and target shRNA sequences for shRNA constructs (TG713727A, TG713727B, 
TG713727C, TG713727D). 
 
 Transcription factor constructs were kindly provided by Prof. Joost Verhaagen, The 
Netherlands Institute for Neuroscience (ATF3, CEBP, Sox11, Egr constructs), Dr Lawrence 
Moon, King’s College London (pCMV-SPORT6-sox4 construct) and Prof. Vance Lemmon and 
Prof. John Bixby, University of Miami (STAT3ACA constructs). REST transcription factor 
construct (pHR’-NRSF-CITE-GFP construct) was obtained from AddGene (plasmid #21310). 




1.2.1 Primary antibodies  
 Rabbit polyclonal anti-ZFYVE27 (ProteinTech, 126801-AP, 1:500), rabbit polyclonal 
anti-tropomyosin-1 (Abcam, ab55915, 1:100); chicken polyclonal anti-68kDa-neurofilament 
(Abcam; ab134460, 1:1000); rabbit polyclonal anti-MAP1A (Abcam, ab89648, 5mg/µL), rabbit 
polyclonal anti-doublecortin (Abcam, ab18723, 5mg/µL); rabbit monoclonal anti-TUBA4A 
(Abcam, ab177479, 1:100); rabbit polyclonal anti-tropomyosin 4 (EMD Millipore, AB5449, 
1:500); rabbit polyclonal anti-REEP5 (ProteinTech, 14643-1-AP, 1:100); chicken polyclonal 
anti-MAP2 (Abcam, ab5392, 1:800); mouse monoclonal pan-neurofascin (NeuroMab, 75/12 
AR-18, 1:100); mouse monoclonal anti-CGRP (Abcam, ab81887, 1:100); rabbit polyclonal anti-
OMgP (Abcam, ab101567, 1:1000); rabbit polyclonal anti-Vangl2 (Merck, ABN373, 1:500); 
mouse monoclonal anti-mCherry (Clontech, 632543, 1:250); rabbit polyclonal anti-ATF3 
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(SantaCruz, Sc-188, 1:500), mouse monoclonal anti-spastin [Sp 6C6] (Abcam, ab77144, 1:500); 
rabbit polyclonal anti-Rab11 (ThermoFisher Scientific, 71-5300, 1:50), rabbit polyclonal anti-
integrin alpha 5 (Chemicon International, AB1928, 1:500), rabbit polyclonal anti-GFP CHIP 
grade (Abcam, ab290, 1:1000), rabbit polyclonal anti-mCherry (Abcam, ab167453, 1:800); 
rabbit polyclonal anti-v5 tag (Bioss, bs-2109R, 1:200); rabbit polyclonal anti-v5-647 
conjugated (Bioss, bs-2109R-A647, 1:200); mouse monoclonal anti-HA tag (BioLegend, 
901501, 1:200), goat polyclonal anti-Brn3a (C-20) (Santa Cruz, sc-31984, 1:200). 
 
1.2.2 Secondary antibodies 
Goat anti-rabbit Alexa®Fluor 488 (Abcam, ab150077, 1:800), donkey anti-rabbit 
Alexa®Fluor 568 (Life Technologies, A10042, 1:800),  goat anti-rabbit Alexa®Fluor 647 (Life 
Technologies, A27040, 1:800), goat anti-mouse 405 (Life Technologies, A31553, 1:200), 
donkey anti-mouse Alexa®Fluor 488 (Life Technologies, A21202, 1:800), goat anti-mouse 
Alexa®Fluor 568 (Life Technologies, A11004, 1:800), goat anti-mouse Alexa®Fluor 660 
(ThermoFischer Scientific, 10103852, 1:200), goat anti-chicken Alexa®Fluor  488 (Life 
Technologies, A11039, 1:800), goat anti-chicken Alexa®Fluor 647 (Abcam, ab150171, 1:800), 
mouse monoclonal anti-beta actin (C4) HRP conjugated (Santa Cruz, sc-47778, 1:5000), goat 
anti-mouse IgG HRP conjugated (Sigma, A9917, 1:80000), goat anti-rabbit IgG HRP conjugated 
(Sigma, A4914, 1:80000), mouse monoclonal Living Colours anti-mCherry (Takara, 632543, 
1:250), mouse monoclonal Living Colours anti-dsRed (Takara, 632392, 1:250), donkey anti-
rabbit IgG biotinylated (GE Healthcare, RPN1004V, 1:500), streptavidin Alexa®Fluor 647 
(ThermoFischer Scientific, S21374, 1:200). 
 
1.3 Reagents and materials  
 
1.3.1 Media and Solutions 
The following media was used: Hank’s Balanced Salt Solution (HBSS) without Ca2+ and 
Mg2+ (Gibco, 14170-088), Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, 41966-029), 
MACS Neurobasal Media (Miltenyi Biotech, 130-093-570, RPMI 1640 media (with sodium 
bicarbonate, without L-glutamine) (Sigma, R0883).  
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1x phosphate buffered saline (PBS) was made from communal 10x PBS lab stock and 
filter sterilised (pH=7.4). 1x Tris non-saline buffer (TNS) (pH=7.6) was prepared from 10x TNS 
stock (30g Trizma-base in 500 mL ddH20). 1x Tris buffered saline with Tween 20 (TBST) 
(pH=7.5) was prepared from 10x TBS stock (24.23g Trizma-base, 87.66g sodium chloride in 1L 
ddH20) with the addition of 0.5 mL of Tween 20. Mild glycine stripping buffer (pH=2.5) was 
prepared by dissolving 7.509g of glycine in 500 mL ddH20 and adding 0.25 mL of Tween 20. 
0.1M borate buffer contained 2.48 g boric acid and 3.8g sodium tetraborate decahydrate, 
dissolved in 800 mL of ddH20 (pH=8.5).  
1.3.2 Chemical reagents 
Collagen Type IV from human placenta (Sigma Aldrich, C5533-5MG) was dissolved in 
10 mL ddH20 containing 25 µL of acetic acid, and was then filter sterilised and kept at 4°C. 
Foetal Bovine Serum (FBS) (Biosera, FB1280/500, French Origin) was used in PC12 cells culture 
media. Foetal Bovine Serum (Invitrogen, 10500064) was used for all other experiments. Nerve 
growth factor (NGFß from rat) (Sigma, N2513-0.1MG) was reconstituted with sterile PBS 
containing 0.1% bovine serum albumin (BSA) to a final concentration of 1 mg/mL. DNAase 
(Sigma Aldrich, D5025) was diluted to 0.01% solution in HBSS without Ca2+ and Mg2+. Poly-D-
lysine (Sigma, D1149-100MG) was dissolved in ddH20 to stock concentration of 2 mg/mL.  
A list of other reagents which did not require reconstitution: 0.05% Trypsin-EDTA 
(Fischer Scientific, 11580626); magnetofection transfection reagents (Neuromag, NM50200); 
GS21 neuronal supplement (AMSBIO, gsm.3100), Papain (Warthington, LK003178, 5 vials); 
Glutamax supplement (Thermofisher Scientific, 3505-060); HEPES (Sigma Aldrich, 15630-056, 
1M); SOC Media (Thermofisher Scientific, 15544-034); DMSO (Sigma Aldrich, D5879), 
Geneticin (Gibco, G418); Penicillin/Streptomycin/Fungiezone (PSF) (Life Technologies, 15240-
062); L-Glutamine (200mM, ThermoFischer Scientific, 25030081); Triton X-100 (Sigma Aldrich, 
X100); Kanamycin (Sigma Aldrich, K0254), Ampicillin (Sigma Aldrich, A5354); 36% 
paraformaldehyde (TAAB Laboratories). 
1.3.3 Materials  
Cell strainers (40 µm) (Falcon, 352340) were used for primary cortical culture. Primary 
neuronal cultures were grown on CELLView glass-bottom culture dishes (Greiner Bio-One, 
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627860). 18mm coverslips were used for mounting of live cell imaging dishes (MatTek 
Coorporation, PCS-0-18). 
      
2. Cell Culture and Transfections  
 
2.1 Primary Cortical Neurons 
Cortical neurons were dissected from E18 Sprague Dawley rat embryos and plated on 
imaging dishes or on acid-washed glass coverslips at the following densities: 1x105cells/dish 
for immunocytochemistry, 2x105 for axotomy or live-cell imaging and 8x104cells/coverslip. All 
surfaces were coated with poly-D-lysine, diluted in borate buffer to a final concentration 50 
µg/mL. The cells were grown in serum-free MACS Neurobasal Media supplemented with 2% 
GS21 and 1% GlutaMAX supplements at 37°C in 7% CO2 incubator. The media was not changed 
during the incubation period. 
 
Cortical neurons (1 DIV) on imaging dishes were transfected using lipofectamine 2000 
reagent (ThermoFisher Scientific) as follows: 10.8μg of DNA plasmid were mixed with 1.2 mL 
NB media and 19.8 μL lipofectamine 2000. The reaction was kept for 30 minutes at room 
temperature and then added to the cells which were in 2 mL of freshly warmed-up NB media 
supplemented with GlutaMAX for 1 hour at 37°C. The transfection media was then removed, 
and the original media was transferred back to the imaging dishes. Plasmid reporter gene 
expression was observed 48 hours post-transfection. Cortical neurons (7 DIV onwards) on 
imaging dishes were transfected using NeuroMag magnetofection system where 7μg of DNA 
plasmid is mixed with 100μL NB media and 8μL of magnetic beads. The reaction was kept for 
30 minutes at 37°C before adding 900μL of pre-warmed NB media to a final volume of 1 mL. 
The original neuronal media was removed, and 1 mL of transfection mixture was added. 
Dishes were then incubated at 37°C for 30 minutes on a magnetic plate before the original 







2.2 Pheochromocytoma cells (PC12s)  
 
PC12 cells were maintained in T75 flasks coated with collagen type IV in RPMI-1640 
media supplemented with 1% L-glutamine, 10% foetal bovine serum and PSF. The media was 
changed every 2 days. When 80-90% confluent, the cells were dissociated by removing the 
media, washing with PBS (1x) and adding 4 mL of 0.05% Trypsin-EDTA for 3-5 minutes at 37°C. 
The reaction was then stopped by the addition of 4 mL of warm cell culture medium. The cells 
were spun down at 800 rpm for 5 mins. Excess liquid was removed, and the pellet was 
resuspended in 5mL of cell culture media – 1 mL was plated to a newly coated flask containing 
warm media and the rest was frozen in 1 mL aliquots in 10% DMSO in FBS at -80°C. PC12 cells 
were transfected using microporator MP-100 and the Neon® Transfection System (Invitrogen) 
as previously described (Covello et al., 2014). 
 
2.3 HeLa cells  
 
HeLa cells were grown in 6-well plates in DMEM media supplemented with 10% FBS and 
PSF. The media was changed every 2 days. When 80-90% confluent, the cells were dissociated 
by removing the media, washing with PBS (1x) and adding 2 mL of 0.05% Trypsin-EDTA for 3-
5 minutes at 37°C. The reaction was then stopped by the addition of 4 mL of warm cell culture 
medium. The cells were spun down at 800 rpm for 5 mins. Excess liquid was removed, and 
the pellet was resuspended in 5 mL of cell culture media. Cells were frozen in 1 mL aliquots 
in 10% DMSO in FBS at -80°C. HeLa cells were transfected using the TransIT-HeLaMONSTER 
transfection kit (Mirus Bio) and the TransIT-LT1 transfection kit (Mirus Bio) following the 
company’s protocol. 
 
3. Cloning  
 
3.1 Site-directed mutagenesis 
The wild-type human protrudin protein (in pmCherry-C1 construct) was mutated using 
Quick II-Site Directed Mutagenesis kit (Agilent Technologies). Forward and reverse 
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mutagenesis primers containing each of the desired mutations were designed using the 
Agilent Technologies primer design tool. A PCR reaction was then carried out using each set 
of mutagenesis primers and the non-mutated protrudin construct using the PCR quantities 
and parameters in Fig. 2.1.  
Figure 2.1 A figure outlining the mutagenesis process, the PCR parameters used and the final mutant products 
of the human protrudin gene. A) The quantities of PCR reagents used (in µL) for a single mutagenesis reaction. 
B. A table showing the cycling PCR parameters used in all reactions. C. A step-by-step schematic representation 
of the mutagenesis process (adapted from Agilent Technologies). 
 
 
The PCR reaction was then treated with 1μL of DpnI enzyme for 1 hour at 37°C. The 
DpnI enzyme recognises and digests the parental methylated and non-mutated plasmid so it 
is able to select for the newly synthesizes mutated plasmid. Once the parental DNA is 
digested, 2 µL of the PCR reaction were transformed in XL-10 Gold Ultracompetent bacteria 
and grown on agar plates containing kanamycin (1:1000 concentration) for 18 hours 
overnight. Colonies were then picked and grown in LB medium containing kanamycin 
overnight. The plasmid DNA was purified using Qiagen Mini Prep kit and sent for sequencing.  
This method was used to create two constitutively phosphorylated forms of protrudin as well 
as the following functional mutants - ∆FYVE and ∆FFAT (Fig. 2.2) (described in Chapter 3, 4 




Figure 2.2 A schematic diagram of protrudin mutants created by site-directed mutagenesis. The protrudin 
protein contains multiple domains – RBD (Rab11-binding domain) (dark blue), TM1 and TM2 (two hydrophobic 
domains) (yellow), FFAT (ER-targeting domain) (green), CC (coiled-coil domain) (light blue) and FYVE 
(phospholipid-binding domain) (purple). Two phosphomimetic forms were created at 6 putative ERK 
phosphorylation sites important for its interaction with Rab11 by converting threonine and serine amino acids 
to aspartic acid (described in more detail in Results) (Shirane et al., 2006). ∆FYVE and ∆FFAT domain mutants 
were create by substitution of lysine (367) and arginine (369) for alanine and aspartic acid (294) for alanine 
respectively  (Saita et al., 2009; Gil et al., 2012). 
 
 
3.2 Gibson Assembly Cloning  
 
Gibson assembly (GA) cloning was performed as described in (Gibson et al., 2009). 
Cloning primers were designed using the NEBuilder Tool and the annealing temperature for 
pairs of primers was derived using the NEB Tm Calculator. A PCR reaction was then carried 
out as described (Fig. 2.3) and the PCR products were analysed on an agarose gel. The correct 
size fragments were then cut out from the gel and purified using the Wizard® SV Gel and PCR 
Clean-Up System (Promega, UK). The DNA fragments were then assembled using the Gibson 
Assembly® Master Mix (New England Biolabs, Inc.) for 1.5 hours at 50°C in the following 
quantities: 50ng of insert DNA was mixed with 25ng of vector DNA and 10 µL of the Master 
Mix and the reaction was complimented with distilled water to final volume of 20 µL. The 
reactions were then transformed in XL-10 Gold Ultracompetent bacteria and grown on agar 
plates containing kanamycin (1:1000 concentration) for 18 hours overnight at 37°C. Colonies 
were then picked and grown in LB medium containing kanamycin overnight. The plasmid DNA 
was purified using Qiagen Mini Prep kit and the sequence was confirmed by DNA sequencing. 
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The DNA was amplified by using Qiagen Endo-free Maxi Prep kit. This cloning method was 
used for several purposes (described below). 
 
Figure 2.3 Figure outlining the Gibson Assembly cloning process and the PCR parameters used. A. The 
quantities of PCR reagents used (in µL) for a single mutagenesis reaction. B. A table showing the cycling PCR 
parameters used in all reactions. C. A step-by-step schematic representation of the cloning process (adapted 
from Gibson, 2011). 
 
3.2.1 Promoter Cloning  
   
Initially, DNA constructs contained the cytomegalovirus promoter (CMV promoter). 
However, after several attempts to transfect these plasmids into primary cortical neurons at 
10 DIV, very low transfection rates were observed (5-10/100 000 cells). In addition, many non-
neuronal cells were also transfected. Therefore, a neuron-specific promoter (synapsin) was 
cloned into all protrudin, Rab11 and integrin constructs to achieve better transfection 
efficiency and specificity of cortical neurons. Transfection efficiency was increased 10x after 





3.2.2 Protrudin Mutants Cloning  
 
GA cloning was also used to create ∆RBD, ∆Spastin, ∆KIF5 and ∆ER domain mutants of 
protrudin (Fig. 2.4) (described in Chapter 5). 
 
Figure 2.4 A schematic diagram of protrudin mutants created by Gibson Assembly cloning. Rab11-binding 
domain mutant (∆RBD) was created by deleting amino acids 50-64 (Shirane and Nakayama, 2006). KIF5-binding 
mutant (∆KIF5) lacked amino acids 274-361 (Matsuzaki et al., 2011), spastin mutant protrudin (∆Spastin) had 
amino acids 151 to 220 removed (Zhang et al., 2012) and ER mutant protrudin where the three transmembrane 
domains (TM1 (67–87a), TM2 (89–109aa) and TM3 (180–214aa) are removed so protrudin cannot associate with 
membranes (Chang, Lee and Blackstone, 2013). 
 
3.2.3 Viral Vectors Cloning  
 
In order to create viruses to transform the retina and perform optic nerve crush (see 
Chapter 4), GFP-WT-protrudin or GFP-Mutant2-Protrudin were cut out from their original 
vector. These inserts placed in AAV2-sCAG-GFP vector which contains interval terminal 
repeats (ITR sites) aiding the insertion into viruses. In all examples above, the vector DNA was 
opened up by a PCR reaction and purified from gel. The GA method, however, also allows for 
the vector DNA to be cut open using restriction enzymes. In the case of viral vectors cloning, 
the vector was opened up by using the restriction enzyme BsrGI as described (Fig. 2.5A). GA 
primers were again designed using the NEBuilder tool with overhangs for the BsrGI enzyme 
and PCR was performed (Fig. 2.5B). The correct size GFP-protrudin (either WT or mutant2) 





Figure 2.5 Cloning details for viral vectors. A. Table with the step-by-step restriction digestion procedure to 
open up the vector plasmid with BsrGI enzyme. B. Gel electrophoresis blot showing the correct size PCR products 
for protrudin GFP wild-type and mutant 2 which were subsequently purified from the gel and inserted into the 
vector digested with BsrGI. C. A gel electrophoresis blot showing SmaI digestion. SmaI restriction sites are 
present in both ITRs so upon digestion 2 bands of a size around 3000bp should be obtained. Many clones were 
tested but only the correct size ones (circled in yellow) were used for viral production.  
 
In order to minimise sequencing waiting times, each clone was screened using the 
restriction enzyme BspEI to determine whether the protrudin gene was inserted. Lastly, the 
restriction enzyme SmaI was used to identify whether both ITR sites are present in the final 
cloning vectors (Fig. 2.5C). Once all characteristics were confirmed, vectors were sent for 
complete sequencing, maxi prepped and used to create AAV2 virus by Raymond Fields at the 
NINDS Viral Production Core Facility at the National Institutes of Health, Bethesda, Maryland, 
US.  
 
4. Immunostaining  
 
5.1 Immunocytochemistry 
Cortical neurons and PC12 cells were fixed in 3% PFA for 15 minutes and then 
thoroughly washed and kept in PBS at 4°C. Cells were permeabilised in 3% BSA in PBS and 
0.1% Triton for 5 minutes and then blocking solution was added (3% BSA in PBS) for 1 hour at 
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room temperature. Primary antibodies (listed in Section 1.2.1) were added at the correct 
concentration and kept overnight at 4°C. On the next day antibodies were washed 3 times in 
PBS for 5 minutes. Secondary antibodies (listed in Section 1.2.2) were applied at the correct 
concentration for 1 hour at room temperature in a dark chamber. The cells were then washed 
twice in 1xPBS and twice in 1xTNS (5-minute washes) and mounted using coverslips and 




Mice were anesthetised using 1-2% isoflurane and rats were anaesthetised using 
phenobarbital, and transcardially perfused with PBS followed by 4% paraformaldehyde (PFA). 
Optic nerves were dissected and immersed in 4% PFA. The tissue was post-fixed overnight, 
then immersed in 30% sucrose for 24 h for cryoprotection. Tissue was embedded in Tissue-
Tek OCT and snap-frozen for cryosectioning. 14 µm-thick longitudinal sections of the optic 
nerve of both groups of animals and 50 µm-thick brain slices from the rats were obtained on 
charged Superfrost microscope slides using a Leica CM3050 cryostat. Slides were dried and 
stored at -80°C. GAP-43 staining was performed as previously described (Leon et al., 2000). 
Briefly, slides were thawed, rinsed in TBS (50 mM Tris buffer containing 8.766 g/L NaCl), 
washed with methanol for 10 min, and then blocked in TBS with 10% donkey serum for 1 h. 
GAP-43 was diluted (1:50 000) in a solution of TBS2T (50 mM Tris buffer, 17.532 g/L NaCl, and 
0.1 % Tween) containing 5% donkey serum and 2% BSA. Slides were incubated with GAP-43 
overnight on a rocking platform, then washed with TBS2T for 1 h, with TBS2T plus 5% donkey 
serum and 2% BSA for 1 h, and with TBS2T for 1 h, all on a rocking platform. The secondary 
antibody (donkey anti-sheep 633, Thermofisher) was diluted 1:1,000 in TBS2T with 5% donkey 
serum and 2% BSA and slides were incubated for 2 h, followed by 30 min washes with TBS2T, 
TBS2T, and TBS. Slides were mounted using Fluormount and glass cover slips, and stored at 
4°C for imaging. Wholemount mice retinas were also stained for retinal ganglion cell marker 
RBMS and the percentage of GFP-virus-positive RGC number was calculated. 
Slides with rat brain sections and wholemount retinas were thawed at room 
temperature for 20 mins, then washed with PBS (5-minute washes) on a slow rocker. 500 µL 
of blocking solution/slide (PBS/2%BSA/0.3% TritonX/10% normal goat serum) was applied for 
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1 hour at room temperature on a slow rocker. 500 µL of primary antibodies diluted in blocking 
solution at the correct concentration were applied on each slide overnight at 4°C. The slides 
were washed on the next day with PBS three times for 15 minutes on a slow rocker. Secondary 
antibodies diluted in blocking solution at the correct concentration were applied for 2 hours 
at room temperature on a rocker. The antibodies were then washed in PBS three times for 10 
minutes at room temperature on a slow rocker. Slides were then mounted with FluorSave 




5.1 Confocal Microscopy   
Images of immunostained cells were taken with a confocal microscope (Leica DMI 
4000 B) using LAS-AF software (Leica). For protrudin localisation, a z-stack of images was 
obtained through each cell by taking an image at every 0.5μm thickness and an average 
intensity z-projection was created in Fiji software (Schindelin et al., 2012). The same strategy 
was used for imaging Rab11 and integrin staining. All images in a particular experiment were 
taken using the same microscope settings. The intensity was measured by placing a line shape 
(usually about 50μm) on processes and taking a background intensity of the same shape 
immediately next to each process (Fig. 2.6A, 2.6B). The same procedure was used for proximal 
(<100 μm from cell body) and distal (>100 μm from cell body) axons as well as dendrites. The 
background was then subtracted from the intensity at each process. For protrudin intensity 
measurements in GFP-transfected neurons, regions of interest were selected in the 488 
channel and a line was placed on each process and immediately next to it to measure 
background. This strategy immediately excludes any biases on selecting processes with higher 
intensity of protrudin staining. The same strategies were used for measuring Rab11 and 
integrin intensity. For all experiments measuring axon-to-dendrite ratio, the intensity in 




Figure 2.6 Quantification of immunocytochemistry in neurons. A. Immunofluorescent images showing the 
measuring strategy for protrudin intensity in neuronal process. The axon was identified by neurofascin staining 
(red) and a measuring line (around 50 µm) was placed on top of it as well as immediately next to it to measure 
background staining. Dendrites were identified by the presence of protrudin staining and the same measuring 
strategy was employed. The same strategy was used when measuring Rab11 and integrin intensity in the axon 
and dendrites. B. For cortical neurons transfected with GFP, the axon was identified by morphology and the 
presence of neurofascin staining (images not shown). A measuring line was drawn across the axon and 
immediately next to it to measure background. Dendrites were identified by the presence of GFP fluorescence 
and the same measuring technique was employed. C. A schematic diagram representing the strategy of 
identifying the cell body and tracing the neurites in the SynD software for dendritic tree analysis.  
 
5.1.1 Morphological Analysis 
 
Dendritic tree analysis was carried out in a semi-automated manner using a recently 
developed, openly available software – SynD (Schmitz et al., 2011). An image of a neuron is 
opened in the software to begin with, and the cell body is identified (soma erode=25, 
morphology threshold=42). Then the neurites coming out of that cell body are traced along 
in radius 200 µm (max cost=0.9, filter size=2) (Fig. 2.6C). Sholl analysis is then applied and the 
dendritic complexity of different protrudin mutants’ overexpression was measured. Spine 
morphology and number were analysed from 63x confocal images of neurons transfected 
with GFP as a control plasmid which diffuses in spines and protrudin mutants using Fiji 







5.1.2 Imaging and quantification of axon regeneration after optic 
nerve crush 
 
Imaging was performed using a Zeiss 780 confocal microscope. Z-stacked images were 
collected with a z interval of 0.87 μm. CTB+ axons were counted in ImageJ at 0.25 mm intervals 
starting from the lesion site. Four sections were counted for each nerve. The number of 
regenerating axons was then calculated at each distance using a previously developed 
formula (Bei et al., 2016; Lim, Stafford, Nguyen, Lien, Wang, Zukor, He and Andrew D. 
Huberman, 2016), with the total number of axons equal to πr2 (r being the maximum recorded 
radius of the optic nerve section) times the average number of counted axons, divided by the 







Axon counting was performed by an observer blind to the experimental conditions. 
 
5.2 Live-cell imaging 
Live-cell imaging was performed using spinning disk confocal microscopy, using an 
Olympus IX70 microscope with a Hamamatsu EM-CCD Image-EM camera and a PerkinElmer 
Ultra-VIEW scanner. Videos were taken using Meta-Morph software. Rab11 and integrin 
vesicle trafficking along the axon was imaged at the proximal (up to 100μm) and distal part 
(beyond 200μm) of axons of neurons transfected with protrudin. One image per second was 
obtained for 3 minutes. Kymographs were obtained by measuring as much as possible from 
an individual axon segment. Anterograde, retrograde, bidirectional and static modes of 
transport were measured. The percentage of co-localisation between integrin or rab11 and 
protrudin was calculated as the number of vesicles containing both was divided by the total 





5.3 Tile scan imaging  
Leica DMi8 tile-scan microscope was used to image the optic colliculus area of the rat 
brains and Brn3a staining in rat wholemount retina. CTB tracing was injected in the retina so 
the edges of each superior colliculus were marked using the fluorescent intensity of the CTB 
and a tile-scan array of images was taken at 20x. Once all images were taken, they were 
stitched together to form one final image (Fig. 2.7A). Brn3a images in retinal wholemounts 
(Fig. 2.7B) were also taken at 20x, however, as single images.  
5.3.1 CTB measurements and analysis  
Tile-scan images of superior colliculus were uploaded on the Fiji Software and the 
superior colliculus was outlined using the polygon tool. Fluorescent CTB intensity, the size of 
the area and the integrated density were measured for each side of the brain – left and right 
superior colliculus. Volumetric analysis was performed as described previously (Chiasseu et 
al., 2017) using the following formula:  
𝑇𝑜𝑡𝑎𝑙 𝐶𝑇𝐵 𝐴𝑟𝑒𝑎 =
∑ 𝐶𝑇𝐵 𝑆𝑒𝑐𝑡𝑖𝑜𝑛 𝐴𝑟𝑒𝑎
𝑠𝑠𝑓 𝑥 𝑎𝑠𝑓 𝑥 𝑡𝑠𝑓
 
Where ssf represents the number of sections used in the analysis over the total number of 
sections (e.g. 8/50), asf represents the areas sampled divided by the total area (1) and tsf 
represents the thickness of the sampled section over the total thickness over which sections 
were analysed (e.g.50/600).  
 
5.3.2 Brn3a analysis 
 24 images of Brn3a staining were obtained from each rat retinal wholemount – 2 
images in the centre of the retina, 2 in the middle and 2 in the periphery of each retinal 
quadrant (Fig. 2.7B). Automated counting of the number of Brn3a-positive cells in each image 
was performed using the Fiji software and an image-based tool for counting nuclei (ITCN) 
plugin. Blinded counts using the plugin were carried out by Yusuf Mushtaq. The final analysis 
was performed as the number of cells per image was divided by the area of the image in order 




Figure 2.7 A. An example of a reconstructed image of the whole superior colliculus of a rat. ROI 0.1 and ROI 0.2 
are examples of the regions of interested which were measured for the superior colliculus volume analysis. CTB 
staining is shown in red. Scale bar is 0.5mm. B. An example of a wholemount retina stained for GFP and the 
sampling method for Brn3a imaging. 24 images per retina were taken (6 images per quadrant – 2 in each area - 
centre, middle and periphery). C. Example images of Brn3a staining (green) from different retinal areas which 
were used for measuring retinal ganglion cell density. Scale bar is 50 µm.  
 
 
5.4 Laser Axotomy  
10 DIV neurons were transfected with various protrudin constructs using 
magnetofection as described above. Between 13-17 DIV, their regeneration ability was 
examined using the laser axotomy model described in detail in Koseki et al., 2017. Axotomy 
was performed by an UV Laser (355 nm, DPSL-355/14, Rapp OptoElectronic, Germany) 
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connected to a Leica DMI6000B (Leica Systems, Germany), and all images were taken with an 
EMCCD camera (C9100-02, Hamamatsu). Axons were cut at least 600 µm away from the cell 
body and regeneration was observed for 14 hours post injury at 30-minute intervals. If more 
than 50% neuronal cell death occurred in the axotomised cells, the experiment was excluded 




Regeneration factors were measured as below when a neuron 
was categorized as regeneration  
Retraction distance 
The length of axon that was lost between the location of 
axotomy and the initial retraction bulb  
Regeneration percentage 
The number of neurons that regenerated, over the total 
neurons which formed a retraction bulb  
Regeneration initiation 
time 
The time between the retraction bulb formation and the start 
of a steady extension lasting more than 1hr and leading to 
regeneration  
Regeneration distance 
after 2 hours 




The length of axon that extended 14 hours after axotomy 
Growth cone area The maximum growth cone area after regeneration initiation  
 




In order to assess the neurite outgrowth of primary cortical neurons transfected with 
9 different forms of protrudin, cortical neurons were grown in 24-well plates, transfected at 
2 DIV and fixed at 4 DIV. Imaging was performed at 10x using the Cellomics ArrayScan XTI 
platform at the NIHR Cambridge BRC Cell Phenotyping Hub. Cells expressing the protrudin 
construct were identified as they were positive both for DAPI and mCherry and their cell body 
area was between 1 and 2000 µm2. An algorithm was then created to trace all fluorescent 
processes coming out of the cell body (Fig. 2.8A-C) and several parameters were measured 
(Fig. 2.8D).  
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Figure 2.8 Figure outlining some characteristics of the Cellomics paradigm. A. B. C. Example cells all treated 
with the same algorithm for tracing neurites. All neurites are traced (in pink) to their maximum length and no 
errors occurred between the different cells. The algorithm worked consistently between different cells of 
different shape and size. D. Table to describe some of the parameters measured in the paradigm, their units and 
descriptions. 
 
6. Immunoprecipitation and Western Blots 
6.1 Cell Lysis  
 
HeLa cells were used for Rab11 and protrudin interaction detection by 
immunoprecipitation. PC12 cells were used for Western Blots to detect protein levels after 
applying shRNA against protrudin. HeLa cells and PC12 cells were transfected as described in 
Sections 2.2 and 2.3. 48 hours later cells were lysed using the cOmplete Lysis Kit (Roche). PBS 
and lysis buffer (plus proteinase inhibitor tables – 1 tablet for 10 mL of buffer) were cooled 
down to 4°C. The medium of each well of a 6-well plate was removed and cells were washed 
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with ice-cold PBS. 500 µL of pre-cooled lysis buffer was added to each well and the lysate was 
scraped using a cell scraper and transferred to a sterile 1.5 mL Eppendorf. The lysate was 
incubated on ice for 30 minutes with occasional mixing. The samples were then centrifuged 
at 10 000 g at 4°C for 10 minutes. The supernatant was transferred to 1.5 mL Eppendorf and 
the pellet was discarded. The total protein concentration was measure by BCA assay using 
Pierce BCA Assay Kit Protocol (ThermoFischer Scientific). The 96-well plate containing the 
sample lysates and BCA reagents was analysed using Gen5.1 software and concentrations 
were derived from a standard curve for albumin control. 15 µg of PC12 cell lysate was then 
treated with LDS Sample Buffer NuPAGE 4x (1:4, ThermoFisher Scientific) and Sample 
Reducing Agent (1:10, ThermoFisher Scientific) and were analysed by Western blot (Section 




Equal amounts of HeLa cell lysate between different conditions was incubated with 50 
µL of GFP beads from µMACS GFP Isolation Kit (Miltenyi Biotech) for 30 mins at 4°C on a 
rotating wheel. Before this step 15 µg of lysate was keep aside in order to serve as an input 
control. In the meantime, µ columns (Miltenyi Biotech) were places on a µMACS magnetic 
separator. The columns were equilibrated with 200 µL of lysis buffer. Once the lysate 
incubation has finished, the whole lysate was applied to the column and the flow through was 
discarded. The columns were washed 4 times with 200 µL of Wash Buffer 1 and once with 100 
µL of Wash Buffer 2. 20 µL of pre-warmed (to 95°C) elution buffer was added to the columns 
and incubated for 5 minutes. Any excess solution coming out of the columns was discarded. 
Further 30 µL of elution buffer was added and the eluate was collected in clean 1.5 mL 
Eppendorf tubes. The eluates were analysed on Wester Blots as described below. 
 
6.3 Western blotting 
 
 Protein lysate samples (from PC12 cells) and IP eluates (from HeLa cells) were analysed 
by SDS-PAGE. Precision Plus Protein Dual Colour Standard (BioRad) was used as a ladder. 
Samples were run on a 4-12% gel until they reached the bottom of the gel (usually 1.5-2 hours) 
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at 120 V at room temperature in 40 mL Running Buffer NuPAGE (ThermoFisher Scientific) 
diluted in H20 to 800 mL. The gel was then transferred onto a nitrocellulose membrane 
(Invitrolon PDVF/Filter Paper Sandwich, ThermoFischer Scientific) for 1.5 hours at 40V at 4°C 
in 50 mL Transfer Buffer NuPAGE (ThermoFisher Scientific) in 100 mL methanol, topped up 
with ddH20 to 1 L. The membrane was then blocked either in 5% milk or 3% BSA depending 
on the antibody for 1 hour and incubated overnight with the primary antibody diluted the 
blocking solution to the right concentration at 4°C. The membrane was then rinsed three 
times in Tris-buffered saline with Tween 20 (TBST buffer) for 10 minutes each. The TBST buffer 
was removed. Secondary peroxidase-conjugated antibodies were diluted to the right 
concentration in blocking solution and were then added for 1 hour at room temperature. 
SuperSignal West Dura Extended Duration Substrate kit (ThermoFischer Scientific) and 
Alliance software were then used for detection.  
 
7. Animal Studies  
7.1 Animals  
For optic nerve crush experiments, all procedures were performed in accordance with 
protocols approved by the Institutional Animal Care and Use Committee (IACUC) at the 
National Institutes of Health. Female C57Bl/6 mice aged 6-8 weeks (Charles River) (n=27) were 
housed in a pathogen free facility with free access to food and a standard 12 hr light/dark 
cycle. For glaucoma experiments, all procedures were performed in accordance with 
protocols approved by the Home Office, UK. Male Sprague-Dawley rats were house in a 
pathogen-free facility (n=26). 
 
7.2 Viral Injections 
Intravitreal injections of viruses (Table 2.3) were administered 14 days prior to optic 
nerve crush or laser injury. 1.5 μL of the injecting solution for mice and 5 μL for rats was drawn 
into a sterile 5 μL Hamilton syringe equipped with a 33-gauge removable needle. The solution 
was injected into the vitreous humor through the superior nasal sclera, with the needle 
positioned at a 45° angle to avoid the lens, external ocular muscle, and blood vessels. Before 
75 
 
removing the needle, a sterile 33-gauge needle was used to puncture the cornea and drain 
the anterior chamber, thereby reducing intraocular pressure and preventing reflux. Different 
needles were used for each virus to prevent contamination, and syringes were rinsed 
between injections with ethanol followed by sterile PBS. The same procedure was used for 
intravitreal viral injections of rats for glaucoma study. 
Table 2.3 A table listing all the viruses used in this research and their titres.  
 
7.3 Optic Nerve Crush 
Optic nerve crush was performed as described previously (Kevin Kyungsuk Park et al., 
2008). Micro-scissors were used to make an incision in the conjunctiva and expose the optic 
nerve. Curved forceps were then inserted below the external ocular muscle, avoiding the 
ophthalmic artery and retrobulbar sinus, and positioned around the exposed nerve. The nerve 
was crushed for 10 s approximately 1 mm behind the eye. Following the crush, eyes were 
observed fundoscopically for signs of ischemia, and mice were monitored for signs of 
intraorbital bleeding. Mice were given a subcutaneous injection of 1 mg/kg buprenorphrine 
as an analgesic and topical application of ophthalmic ointment to prevent corneal drying. 
 
7.4 Laser Injury to Induce Intraocular Pressure (IOP) Rise 
Ocular hypertension was induced in the left eye of rats. Rats were placed in front of a 
slit-lamp equipped with a 532-nm diode laser that delivers 0.7-W pulses for 0.6 seconds. Fifty 
to sixty laser pulses (50-μM diameter) were directed to the trabecular meshwork 360° around 
the circumference of the aqueous outflow area of the left eye. Animals were under general 
anaesthesia for the duration of the procedure - ketamine (50 mg/kg) and xylazine (10 mg/kg) 
Virus Titre 
AAV2-CAG-eGFP 5×1012 vg/mL 
AAV2-CAG-protrudinWT-eGFP 2×1013 vg/mL 
AAV2-CAG-protrudinMUT-eGFP 2×1013 vg/mL 
AAV2-CAG-integrinα9-V5  1.2×1013 vg/mL 
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injected intraperitoneally.  Afterwards, postoperative Viscotears were applied to the eye and 
animals recovered from anaesthesia in a warm cabinet under observation. Animals required 
daily lubrication with Viscotears following laser treatment. IOP was measured using a 
TonoLab tonometer on the day after laser injury and a week later, immediately before second 
injury, then again a day and a week after the second injury.  
7.5 CTB Injection  
Intravitreal injections of CTB (1.0 μg/μL, Sigma) were administered 2 d prior to 
perfusion harvest in both mice and rats. 2 μL of the solution injected as described above. The 
syringe was rinsed with ethanol and sterile PBS between injections. 
 
8. Statistics  
 
Statistical analysis was performed using GraphPad Prism 8.0 (GraphPad Software, La 
Jolla, CA). Each data set was individually tested for normal distribution using the D'Agostino-
Pearson normality test. When data was normally distributed one-way ANOVA with multiple 
comparisons was used to test statistical significance between the experimental groups with 
Tukey’s post hoc test. Several data sets were shown to be non-normally distributed. 
Therefore, a non-parametric Kruskal-Wallis test with multiple comparisons was used to test 
for significant differences across experimental groups. Dunn’s multiple comparison post-hoc 
test was also performed. All outliers were removed after testing each set of data with the 
GraphPad outlier removal function. Data from different staining experiments for each 
experimental group were tested for statistical difference using Kruskal-Wallis test in order to 
determine whether values could be combined together. All statistics were carried out at 95% 
confidence intervals, therefore a significant threshold of p<0.05 was used in all analyses. For 
Sholl analysis, repeated measures two-way ANOVA was performed using SPSS (IBM Statistics). 
When comparing percentages (e.g. of regenerating cells), Fisher’s exact test was performed 
between each two groups compared. p-values were then analysed with the “Analyse a stack 
of p values” function in GraphPad Prism with a Bonferroni-Dunn pairwise comparison to test 




CHAPTER III: MUTAGENESIS OF PROTRUDIN  












This chapter explores the cellular localisation of endogenous protrudin in several cell 
culture paradigms and its interaction with known molecular partners. The effects of wild-type 
and mutant protrudin overexpression in cortical neurons are also investigated in terms of 
morphology, localisation and actions of the protein. Lastly, protrudin overexpression 




1.1 Protrudin expression during development 
 
Protrudin is an integral membrane protein, a member of ZFYVE family of zinc-binding 
proteins (Shirane and Nakayama, 2006). Protrudin’s CNS expression during development and 
after injury has not been studied extensively. Despite that, protrudin expression has been 
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detected in several large-scale RNA sequencing studies summarised in Fig. 3.1A. For example, 
in primary rat cortical neurons protrudin’s expression doubles from 1 DIV to 16 DIV (15.5 to 
37.3 fragments per kilobase million (FPKM)), and then plateaus by 24 DIV (27 FPKM) (Koseki 
et al., 2017). This expression level, however is very low compared to that of other proteins 
present abundantly throughout the cell such as beta-actin (1092 average FPKM) and GAPDH 
(285 average FPKM) or compared to other regeneration-associated scaffolding molecules 
such as GAP43 (628 average FPKM) and YWHAZ (14-3-3 zeta proteins) (570 FPKM) (Kaplan et 
al., 2017; Koseki et al., 2017).  
 
In a separate RNA analysis study in DRG cultured neurons, protrudin expression is 
slightly increased after 36 hours in culture (from 1439 at 6 hours to 1728 normalised 
expression levels at 36 hours) as well as from E12.5 to E17.5 during mouse embryonic 
development in vivo, (684 to 846 normalised expression levels) but these are not considered 
large scale changes (Tedeschi et al., 2016) (Fig. 3.1A). In this study, protrudin levels were again 
much lower than other ubiquitously expressed proteins such as beta-actin (14 020 in vitro and 
23 153 in vivo average normalised expression levels). Protrudin’s levels were also much lower 
than other regeneration-associated proteins such as GAP43 and 14-3-3s both in vitro (3265 
and 12 320 average normalised expression levels, respectively) and in vivo (7853 and 12 399 
average normalised expression levels, respectively) (Tedeschi et al., 2016).  
 
Overall, these two studies show that protrudin has a relatively stable expression 
pattern during different stages of development both in vitro and in vivo and that protrudin 
levels in neuronal cells, especially CNS neurons are relatively low compared to the expression 
of other highly abundant or regeneration-associated proteins. These studies, however 
focused on exploring the mRNA levels, therefore further studies are needed in order to 
validate the abundance of the protrudin protein in different cell types and tissues with 
development.  
 




The expression levels of protrudin after injury were also analysed from several 
different datasets. Protrudin expression in DRGs after peripheral nerve injury is slightly 
increased compared to sham animals (from 1692 to 2125 normalised expression values) 
(Tedeschi et al., 2016) (Fig. 3.1A). However, in this paradigm, GAP43 increases from 4323 to 
11 375, beta-actin from 12 585 to 17 145 and 14-3-3s from 15 605 to 16 618 normalised 
expression values in sham compared to injured animals (Tedeschi et al., 2016).  
 
Furthermore, protrudin expression levels after optic nerve crush in the retinal ganglion 
cells (RGCs) doubled from 5.5 in uncrushed to 12 expression units 3 days post injury (3dpi) 
but then returned to basal level at 14dpi (5.8 expression units) (Smith et al., unpublished 
data). Protrudin levels are only 0.3 expression units different at 14dpi compared to uncrushed 
optic nerve. This change is very negligible compared to the most highly differentially 
expressed protein – Gm12563 where the difference between expression at 14dpi to 
uncrushed nerve is 298 105 expression units (Smith et al., unpublished data). Similar to during 
development, protrudin expression levels after optic nerve crush are, in general, very low 
compared to some proteins which are upregulated such as beta-actin (352 average expression 
units) or 14-3-3s (160 average expression units).  
 
Lastly, the expression of protrudin in the spinal cord after a spinal cord injury remains 
almost unchanged 2dpi (11.35 FPKM) and 7dpi (7.12 FPKM) compared to sham control 
animals (11.74 FPKM) (Chen et al., 2013). Again, these values are very low when compared to 
GAP43 (sham – 61 FPKM, 2dpi – 122 FPKM, 7dpi – 82 FPKM), GAPDH (sham – 134 FPKM, 2dpi 
– 202 FPKM, 7dpi – 155 FPKM), beta-actin (sham – 423 FPKM, 2dpi – 1212 FPKM, 7dpi – 1330 
FPKM) and 14-3-3s (sham – 102 FPKM, 2dpi – 117 FPKM, 7dpi – 88 FRKM) (Chen et al., 2013). 
In summary, protrudin expression levels do not change significantly after peripheral or central 
nervous system insult and the levels of protrudin in these cells and tissues are much lower 
even in the absence of injury compared to some abundantly expressed or regeneration-




Figure 3.1 Protrudin expression levels, molecular interactions and cellular localisation. A. Table summarising 
the expression levels of protrudin during development in cortical neurons and peripheral nervous system 
neurons as well as after peripheral and central nervous system injury from several RNA sequencing studies.  B. 
Bar graph showing the percentage of protrudin-associated protein interactions in different molecular and 
cellular processes derived from a large-scale proteomics study (adapted from Matsuzaki et al., 2011). C. 
Schematic diagram showing protrudin cellular distribution which has been documented in peer-reviewed 










1.3 Protrudin is involved in multiple molecular processes 
 
The protrudin protein contains multiple molecular domains which mediate its 
interaction with other proteins and its involvement in multiple molecular mechanisms 
(summarised in Introduction, Section 4). Numerous interacting partners of protrudin were 
identified in a large proteomics study carried out by Matsuzaki and colleagues in 2011 
including Rab11, VAP-A, VAP-B, reticulon-3, KIF5 and others. Protrudin was found to associate 
mostly with proteins involved in intracellular trafficking and transport, signal transduction, 
protein metabolism and modification and lipid, fatty acid and steroid metabolism (Fig. 3.1B). 
Our initial hypothesis was that protrudin could be used as a tool to promote Rab11 transport 
into the axon, leading to an increase in regenerative ability. Given that protrudin has 
numerous interactions, it was important to also investigate a potential role for these in the 
regenerative process. If protrudin could be used to stimulate regeneration, studying these 
component properties of protrudin could have important implications for the identification 
of new molecular pathways involved in the process of regeneration.  
 
1.4 Protrudin localisation in the cell 
 
Protrudin localisation in the cell has so far only been studied in several cancer cell 
types. When overexpressed in HeLa cells protrudin results in the formation of neuronal-like 
processes in 5-30% of cells and is enriched at the tip of growing processes (Shirane and 
Nakayama, 2006). In PC12 cells, in the absence of nerve growth factor (NGF), protrudin is 
found in a diffuse fashion throughout the cell body. After 6 hours of NGF treatment, protrudin 
localises to the pericentrosomal region colocalising with the endosomal marker – Rab11 
(Shirane and Nakayama, 2006). Interestingly, 24 hours of NGF treatment induces the 
formation of long neuronal processes where protrudin re-distributes to the growing tip. 
Protrudin’s interaction with Rab11-GDP is necessary for anterograde transport to the tip of 
newly growing processes (Shirane and Nakayama, 2006). The effect of protrudin 
overexpression on neurite outgrowth in various cell types is extensively discussed in 
Introduction, Section 4.5. These observations point towards an important role for protrudin 




Protrudin localisation in neuronal cells is less well-studied. Protrudin overexpression 
in rat hippocampal neurons at 1 DIV results in increased neurite extension at 3 DIV (Shirane 
and Nakayama, 2006). Furthermore, protrudin was found in the soma and neurites of 1 DIV 
mouse primary cortical neurons and was also observed in dendrites, the axon and the growth 
cone of 3 DIV cortical neurons (Shirane and Nakayama, 2006). In this chapter, the localisation 
of endogenous protrudin in primary cortical neurons at different stages of development as 
they mature to become electrically active and lose their regenerative ability, is examined. One 
hypothesis is that protrudin may not be present in mature axons in levels that could enable 
protrusive growth. 
 
 In terms of organellar localisation, protrudin’s association with membranes results in 
its localisation to membrane-bound cellular components such as the endoplasmic reticulum, 
the plasma membrane and recycling endosomes (Fig. 3.1C).  
 
1.5 Protrudin mutagenesis 
 
In order to test our hypothesis that enhancing the interaction between protrudin and 
Rab11 could improve anterograde transport and axon regeneration, two constitutively 
phosphorylated forms of protrudin were created as described in Methods, Section 3. The 
mutagenesis sites in the protein were selected based on previous reports. Shirane and 
colleagues (2006) created constitutively inactive phosphorylation mutants at various ERK 
phosphorylation sites in different combinations. They found that two mutants in particular 
(P-mut-1 and P-mut-4, mutated at S14,25,32/T265 and T265/T269/T276 respectively) 
dramatically reduced the interaction between protrudin and Rab11. They concluded that 
phosphorylation of protrudin at multiple sites by ERK is essential for its interaction with 
Rab11-GDP and anterograde transport to the tip of growing processes. In the paper 
described, the authors used a form of mouse protrudin. In our experiment, the human 
protrudin protein was used and was mutated at the sites equivalent to the mouse phospho-
sites identified above. In addition, when FKBP38 (an interactor of protrudin) is knocked out in 
mice, protrudin was found to be hyperphosphorylated and to result in abnormal axon 
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extension in these mice (Shirane et al., 2008). The constructs that are used throughout this 
thesis are mCherry only control plasmid (syn-mCh only), mCherry-tagged wild-type protrudin 
(syn-mCh-WT), mCherry-tagged mutant 1 protrudin (syn-mCh-MUT1) and mCherry-tagged 
mutant 2 protrudin (syn-mCh-MUT2) (see Methods, Section 3). All constructs were tested in 
PC12 cells and in primary cortical neurons in order to evaluate their effects on cell 






























2.1 Protrudin is Preferentially Re-distributed to Dendrites compared to 
Axons as Neurons Mature in vitro 
 
 The localisation of the protrudin protein in primary cortical neuronal cultures was 
examined using immunocytochemistry. Firstly, neurons at different stages of development – 
2-4 DIV, 7-9 DIV and 14-16 DIV were immunostained for protrudin and for neurofascin, an 
axon initial segment (AIS) marker to identify the beginning part of the axon (Fig. 3.2A). As the 
AIS forms around 3-4 DIV in vitro, in early, 2-4 DIV neurons due to lack of neurofascin 
immunoreactivity, the axon was identified as the longest process. The intensity of the 
protrudin staining was measured in axons and dendrites as described in Methods, Section 
5.1.1.  
 
Our results showed that the amount of protrudin in the proximal axon declines with 
maturation as the intensity of protrudin staining was lower at 7-9 DIV (23 grey values) and 14-
16 DIV (21 grey values) compared to 2-4 DIV (39 grey values) (p=0.002) (Fig. 3.2B). There was 
no statistical difference in protrudin’s abundance in axons between 7-9 DIV and 14-16 DIV 
(p=0.999). This observation prompted us to examine whether protrudin might have a similar 
axon-to-dendrite distribution pattern as other growth-promoting and transport-related 
molecules such as integrins and Rab11 in aged neurons (see Introduction, Section 3.3.1). 
 
When examining the amount of protrudin in dendrites, there were no significant 
differences with development from 2-4 DIV (49 grey values) to 7-9 DIV (52 grey values) 
(p=0.91) and then to 14-16 DIV (49 grey values) (p=0.99) (Fig. 3.2C). Finally, the relative 
amounts of protrudin staining intensity were used to calculate axon-to-dendrite ratio for each 
cell across the three different developmental stages. The results showed an increased axon-
to-dendrite abundance of protrudin at earlier (2-4 DIV, ratio=1) compared to later stages of 
development (7-9 DIV, ratio=0.47 and 14-16 DIV, ratio=0.44) (p<0.0001) (Fig. 3.2D). There was 
no statistical difference in the axon-to-dendrite distribution of protrudin between 7-9 DIV and 




Interestingly, in contrast to our RNA sequencing results in primary cortical neurons 
where the amount of protrudin mRNA is relatively stable during development in culture 
(Koseki et al., 2017)(see Fig. 3.1A), the amount of the protrudin protein in the cell body seems 
to decline with maturation in this paradigm. There is less protrudin in 7-9 DIV (154 grey values) 
and 14-16 DIV (153 grey values) compared to younger neurons at 2-4 DIV (184 grey values) 
(Fig. 3.2E). This experiment, however, had some major caveats which are explained in this 

















Figure 3.2 Protrudin distribution in primary cortical neurons at different stages of development. A. 
Immunofluorescent images of protrudin (green) and neurofascin (red) localisation at 2-4, 7-9 and 14-16 DIV 
taken at 63x magnification. White arrows indicate segments of the axons. Scale bars are 20 µm. B., C. Bar graphs 
to compare the mean protrudin intensity in axons and dendrites across the different ages. Protrudin’s staining 
intensity is significantly higher in axons at 2-4 DIV compared to 7-9 DIV and 14-16 DIV (p<0.0001, Kruskal-Wallis 
statistic=20.82, n=4). Protrudin’s abundance in dendrites does not change with development (p=0.9816, Kruskal-
Wallis statistic=0.037, n=4). D. Scatter plot to present the axon-to-dendrite ratio of protrudin abundance across 
the different groups. The axon-to-dendrite ratio is higher at 2-4 DIV compared to 7-9 DIV and 14-16 DIV 
(p<0.0001, Kruskal-Wallis statistic=59.12, n=4). E. Bar graph showing the relative amount of protrudin protein in 
the cell body across different developmental stages. There is less protrudin in the cell body at 7-9 DIV and 14-
16DIV compared to 2-4 DIV (p<0.0001, Kruskal-Wallis statistic=19.55, n=4). Error bars represent mean ± SEM.  
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The localisation experiment was refined by transfecting 1, 6 and 12 DIV neurons with 
a GFP-expressing construct in order to label all neuronal processes. The transfected neurons 
were then fixed in PFA at 4, 9 and 15 DIV and immunostained for protrudin and neurofascin 
(Fig. 3.3A). The intensity of the protrudin staining was measured in axons and dendrites as 
described in Methods, Section 5.1.1. Confirming our findings above, the amount of protrudin 
in proximal axons seems to decline between 4 DIV (28 grey values) and 15 DIV (18 grey values) 
(p=0.004) (Fig. 3.3B). However, there is no significant decline between 4 DIV and 9 DIV (23 
grey values) contrary to our previous result (p=0.114). No significant difference was observed 
between protrudin levels in dendrites at 4 DIV (37 grey values), 9 DIV (46 grey values) and 15 
DIV (42 grey values) (p=0.1558) although there is a trend towards a higher amount of 
protrudin at the later stage of development (Fig. 3.3C). Similar to our endogenous protrudin 
staining without GFP overexpression, the axon-to-dendrite ratio in this experiment was 
significantly higher at 4 DIV (ratio=0.84) compared to 9 DIV (ratio=0.52) and 15 DIV 
(ratio=0.49) (p<0.0001) but there was no difference in the axon-to-dendrite abundance of 
protrudin between 9 DIV and 15 DIV (p=0.999) (Fig. 3.3D).  
 
The use of overexpressed GFP to mark the axonal processes allowed us to examine 
the amount of protrudin in the distal axon (600-800 µm away from the cell body) at 9 DIV and 
15 DIV. Very little protrudin (<5 grey values) was observed in the distal axon of mature 
neurons at 9 DIV and 15 DIV (Fig. 3.4A). As the axons of 4 DIV neurons were mostly shorter 




















Figure 3.3 Protrudin’s distribution in GFP-transfected primary cortical neurons at different stages of 
development. A. Immunofluorescent images of protrudin (red), GFP (green) and neurofascin (blue) localisation 
in the proximal axons at 4, 9 and 15 DIV taken at 40x magnification. White arrows indicate segments of the 
axons. Scale bars are 20 µm. B., C. Bar graphs to compare the mean protrudin intensity in axons and in dendrites 
across the different groups. Protrudin’s staining intensity is significantly higher in proximal axons at 4 DIV 
compared to 15 DIV (p=0.004) but not compared to 9 DIV (p=0.114, one-way ANOVA, n=4). There is no 
difference in protrudin amount in dendrites at 4 DIV compared to 9 DIV and 15 DIV (p=0.155, one-way ANOVA, 
n=4). D. Scatter plot showing axon-to-dendrite ratio of protrudin. The axon-to-dendrite ratio of protrudin 
abundance is higher at 4 DIV compared to 9 DIV (p<0.0001) and 15 DIV (p<0.0001, Kruskal-Wallis statistic=32.22, 
n=4). All error bars represent mean ± SEM.  
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Last but not least, the amount of GFP fluorescence was also measured in axons and 
dendrites across the different developmental stages. There were no significant differences 
were observed in its distribution in axons at 4 DIV (82 grey values), 9 DIV (81 grey values) and 
15 DIV (82 grey values) (p=0.999) (Fig. 3.4C). The axon-to-dendrite ratio similarly to protrudin 
decreased with maturation as there was more GFP in the axon compared to dendrites at 4 
DIV (ratio=0.84) compared to 9 DIV (ratio=0.61) (p=0.008) and 15 DIV (ratio=0.68) (p=0.01) 
(Fig. 3.4E). Contrary to protrudin distribution though, this change in axon-to-dendrite 
distribution could be explained by higher amount of GFP observed in the dendrites of more 
mature neurons rather than a change of axonal distribution with maturation. 9 DIV (131 grey 
values) (p=0.0008) and 14 DIV (124 grey values) (p=0.008) neurons had more GFP in their 
dendrites compared to immature neurons at 4 DIV (92 grey values) (Fig. 3.4D). This increase 
in the amount of GFP in dendrites could most likely be attributed to the change in size of 
dendrites and the ability of more GFP to be carried in through diffusion. These results show 
that the reduced axon-to-dendrite ratio of protrudin with maturation is specifically a result of 
a reduced amount of protrudin in the axon rather than changes in its amount in dendrites.   
 
Similar to the experiment above with no GFP, the amount of protrudin in the cell body 
seems to decline with maturation. There is less protrudin in 7-9 DIV (160 grey values) 
(p=0.027) and 14-16 DIV (157 grey values) (p=0.003) compared to younger neurons at 2-4 DIV 
(179 grey values) (Fig. 3.4B). This result is again contradictory to our RNA sequencing results 
in the primary rat cortical neurons (Koseki et al., 2017), but this could be attributed to the 
high density of the neuronal cultures with maturation and the high background staining 



























Figure 3.4 Protrudin’s distribution in the distal axon of GFP-transfected primary cortical neurons at different 
stages of development and GFP distribution. A. Distal axon segments immunofluorescence of protrudin. White 
arrows indicate segments of the axons. Scale bars are 5 µm. B. The intensity of protrudin in the cell body at 4 
DIV is higher than that at 9 DIV and 15 DIV (p=0.002, Kruskal-Wallis statistic=12.06, n=4). C. Bar graph to show 
that GFP amount in the axons of 4 DIV, 9 DIV and 15 DIV neurons does not change with development (p=0.999, 
one-way ANOVA, n=4). D. Bar graph to show that there is more GFP in the dendrites of 9 DIV and 15 DIV neurons 
compared to 4 DIV (p=0.0005, Kruskal-Wallis statistic=15.35, n=4). E. Scatter plot showing that the axon-to-
dendrite ratio of the GFP protein is higher in 4 DIV compared to 9 DIV and 15 DIV neurons (p=0.0007, Kruskal-




2.2 Protrudin overexpression in PC12 cells  
 
Once protrudin mutants were created and promoters were changed from CMV to 
synapsin to enable better expression in neuronal cells (see Methods, Section 3.2.1), they were 
first tested in PC12 cells. When overexpressed in PC12s cells, wild-type protrudin was found 
to co-localise at the end of neurites with Rab11 as previously described (Shirane and 
Nakayama, 2006) (Fig. 3.5). Rab11 is a key molecule involved in the axonal transport of 
integrin growth receptors as described in Introduction, Section 3.2. Protrudin was found to 
colocalise with the integrin alpha 5 receptor in addition to Rab11 at the end of processes (Fig. 
3.5A).  Furthermore, when either the wild-type or any of the two mutants are overexpressed 
in PC12s, treated with nerve-growth factor (NGF) for one day, all forms of protrudin were 
found to localise to the cell body but also to the tip of growing neurites in agreement with 
previous findings (Fig. 3.5B) (Shirane and Nakayama, 2006). The longest neurite and the 
percentage of neurite-bearing cells were measured in cells overexpressing syn-mCh, syn-
mCh-WT, syn-mCh-MUT1 or syn-mCh-MUT2 at 1, 3 and 6 days of NGF treatment. There were 













Figure 3.5 Protrudin overexpression in PC12 cells. A. Immunofluorescent images of PC12 cells transfected 
with syn-mCh-WT protrudin (red) and stained for Rab11 (green) and integrins (magenta). The yellow circle 
represents areas where protrudin, Rab11 and integrins colocalise. Scale bars are 50μm. B. 
Immunofluorescent images of PC12 cells overexpressing syn-mCh-WT (with no NGF or treated with NGF for 
1 day), syn-mCh-MUT1 and syn-mCh-MUT2 (treated with NGF for 1 day). White arrows represent protrudin 
at the tip of growing processes. C. Bar graph to show the average longest neurite in cells expressing each 
construct. There is no significant differences between cells overexpressing syn-mCh, syn-mCh-WT, syn-mCh-
MUT1 and syn-mCh-MUT2 treated with NGF for 1 (p=0.3821, Kruskal-Wallis statistic=3.062, n=1), 3 (p=0.162, 
Kruskal-Wallis statistic=5.134, n=1) or 6 days (p=0.697, Kruskal-Wallis statistic=1.436, n=1). D. Bar graph to 
show the percentage of neurite bearing cells expressing each construct. There is no significant differences 
between cells overexpressing syn-mCh, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 treated with NGF 
for 1 (p=0.345, Kruskal-Wallis statistic=3.317, n=1), 3 (p=0.208, Kruskal-Wallis statistic=4.544, n=1) or 6 days 
(p=0.093, Kruskal-Wallis statistic=6.410, n=1). Error bars represent mean ± SEM. 
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2.3 Overexpression of protrudin constructs result in drastically elevated 
protein levels in primary cortical neurons and PC12 cells  
 
syn-mCh, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 were transfected into 10 
DIV neurons which were then fixed at 14 DIV in ice-cold methanol. Neurons were then stained 
using anti-protrudin antibody (ProteinTech, 1:500) and imaged (Fig. 3.6A, 3.6B). The amount 
of protrudin expression detected by the antibody was measured across the groups in cells 
expressing the different fluorescent constructs. Cells overexpressing wild-type protrudin (48 
times higher) as well as mutant 1 (41 times higher) and mutant 2 (39 times higher) were all 
found to express higher levels of protrudin compared to cells transfected with empty control 
mCherry vector (Fig. 3.6C).  
 
 These results were further validated by overexpressing the same constructs in PC12s 
cells and lysing them 72 hrs post transfection. The protein lysate was analysed by SDS PAGE 
and Western blotting, and then by detection with anti-protrudin antibody. The molecular 
weight of protrudin is 46 kDa and in previous reports the protein has been observed to run 
between 50-60 kDa on a Western Blot (Shirane and Nakayama, 2006; Matsuzaki et al., 2011). 
A clear band above the 50 kDa of endogenous protrudin as well as another band at 75 kDa 
where our wild-type or mutant protrudin constructs were expressed, were detected in all 
samples (Fig. 3.6D). The difference in size could be accounted for as the overexpressed 
protrudin plasmid contains the protrudin protein which is fused to the mCherry protein (29 
kDa). Protrudin has previously been shown to oligomerise so the band at 150 kDa could 
represent protrudin oligomers (Pantakani et al., 2011). 
 
In summary, all the constructs generated here were expressed reliably in primary rat 
cortical neurons and PC12 cells and resulted in substantially higher levels of the protrudin 







Figure 3.6 Overexpression of synapsin-protrudin plasmid constructs resulted in increased protein levels of 
protrudin in primary cortical neurons. A. Immunofluorescent images of endogenous mCherry signal from syn-
mCh control, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 constructs (red). Protrudin amount is 
detected by anti-protrudin immunostaining (green). Images were taken at 40x magnification. Scale bars are 
20 µm. B. When imaging settings are altered to overexpose neurons expressing protrudin constructs, the 
endogenous protrudin in cells not overexpressing plasmids could be observed. C. Bar graph to show the 
average staining intensity of the protrudin in cells expressing the plasmid constructs. Protrudin’s staining 
intensity is significantly higher in cells overexpressing syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 
protrudin compared to cell expressing control syn-mCh vector (p=0.0001, Kruskal-Wallis statistic=117, n=3). 
Error bars represent mean ± SEM. D. Western blot image of PC12 cells lysate of cells overexpressing the four 
different constructs. The blot is stained for protrudin and beta actin to ensure that loading is equal. Blue box 
indicates the endogenous protrudin, red box indicates overexpressed protrudin-mCherry and yellow box 




2.4 Overexpression of protrudin causes minimal morphological changes in 
primary cortical neurons 
Once the overexpression efficiency of our constructs was confirmed, their effect on 
cellular morphology was examined by dendritic tree analysis (Sholl analysis), spine 
morphology analysis and cell body size.  
 Dendritic tree analysis and soma size were obtained using semi-automated software 
– SynD (Schmitz et al., 2011) (see Methods, Section 5.1.1). Cortical neurons were transfected 
at 10 DIV with syn-mCh, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 protrudin 
constructs and fixed at 14 DIV in PFA (Fig. 3.7A). Images were taken at 40x magnification and 
imported into the software. Cell bodies were first identified and then neurites extending from 
the cell body out to a radius of 250 µm. The number of processes crossing imaginary 
concentric circles irradiating from the cell body towards the periphery of the cell (every 10 
µm) were automatically counted. There were no significant changes detected in the cell body 
size of cortical neurons expressing each of the four constructs (Fig. 3.7B). The total dendritic 
length of cells expressing syn-mCh-MUT2 was found to be longer compared to cells expressing 
syn-mCh only (p=0.04) suggesting that mutant 2 protrudin might enhance dendritic length 
(Fig. 3.7C). Interestingly, Sholl analysis revealed that there are no significant differences 
across the different conditions in dendritic tree complexity (Fig. 3.7D) although there is a 
trend towards cells expressing syn-mCh-MUT2 to have more complex morphologies between 
100-200 microns away from the cell body compared to syn-mCh only.  
 The number and type of dendritic spines was also examined. It was initially observed 
that overexpressed protrudin is not evident in dendritic spines (data not shown), therefore 
co-transfection with a GFP-expressing construct was required to analyse spine morphology. 
Primary cortical neurons were transfected with GFP together with either syn-mCh, syn-mCh-
WT, syn-mCh-MUT1 or syn-mCh-MUT2 at 10 DIV and fixed at 14 DIV. The cells were then 
imaged at 63x. Spine number and morphology in a 20 µm length from the cell body were 
examined in the Image J Fiji software using the Cell Counter plugin (Schindelin et al., 2012). 
Each spine was categorised as either stubby, mushroom or thin in accordance to previously 
defined categories (Hoogenraad and Akhmanova, 2010). Protrudin overexpression (wild-type 
or mutants) did not have any significant effects on the number or the morphology of dendritic 
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spines (Fig. 3.8). Interestingly, it was observed that syn-mCh-MUT2 protrudin overexpression 
resulted in protrudin localising more readily to the dendritic spines compared to 
overexpression of syn-mCh-WT or syn-mCh-MUT1 (Fig. 3.8A).  
 In conclusion, overexpression of wild-type or either of the two constitutively 
phosphorylated mutant forms of protrudin causes minimal changes in the morphology or 


















Figure 3.7 Overexpression of synapsin-protrudin plasmid constructs causes minimal morphological changes 
in primary cortical neurons at 14 DIV in culture. A. Immunofluorescent images of endogenous mCherry signal 
from syn-mCh control, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 constructs (red). Images were taken 
at 40x magnification. Scale bars are 20 µm. B. Bar graph to show that there are no significant differences in 
the average soma area in cells expressing the four different mCherry constructs (p=0.1365, Kruskal-Wallis 
statistic=5.54, n=4). C. Bar graph to show the dendritic tree total length across the different conditions. Cells 
overexpressing syn-mCh-MUT2 seem to have a more complex dendritic structure than cells overexpressing 
syn-mCh control (p=0.04, Kruskal-Wallis statistic=7.391, n=4). D. Line graph to show the dendritic tree 
complexity of neurons transfected with each construct - the number of intersections at each distance from 
the cell soma was plotted for each condition. There are no significant differences between the conditions 












Figure 3.8 Overexpression of synapsin-protrudin plasmid constructs causes no changes to the dendritic 
spine morphology in 14 DIV primary cortical neurons. A. Representative z-project images of 20 µm z-stack 
sections examined for dendritic spine number and morphology in cells overexpressing syn-mCh only, syn-
mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2. Images were taken at 63x, 3.5 zoom. White arrows point to 
individual spines. Scale bars are 5µm. B. Pie charts of the percentages of different spine morphology (thin, 
stubby, mushroom) in each condition. C. Box plot to show the number of dendritic spines in a 20 µm 
segment. No significant differences were observed in the number or type of dendritic spines (p=0.075, 
Kruskal-Wallis statistic=6.89, n=2). D. Box plot to show the spine area (µm2) per the total number of spines 
for each condition. There were no significant differences between the four conditions (p=0.127, Kruskal-




2.5 Overexpression of protrudin enhances axon outgrowth in primary 
cortical neurons  
As described above, overexpression of wild-type or mutant protrudin does not 
enhance NGF-induced neurite outgrowth in PC12 cells (Fig. 3.5). Overexpression of protrudin, 
however was previously reported to enhance neuronal neurite outgrowth in rat hippocampal 
neurons at early stages of development (Shirane and Nakayama, 2006). It was therefore not 
clear whether protrudin would function to promote axon growth in primary cortical neurons 
developing in vitro. Rat primary cortical neurons were, therefore, transfected with syn-mCh, 
syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 protrudin constructs at 2 DIV and fixed in 
3% PFA at 4 DIV (Fig. 3.9A). The longest process, the number of neurites per cell and the total 
dendritic length were measured.  
 
The longest neurite (classified as the axon) in cortical neurons overexpressing syn-
mCh-MUT1 (921 µm) was significantly longer than syn-mCh only (731 µm) (p=0.005) (Fig. 
3.9C). Despite not reaching significance, the longest neurites of cells overexpressing syn-mCh-
WT (890 µm) or syn-mCh-MUT2 (843 µm) showed a trend towards being longer than syn-mCh 
only (p=0.152 and 0.239 respectively). The total dendritic length of syn-mCh-MUT1 (265 µm) 
and syn-mCh-MUT2 (247 µm) was shorter than syn-mCh only (359 µm) (p=0.02 and p=0.002 
respectively) but not from syn-mCh-WT (280 µm) (p=0.157) (Fig. 3.9D). Lastly, the number of 
primary neurites (defined as the neurites originating from the cell body) was not found to be 
significantly different between syn-mCh (7.15 neurites), syn-mCh-WT (6.49 neurites), syn-
mCh-MUT1 (6.49 neurites) and syn-mCh-MUT2 (6.28 neurites) (p=0.157) (Fig. 3.9E).  
 
This experiment, however had some caveats which are discussed in Discussion in 
detail. One caveat, for example, is that when overexpressing protrudin in primary cortical 
neurons, the amount reaching the distal axon is smaller than that reaching the proximal axon 
(Fig. 3.9B). During data collection, it was noticed that some axons of neurons expressing 
protrudin-containing constructs are very long and it becomes hard to trace them as the 
amount of protrudin declines and the fluorescence is not bright enough at 20x to trace. This 
immediately introduces a bias towards only measuring length of axons which could be traced, 




Figure 3.9 Overexpression of synapsin-protrudin constructs enhances axon outgrowth in 4 DIV primary cortical 
neurons. A. Representative images of 4 DIV neurons overexpressing syn-mCh only, syn-mCh-WT, syn-mCh-MUT1 
and syn-mCh-MUT2. Images were taken at 20x. B. A line graph to show reduced amount of protrudin-mCherry 
signal in distal axon compared to the proximal axon in 14 DIV neurons. C. A bar graph to show that syn-mCh-
MUT1 protrudin has longer average longest neurites than syn-mCh only but not than syn-mCh-WT or syn-mCh-
MUT2 (p=0.008, Kruskal-Wallis statistic=11.82, n=4). D. A bar graph to show that syn-mCh-MUT1 and syn-mCh-
MUT2 protrudin have smaller dendritic length compared to syn-mCh but not to syn-mCh-WT (p=0.002, Kruskal-
Wallis statistic=14.62, n=4). E. A bar graph to show that there is no significant difference between the number 
of primary neurites in 4 DIV cortical neurons overexpressing syn-mCh only, syn-mCh-WT, syn-mCh-MUT1 and 





potential way to improve this experiment. However, similar observations were made even 
when the antibody was used (data not shown). 
 
In order to address this problem, an additional experiment was carried out where 2 
DIV primary cortical neurons were transfected with much brighter constructs – CAG-GFP 
control, CAG-GFP-WT and CAG-GFP-MUT2 protrudin (Fig. 3.10A). These constructs were 
created as described in Methods, Section 3.2.3 in order to make viruses for the in vivo 
experiments described in Chapter 4. As only protrudin mutant 2 was selected to be included 
in in vivo experiments due to its effects on axon regeneration in vitro (see Chapter 4), mutant 
1 protrudin was not included in these neurite outgrowth experiments.  
 
Our results showed that cells overexpressing CAG-GFP-MUT2 (444 µm) had an axon 
significantly longer than cells overexpressing CAG-GFP only as a control (342 µm) (p=0.006) 
(Fig. 3.10B). Despite not reaching significance CAG-GFP-WT (387 µm) longest process was 
longer than CAG-GFP only (p=0.493) (Fig. 3.10B). Contrary to our previous experiment, the 
total dendritic length was not significantly different between cells overexpressing CAG-GFP 
control (140 µm), CAG-GFP-WT (144 µm) or CAG-GFP-MUT2 (137 µm) protrudin (p=0.668) 
(Fig. 3.10C). Similar to our previous findings, the number of primary neurites was not 
significantly different between CAG-GFP control (5.75 neurites), CAG-GFP-WT (5.98 neurites) 











Figure 3.10 Overexpression of CAG-GFP-protrudin plasmid constructs enhances neurite outgrowth in 4 DIV 
primary cortical neurons. A. Representative images of 4 DIV neurons overexpressing CAG-GFP control, CAG-
GFP-WT and CAG-GFP-MUT2 constructs. Images were taken at 20x. B. A bar graph to show that CAG-GFP-MUT2 
protrudin-expressing cells have longer average longest neurites than CAG-GFP only but not than CAG-GFP-WT 
(p=0.008, Kruskal-Wallis statistic=9.494, n=4). C. A bar graph to show that there is no significant difference 
between the total dendritic length in 4 DIV cortical neurons overexpressing CAG-GFP control, CAG-GFP-WT and 
CAG-GFP-MUT2 (p=0.668, Kruskal-Wallis statistic=0.806, n=4). D. A bar graph to show that there is no significant 
difference between the number of primary neurites in 4 DIV cortical neurons overexpressing CAG-GFP control, 









This chapter focuses on examining the localisation of endogenous protrudin in primary 
cortical neurons and on studying the effects of wild-type and mutant protrudin 
overexpression on cell morphology and function. Here, it was demonstrated in two separate 
paradigms that endogenous protrudin abundance in the axon compared to dendrites declines 
with maturation. It was also found that overexpression of wild-type and two phosphomimetic 
forms of protrudin in PC12 cells shows similar distribution to previously published reports 
where protrudin re-distributes from the pericentrosomal compartment to the end of growing 
neurites upon NGF treatment. Overexpression did not lead to an effect on neurite outgrowth 
of PC12 cells upon NGF treatment. Furthermore, overexpression of wild-type and the 
phosphomimetic mutant forms of protrudin resulted in highly increased amount of the 
protrudin protein in primary cortical neurons but had minimal effects on cell morphology in 
terms of soma size, dendritic tree complexity or spine number and type. Lastly, the two 
phosphomimetic mutants showed promising ability to improve neurite outgrowth in primary 
cortical neurons.  
 
In previous reports, protrudin has been detected in mouse primary hippocampal 
neurons at 1 DIV and 3 DIV. At 1 DIV protrudin was found to be localised to the 
pericentrosomal compartment and to growing neurites. Later on in development (3 DIV), the 
distribution of protrudin changed and it was abundant in axons, dendrites and especially at 
the growth cone (Shirane and Nakayama, 2006). Most previous studies examining protrudin 
distribution were carried out either in cancer cells or in immature neurons. This prompted us 
to examine the distribution of the protrudin protein in rat primary cortical cultures over 
development from 2-4 DIV to 14-16 DIV (electrically-active, Koseki et al., 2017) and to explore 
whether protrudin is distributed differentially in axons and dendrites similar to integrins and 
Rab11 distribution (Eva et al., 2010; Franssen et al., 2015; Andrews et al., 2016). Upon staining 
for endogenous protrudin, it was found that the axon-to-dendrite distribution of protrudin is 
much higher at earlier stages (2-4 DIV) than at later stages of neuronal development and 
differentiation (7-9 DIV and 14-16 DIV) (Fig. 3.2). This phenomenon could be explained by the 
fact that protrudin seems to be more abundant in the axons at early compared to later stages 
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of development as there is no change in its amount in the dendrites with maturation. These 
results suggest that early on in development protrudin is needed in the newly extending axons 
but then as neurons mature and polarise, the protrudin protein is redistributed towards the 
cell body and dendrites. This distribution is very similar to other proteins such as Rab11 and 
integrins which are essential for neurite growth and axon transport (Eva et al., 2010, 2012; 
Franssen et al., 2015; Andrews et al., 2016). 
  
This experiment, however, had several caveats: firstly, the amount of protrudin in the 
axon was only measured at the AIS as this is where the neurofascin stain was mostly visible 
so the amount of protrudin in the distal axons could not be accounted for. Secondly, the 
neurofascin protein is not expressed at high levels during 2 DIV (Boiko et al., 2007; Yang et al., 
2007) so in some of the cases the longest process showing protrudin-positive staining was 
assumed to be the axon. Furthermore, because no cytosolic protein marker was used to label 
all neuronal processes, the difference of protrudin’s abundance in thick vs. thin processes 
could not be observed and only processes containing the highest amounts of protrudin which 
could be visually identified were used in the experiment. Lastly, the amount of protrudin in 
the cell body seemed to decline with maturation which is contradictory to our RNA 
sequencing data which points to relatively similar amount of the gene during development. 
This discrepancy could be attributed to the much higher confluency of the more mature 
neurons accounting for much higher background staining resulting in artificially lower soma 
amount levels of protrudin.  
 
In order to improve the above experiment, primary cortical neurons were transfected 
with a GFP construct. GFP is a cytosolic protein so it readily diffuses in all neuronal processes 
and it allows for their visualisation. This experiment confirmed the observation that the axon-
to-dendrite distribution of protrudin changes with maturation (Fig. 3.3D). Again, this 
reduction was attributed to reduced protrudin levels in the axon rather than a change in the 
dendrites confirming our previous results. This experiment allowed for the visualisation of the 
distal axon which revealed that there is very little endogenous protrudin present in the distal 
axon at later stages of development (Fig. 3.4A). This observation led to the hypothesis that 
overexpressing protrudin in mature neurons, could restore developmental growth state as 
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one of protrudin’s functions in the cell is to aid the anterograde movement of recycling 
endosomes containing growth-molecules to the tip of axons.  
 
The GFP protein amount was also measured in axons and dendrites to act as a control 
protein. Interestingly, the axon-to-dendrite ratio of GFP seems to also decline with 
maturation (Fig. 3.4B-E) – this effect was, however a result of increased amount in the 
dendrites possibly due to their growth with maturation rather than a change in the axon. This 
suggests that the changes observed with protrudin distribution are axon-specific.  
 
Overall, there were difficulties in validating the anti-protrudin antibody used for the 
experiments above as no reliable knock-down model of rat endogenous protrudin was 
achieved (see Chapter 5). Therefore, the results obtained should be considered with caution. 
Currently, other rat cell lines are being tested to create a knockdown system and knock-out 
mouse tissues is in the processes of being obtained.  
 
Mutagenesis of protrudin was carried out in order to validate whether mimicking 
phosphorylation of protrudin at ERK phosphorylation sites can potentially have similar effects 
to those induced by NGF treatment and ERK/MAPK activation without these pathways 
actually being active. Because separate concurrent experiments in the lab are finding that 
signalling through pathways downstream of growth factor receptors also declines with 
development, it was hypothesised that mimicking aspects of their activation such as protrudin 
phosphorylation might improve neuronal growth potential. This is particularly important in 
the context of improving growth after injury as discussed in Chapter 4.  
 
Mutagenesis site selection was carried out according to the functional mutants which 
Shirane and Nakayama, 2006 identified. They showed that mutants lacking the same 
phosphorylation site combinations as in mutant-1 and mutant-2 in this study result in reduced 
capacity of protrudin for binding to Rab11 upon NGF treatment and ERK/MAPK pathway 
activation. This suggested that phosphorylation of protrudin at multiple sites in the 
combinations shown might be necessary for its interaction with Rab11. An interesting 
observation is that mutant-1 phosphorylation sites are located near the KIF5A-binding site 
and mutant-2 phosphorylation sites are located near the Rab11-binding site which could 
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possibly account for different activity of the two mutants. The main purpose for creating a 
phosphomimetic form of the protrudin protein was to examine its effects on Rab11-
dependent transport of endosomes along axons and the effects that any change might have 
on the regenerative abilities of neurons. To begin with, protrudin constructs contained the 
cytomegalovirus (CMV) promoter so when attempts were made to transfect primary neuronal 
cultures, the transfections efficiencies were extremely low. This necessitated changing the 
promoters of all constructs to a more neuron-specific promoter such as synapsin (SYN) (see 
Methods, Section 3.2.1. Once the synapsin promoter was cloned into all constructs, the 
transfection efficiency and selectivity were much better, and all further experiments were 
carried out using these constructs.  
 
The protrudin mutants were first overexpressed in PC12 cells to test their toxicity and 
effects on PC12 differentiation. Firstly, protrudin was found to co-localise with a known 
interactor – Rab11 but also with the integrin receptor which is found in Rab11-recycling 
endosomes (Fig. 5A). Interestingly, overexpression of syn-mCh-MUT1 and syn-mCh-MUT2 in 
PC12 cells was not sufficient to promote neurite extension in PC12 cells (data not shown). 
This observation suggests that complete activation of the ERK/MAPK pathway by NGF is 
required for neurite extension in PC12 cells and mimicking a single aspect of its downstream 
effects does not lead to its full effects. For example, it has been shown before that ERK 
activation results in ERK translocation to the nucleus where it induces a set of neuron-specific 
genes needed for neurite outgrowth (Vaudry et al., 2002). Furthermore, the phosphorylation 
of other downstream targets such as Rap1 aids the sustained activation of the ERK pathway 
and is required for the ability of PC12 cells to be electrically excitable – another neuron-like 
feature induced by NGF treatment (York et al., 1998). Although protrudin phosphomimetic 
mutants do not on their own induce neurite outgrowth in PC12 cells, they show similar 
redistribution to wild-type protrudin upon NGF treatment – from the pericentrosomal 
compartment to the end of growing processes (Fig. 3.5B). Overexpression of wild-type or 
mutant protrudin also did not have an effect of the length of newly growing process or on the 
percentage of neurite-bearing cells after 1, 3 or 6 days of NGF treatment (Fig 3.5C, 3.5D).  
  
 Before any further experiments were carried out, it was important to examine 
whether overexpression of wild-type or any of the phosphomimetic mutants cause any 
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morphological changes in primary cortical neurons. No changes were detected in the cell body 
area or the complexity of the dendritic tree although syn-mCh-MUT2 protrudin showed a 
small increase in total dendritic length compared to control (Fig. 3.7). Furthermore, there 
were no significant differences between the number or type of dendritic spines in either of 
the condition (Fig. 3.8). An interesting observation from this experiment is that when wild-
type or syn-mCh-MUT1 protrudin is overexpressed, very little protrudin is found in the spines. 
This could be due to protrudin’s association with KIF5 – a microtubule-associated motor 
protein (Matsuzaki et al., 2011) whereas the structure and the remodelling of dendritic spines 
is mostly dependent on the actin cytoskeleton (Hotulainen and Hoogenraad, 2010). Neurons 
overexpressing syn-mCh-MUT2, however, seem to be found more often in spines suggesting 
that this mutant might be interacting with the actin cytoskeleton and its adaptors too – a 
hypothesis not yet tested. Overall, overexpression of wild-type or phosphomimetic protrudin 
in mature neurons did not cause any major morphological changes that could interfere with 
normal cell function.  
 
 Lastly, the effects of protrudin overexpression on neurite outgrowth in immature 
neurons were also examined. Initially, wild-type and mutant protrudin fused to mCherry were 
overexpressed in neurons and only Syn-mCh-MUT1 was shown to increase neurite outgrowth 
although wild-type and mutant 2 protrudin also showed a trend towards increased neurite 
outgrowth (Fig. 3.9). The total dendritic length of neurons overexpressing all forms of 
protrudin was shorter which could possibly be explained as a compensation for using more 
cellular building blocks to build a longer axon. Nevertheless, this experiment had a major 
caveat – during the quantification phase it was observed that some really long axons “dim 
out” and could not be traced to the axon tip in the culture which automatically introduced a 
bias that only the shorter, brighter axons were accounted for. The drop in mCherry intensity 
was measured in older neurons with long axons and indeed, it was shown that the intensity 
drops dramatically in the distal axon (Fig. 3.9B). Interestingly, protrudin abundance in growth 
cones is very prominent and growth cones could be found easily throughout the culture dish 
at these early stages of development (data not shown). In order to improve the tracing of 
protrudin-transfected axons, an alternative approach could be used where neurons are co-
transfected with a brighter GFP construct or a mixed culture with GFP-positive neurons from 
transgenic animals is used (Gomis-Rüth et al., 2014).  
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In order to improve this experiment, different constructs which were initially created for 
viral production for in vivo experiments where protrudin is fused to GFP instead of mCherry, 
were used as the fluorescent protein signal was much brighter. Mutant 1 was not included in 
these experiments as mutant 2 was the only mutant selected for further use in vivo due to its 
effects on axon regeneration in vitro (see Chapter 4). Overexpression CAG-GFP-MUT2 induced 
increased neurite outgrowth and CAG-GFP-WT showed a similar trend towards increased 
neurite outgrowth (Fig. 3.10B). There was no effect of protrudin overexpression on total 
dendritic length or number of primary neurites (Fig. 3.10C, D).   
 
These experiments suggest that both protrudin mutants might have some effect on 
increasing neurite outgrowth in primary cortical neurons. Interestingly, all forms of protrudin 
accumulated at the tip of the growing axons (Fig. 3.9A, 3.10A) suggesting that protrudin might 






















CHAPTER IV: PROTRUDIN ENHANCES AXON 









This chapter explores the ability of wild-type and mutant protrudin overexpression to aid 
axon regeneration in primary cortical neurons after laser axotomy and in intact animals after 
an optic nerve crush. Protrudin is also tested in a neuroprotective paradigm in a rat model of 
glaucoma, a neurodegenerative disease of the optic nerve.  
 
1. Introduction 
In this chapter, three different models of CNS axon regeneration were utilised in order to 
test the ability of wild-type and constitutively phosphorylated protrudin to enhance axon 
regeneration.  
 
1.1 In vitro Laser Axotomy  
 
The in vitro laser axotomy model of primary cortical neurons is a newly developed 
method which allows for injury of individual axons and monitoring of their regeneration over 
14 hours after the injury. This method has previously been used in our laboratory in two 
separate studies. In 2017, Koseki et al. showed that E18 primary cortical neurons grown in 
vitro develop electrical properties between 8 and 16 DIV and that they form coordinated 
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networks. They also showed that this maturational change is accompanied by gene 
expression changes as observed by RNA sequencing analysis. Maturation of cortical neurons 
in vitro resulted in an increase in the expression of synaptic proteins and a decrease in the 
levels of proteins involved in neuronal development (Koseki et al., 2017). The regenerative 
potential of the cortical cultures was also examined: immature neurons (4 DIV) regenerated 
better after laser axotomy (63%) compared to more mature neurons (24 DIV, 8%). 
Furthermore, axons cut distally (>800 µm) from the cell body regenerated more poorly than 
axons cut proximally to the cell body at all developmental stages. Lastly, Koseki and colleagues 
(2017) showed that axon regeneration of mature cortical neurons could be improved in this 
model by a genetic manipulation. In this case, overexpression of Rab11 (a small GTPase 
involved in the axonal transport of growth molecules and which is normally excluded from 
mature axons) resulted in enhanced axon regeneration (38%) compared to control (11%). This 
increase in regenerative potential was accompanied by an increase in the trafficking of the 
growth-associated integrin alpha5 receptor along the axon. This was the first proof of 
principle experiment in our model that genetic manipulations of axon transport machinery 
could influence axon regeneration in the CNS in vitro. 
 
Another study from our laboratory further strengthened the reproducibility and the 
validity of our in vitro axotomy method and the idea that enhancement of the transport of 
growth-molecules can boost regeneration. In their study, Eva and colleagues (2017) show that 
blockade of an ARF6 activator – EFA6, which is enriched at the axon initial segment (AIS) 
allows for enhanced transport of growth-promoting cargo along the axon and enhances 
regeneration after laser axotomy (58%) compared to control (27%). Interestingly, EFA6 is not 
found at the AIS in regenerative DRG neurons and its overexpression in these neurons 
suppresses their regenerative properties (Eva et al., 2017). 
 
 In summary, two genetic manipulations targeting the transport of growth-promoting 
molecules along mature CNS axons have successfully promoted axon regeneration after laser 
axotomy in our model. Therefore, in vitro laser axotomy in primary cortical neurons was found 
to be a suitable model to test the ability of wild-type and constitutively phosphorylated 
protrudin to enhance axon regeneration in a dish.  
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1.2 Optic Nerve Crush in Mice 
 
In order to test protrudin overexpression as a regenerative intervention of protrudin in 
the CNS in vivo, we used the optic nerve crush model. The optic nerve is a white matter tract 
connecting the retinal ganglion cells (RGCs) in the retina to their synaptic targets in the 
contralateral side of the brain. The optic nerve tracts run ipsilaterally from the retina until 
they reach the optic chiasm – an X-shaped structure where the majority of the axons within 
each tract cross to the contralateral part of the brain and where they synapse within the 
superior colliculus (Fig. 4.1). The injury in an optic nerve crush model is normally inflicted 1-
3mm behind the eyeball and because of the isolation of the optic nerve from any surrounding 
grey matter, the injury is purely axonal (Templeton and Geisert, 2012). Furthermore, the 
injury results in a substantial loss of RGC (85-90%) in the retina 2-3 weeks after injury which 
also allows for testing the effects of different manipulations on RGC survival. This model was 
used in the current experiments because it is highly reproducible, regeneration could be 
observed in only 1-2 weeks after injury, and it allows for the testing of both axon regeneration 













Figure 4.1 A schematic diagram of the anatomy of the optic nerve and the location of the optic nerve crush in a 
mouse optic nerve crush model (adapted from Tang et al., 2011).  
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 Several studies so far have successfully targeted intracellular pathways to promote 
axon regeneration after optic nerve crush. For example, deletion of PTEN (phosphatase and 
tensin homolog), a negative regulator of the mammalian target of rapamycin (mTOR) resulted 
in improved RGC survival (45%) compared to control (20%) as well improved axon 
regeneration 2 weeks post crush in transgenic mice with some axons reaching the optic 
chiasm (but not extending beyond) after 4 weeks post injury (Park et al., 2008). This effect 
was attributed to maintained activation of the mTOR intracellular pathway which enhances 
regeneration and survival. In addition, when PTEN deletion is combined with deletion of 
another intracellular inhibitor - suppressor of cytokine signalling 3 (SOCS3), a negative 
regulator of Janus kinase/signal transducers and activators of transcription (JAK/STAT) 
pathway, an additive effect on RGC survival and regeneration was observed (Sun et al., 2011). 
This study is seminal in showing that activating two separate intracellular pathways that 
converge to trigger similar molecular effects, can improve CNS axon regeneration. It was also 
the first study to show regeneration beyond the optic chiasm with some axons entering the 
brain although no successful connections were formed (Sun et al., 2011).  
 
Recently, co-deletion of PTEN and SOCS3 as well as another treatment targeting 
several growth factors – a combination of osteopontin (OPN)/insulin-like growth factor 1 
(IGF1)/ciliary neurotrophic factor (CNTF), were shown to dramatically enhance regeneration 
4 weeks after injury where regenerated axons reach the superior colliculus in the brain and 
synapse (Bei et al., 2016). The regenerated axons were, however, incapable of electrical 
conduction and despite robust, long-range regeneration, there was no functional recovery.  
This deficiency was corrected for by introducing a potassium channel blocker which 
stimulated the firing activity of newly regenerated neurons, which led to a modest 
improvement in visual acuity (Bei et al., 2016). Electrical activity is certainly beneficial for 
repair: in a different study, elevation of mTOR signalling (by injecting an mTOR activator, 
cRheb1) coupled with visual stimulation or chemogenetic activation of electrical activity, 
resulted in RGCs regenerating to the correct brain areas, forming functional synapses and 
improving outcome (Lim et al., 2016). Many other intracellular interventions have been so far 
used to promote axon regeneration and RGC survival after optic nerve crush such as elevation 
of cAMP, modulation of multiple transcription factors or expression of CNTF (Leaver et al., 
2006; Moore et al., 2009; Kurimoto et al., 2010; de Lima et al., 2012). Advances in technology 
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have made it possible to track the regenerative pathways of individual cells using clearance 
techniques and confirmed that long-range axon regeneration is indeed possible, however 
guidance and targeting to the correct areas in the brain is still a formidable challenge in the 
field due to the highly dynamic and complex pattern of growth of newly regenerating axons 
and the lack of appropriate guidance cues (Luo et al., 2013; V Pernet et al., 2013; Bray et al., 
2017). 
 
In summary, the optic nerve crush model has proven to be a reliable model to test 
intracellular interventions for the improvement of axon regeneration, neuronal survival and 
restoration of function after injury but there remains much to learn about the mechanisms 
required for successful regeneration. Studying these may help to reveal strategies which allow 
for guided regeneration. Previous studies in the lab have identified trafficking interventions 
which might allow for guided growth as a result of the axonal targeting of integrins. Integrins 
can drive guided regeneration of sensory axons through the spinal cord (Cheah et al., 2016), 
but it has not been tested whether this might be similarly possible in the optic nerve. 
 
So far, intracellular interventions targeting the trafficking of growth-molecules into 
CNS axons have been used to promote axon regeneration in vitro, but these have not been 
tested after optic nerve crush. AAV-mediated expression of wild-type and mutant protrudin 
in the current study is the first of its kind directly targeting axon trafficking pathways to 
improve axon regeneration and survival. Through this, we aim to achieve an influx of growth-
promoting machinery such as integrins in recycling endosomes in order to provide guided 
growth to the original brain targets of the injured axons.  
 
1.3 Laser Glaucoma Model in Rats  
 
Glaucoma is a condition which features sustained damage to the optic nerve. One of 
the main associated risks for developing glaucoma is increased intraocular pressure (IOP) due 
to ineffective drainage of intraocular fluid. In severe cases (approximately 10% of patients), 
this results in optic nerve axon degeneration, retinal ganglion cell death, and ultimately 
blindness. IOP lowering treatments are already existent in the clinic, although they are only 
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effective in some patients whereas others continue deteriorating. Glaucoma is the leading 
cause of blindness around the world and currently there is no treatment for protecting the 
cells of the retina or for repairing the damaged nerves (Glaucoma Facts and Stats | Glaucoma 
Research Foundation, 2019). 
 
Several animal models exist which mimic some of the main characteristics of 
glaucoma. The model used in this study was first described in 2002 (Levkovitch-Verbin et al., 
2002) and was later refined in 2010 (Marina, Bull and Martin, 2010). Increased IOP is the main 
risk for glaucoma, therefore many animal models have focused on elevating IOP and studying 
the effects downstream of that event. Our model relies on laser photocoagulation (40-60 laser 
pulses at 532nm wavelength) of the trabecular meshwork surrounding the eye. This normally 
drains intraocular fluid (aqueous humour), so its disruption results in a build-up of fluid and 
ocular hypertension (Fig. 4.2). This model is simple, relatively fast as many animals could be 
treated in a single session and IOP elevation is observed in most treated eyes (Marina, Bull 
and Martin, 2010). The increase in IOP is transient with ocular pressure going back to normal 
values after 24-48 hours with all eyes returning back to basal level pressure 7 days post injury. 
For this reason, two insults are required in the space of a week in order to ensure that 
substantial neuronal damage is triggered. The elevated IOP in turn results in a loss of RGCs in 
the retina and in some cases up to 50% axonal loss 6 weeks after elevation making this a 


















Figure 4.2 A schematic diagram of the anatomy of the eye showing the trabecular meshwork targeted by laser 
treatment in our model (adapted from Schultz J., 2016).  
 
 Several studies have already showed promising neuroprotective results in this model. 
Neurotrophins such as brain-derived neurotrophic factor (BDNF) and its receptor tyrosine 
kinase B (TrkB) have previously been shown to be neuroprotective to RGCs. Recently, 
however, the retrograde transport of BDNF and TrkB along the optic nerve back to the RGC 
soma was found to be obstructed in experimental glaucoma as well as in patients, which could 
contribute to the observed cell death (Pease et al., 2000; Quigley et al., 2000). Many studies 
since have focused on improving the TrkB-BDNF transport and signalling in RGC soma as a 
neuroprotective strategy. For example, Martin et al. (2003) injected an AAV-virus 
overexpressing BDNF intravitreally two weeks before inducing high IOP in an experimental rat 
model of glaucoma. They showed that increasing the levels of BDNF in the eye resulted in 
improved neuronal survival (32% RGC loss) compared to control (52% RGC loss) (Martin et al., 
2003). In a different study, however no positive effect of BDNF or a combined treatment 
between BDNF and CNTF (ciliary-derived neurotrophic factor) was observed in the same 
model whereas CNTF alone was found to reduce RGC loss after glaucoma induction by 15 % 
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(Pease et al., 2009). This effect could have been a result of downregulated expression of the 
BDNF receptor with high levels of the ligand present or insufficient axonal transport as shown 
previously. Recently, Osborne and colleagues (2018) refined the previous study and showed 
that simultaneous expression of BDNF and TrkB from a single virus, resulted in enhanced 
neuroprotection of RGCs as well as of  retinal axons in the optic nerve after elevation of IOP 
in the same experimental model of glaucoma described here (Osborne et al., 2018). 
  The TrkB receptor has previously been implicated as a cargo in Rab11-recycling 
endosomes (Lazo et al., 2013; Song et al., 2015). Therefore, we hypothesised that 
overexpression of wild-type and specifically constitutively phosphorylated protrudin might 
additionally result in enhanced transport of this growth-receptor along the axons resulting in 
neuroprotection similar to the studies described above. Work to test this hypothesis is 
ongoing in the lab, and so it is not described here. Furthermore, this model was also selected 
so that the effects of protrudin on another growth-related receptor – integrin alpha 9 could 

















2.1 Overexpression of protrudin enhances axon regeneration of 
primary cortical neurons in vitro after laser axotomy 
 
Rat primary cortical neurons were grown in culture for 10 days and were transfected 
with the constructs described previously – GFP control, syn-mCh-WT, syn-mCh-MUT1 and 
syn-mCh-MUT2 protrudin (see Methods, Section 3.1). Their regenerative abilities were tested 
at 13-17 DIV in an in vitro axotomy model where the injury is inflicted by a laser and injured 
axons are imaged for 14 hours post injury to look for characteristics of regeneration (Fig. 4.3, 
Table 4.1). All axons were identified based on morphological appearance as the longest 
neuronal process in the cell. They were traced and cut at least 600 µm away from the cell 
body as previously described by Koseki et al., 2017.   
 
Figure 4.3 Laser axotomy model. A. Experimental set up for carrying out laser axotomy. 10 DIV neurons were 
transfected with GFP control, syn-mCh-WT, syn-mCh-MUT1 or syn-mCh-MUT2 protrudin using magnetofection. 
Axons were cut at 13-17 DIV at least 600 µm away from the cell body using a laser beam and were monitored 
for regeneration for 14 hours after injury. Yellow star indicates the location of the injury (adapted from Koseki 
et al., 2017). B. An example of non-regenerating and regenerating axons. The red arrows at 0hours post-injury 
indicate the injury site. The red arrows at 14 hours post-injury indicate a regenerating axon.  
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Neurons which died and fragmented during the imaging procedure were excluded 
from the analysis and experiments where more than 50% cell death occurred were excluded. 
Axons were cut as far as possible from visible branch points and if upon axotomy a branch 
point became visible within 200 µm of the cut, that particular neuron was excluded from the 
analysis. Regeneration was classified as the process of re-growth of a cut axon for more than 
50 µm after 14 hours of regeneration. Several regenerative parameters were measured in our 
experiments (Table 4.1). At least three independent experiments were carried out per 
experimental condition and 30-50 neurons were analysed in each group. 
 
Regeneration factor  Regeneration factors were measured as below when a 
neuron was categorized as “a regenerator” 
Retraction distance  The length of axon that was lost between the location of 
axotomy and the initial retraction bulb  
Regeneration percentage The number of neurons that regenerated, over the total 
neurons which formed a retraction bulb  
Regeneration initiation 
time  
The time between the retraction bulb formation and the start 
of a steady extension lasting more than 1hr and leading to 
regeneration  
Regeneration distance 
after 2 hours  




The length of axon that extended 14 hours after axotomy 
Growth cone area  The maximum growth cone area after regeneration initiation  
Branching  The newly growing axon branches into several newly formed 
individual branches while regenerating  
Ectopic Growth  A new branch grows for more than 50μm within 100μm from 
the retraction bulb 
 
Table 4.1 Table to explain the regeneration factors measured during laser axotomy (adapted from Koseki et al., 
2017). 
 
Our initial hypothesis stated that constitutively phosphorylated protrudin (either 
mutant 1 or mutant 2) will associate more readily with Rab11-GDP than wild-type protrudin, 
therefore increasing the anterograde transport of growth molecules and ultimately improving 
regeneration. In this experiment, both constitutively phosphorylated protrudin forms (syn-
mCh-MUT1 - 64% and syn-mCh-MUT2 - 70%) but also wild-type protrudin (syn-mCh-WT - 
60%) increased the proportion of regenerating axons compared to control (GFP control - 24%) 
(Fig. 4.4A). Moreover, syn-mCh-MUT1 (6.2hrs) and syn-mCh-MUT2 (5hrs) regenerated faster 
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than the cells overexpressing GFP control (8.8hrs) (Fig. 4.4B). syn-mCh-WT (6.5hrs) also 
regenerated faster than control – this difference, however did not reach statistical 
significance. In addition, syn-mCh-WT (155 µm) and syn-mCh-MUT2 (180 µm) regenerated 
further distances than the control (95 µm) (Fig. 4.4C). Syn-mCh-WT (76 µm) also showed 
increased regeneration length after 2 hours of initial regeneration compared to GFP only (43 
µm) (Fig. 4.4D). No significant differences were observed in the retraction distance between 
conditions (Fig. 4.4E). The maximum growth cone area was reduced when protrudin was 
overexpressed – syn-mCh-MUT1 protrudin-expressing neurons (10 µm2) had significantly 
smaller growth cones than control neurons (18 µm2) (Fig. 4.4F). This result is mostly likely due 
to the decreased transport of protrudin to the tip of growth cones, rather than growth cones 
being physically smaller in these conditions (discussed in Section 2.2).  
 
Two additional criteria were included when the regeneration data was analysed – the 
percentage of regenerating neurons which show branching or ectopic growth (Table 4.1). 
Interestingly, when regenerating, neurons expressing all forms of protrudin – syn-mCh-WT 
(10%), syn-mCh-MUT1 (25%) and syn-mCh-MUT2 (19%) showed increased branching 
compared to control (0%) (Fig. 4.4G). This result might have implications that protrudin could 
play a role in axon branching. Furthermore, control-expressing cells (64%) showed more 
ectopic growth, i.e. regenerative growth not from the main branch that was cut but from 
newly formed or auxiliary branches compared to syn-mCh-WT (10%), syn-mCh-MUT1 (10%) 
or syn-mCh-MUT2 (15%) (Fig. 4.4H). 
 
One caveat of this experiment was, as described in Chapter 3, Section 2.5, that the 
amount or protrudin in the distal axon was lower than that at the proximal axon. This created 
difficulties when tracing distal axons at large distances compared to our control neurons 
which were easily traceable. Inducing the injury at further distances away from the cell body, 
results in decreased axon regeneration (Koseki et al., 2017). In order to account for any 
discrepancies that might have occurred by having an easily traceable GFP control and dimmer 
mCherry-fused protrudin protein, we performed an additional experiment in which all control 
and protrudin-mCherry constructs were co-transfected with GFP to identify distal axons.  
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Figure 4.4 Quantification of Axon Regeneration (no GFP). A. Bar graph to show the percentage of regenerating 
axons (n=3). Syn-mCh-MUT1 and syn-mCh-MUT2 and syn-mCh-WT protrudin increased the proportion of 
regenerating axons compared to control (p=0.0006) B. Syn-mCh-MUT1 and syn-mCh-MUT2 protrudin initiated 
the process of regeneration faster compared to control (p=0.0008, one-way ANOVA). C. Box plot to show that 
syn-mCh-WT and syn-mCh-MUT2 protrudin-expressing cells regenerated further distances than the control 
(p=0.019, Kruskal-Wallis statistic=9.945). D. Box plot to show that syn-mCh-WT regenerate further distances 2 
hours after regeneration initiation compared to control (p=0.0236, Kruskal-Wallis statistic=9.475). E. Box plot to 
show that there are no changes in the retraction distance between conditions (p=0.264, Kruskal-Wallis 
statistic=3.976). F. Box plot showing that syn-mCh-MUT1 protrudin-expressing cells have smaller growth cones 
than control (p=0.0153, Kruskal-Wallis statistic=10.42). G., H. Bar graphs to show the percentage of regenerating 
neurons which also show branching and ectopic growth. Syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 
showed more branching (p=0.009, p=0.0006 and p=0.0006 respectively) but less ectopic growth than control 
(p=0.0006) (n=3). All percentage comparisons were calculated using Fisher’s exact test with Bonferroni-Dunn 
pairwise comparison. Values in box plots represent n numbers. All values show mean ± SEM. 
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2.2 Overexpression of protrudin together with GFP enhances axon 
regeneration of primary cortical neurons in vitro after laser 
axotomy 
 
In order to test whether the regeneration data obtained above is reproducible and 
valid, primary cortical neurons were transfected at 10 DIV with both GFP control and syn-mCh 
protrudin constructs (Fig. 4.5). The green channel was used to trace the distal axons. The 
regenerative ability of the neurons was tested at 13-17 DIV in the same way as described 
above.  
 
Figure 4.5 Laser axotomy model (with GFP). Experimental set up for laser axotomy. 10 DIV neurons were co-
transfected with GFP control and either syn-mCh, syn-mCh-WT, syn-mCh-MUT1 or syn-mCh-MUT2 protrudin 
using magnetofection. Axons were cut at 13-17 DIV at least 600 µm away from the cell body using a laser beam 
and were monitored for regeneration for 14 hours after injury. Yellow star indicates the location of the injury. 
 
Similar to our previous findings in neurons expressing protrudin constructs without 
GFP co-expression, we found that when co-expressed with GFP, both constitutively 
phosphorylated protrudin forms (syn-mCh-MUT1 - 45% and syn-mCh-MUT2 - 40%) increased 
the proportion of regenerating axons compared to control (syn-mCh - 22%) (Fig. 4.6A). syn-
mCh-WT protrudin and GFP (36%) also showed increased regeneration compared to control 
neurons, however this did not reach significance (p=0.253). In addition, when expressed 
together with GFP, syn-mCh-WT (167 µm) and syn-mCh-MUT2 (161 µm) again regenerated 
further distances than the control (87 µm) (Fig. 4.6C). Overall, there was less of an increase in 
regeneration in cells co-expressing protrudin constructs together with GFP than was observed 




Contrary to our previous findings (Fig.4.4B), no significant changes were observed 
between cells co-expressing  syn-mCh, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 
together with GFP in the following parameters: regeneration time (8.6, 6.4, 7.5 and 7.3 hours 
respectively) (Fig. 4.6B), distance regenerated after 2 hours of regeneration initiation (42, 51, 
55 and 54 µm respectively) (Fig. 4D), or the maximum growth cone area (12, 16, 13 and 15 
µm2 respectively) (Fig. 4.6F). Similar to our previous observations, no significant differences 
were observed in the retraction distance between conditions (85, 97, 101 and 84 µm 
respectively) (Fig. 4.6E). 
 
Interestingly, when regenerating, neurons expressing both constitutively 
phosphorylated protrudin together with GFP control – syn-mCh-MUT1 (15%) and syn-mCh-
MUT2 (12%) but not syn-mCh-WT (7%) showed increased branching compared to control (0%) 
(Fig. 4.6G). Unlike in the experiment described above (Fig. 4.4H), here there were no 
significant differences between the percentage of neurons showing ectopic regenerative 
growth between the conditions – GFP co-expressed with either syn-mCh (38%), syn-mCh-WT 
(35%), syn-mCh-MUT1 (42%) and syn-mCh-MUT2 (37%) (Fig. 4.6H). 
 
This experiment showed that when co-expressed with GFP, overexpression of all 
forms of protrudin failed to initiate a regenerative response as robust as when expressed on 
their own (Fig. 4.4). It was hypothesised that this discrepancy could be due to reduced 
protrudin expression, as the translational machinery of the cells is also occupied with 
producing the GFP protein. This hypothesis was addressed by measuring the levels of 
protrudin in neurons which express protrudin constructs either on their own or together with 
GFP (Fig. 4.7A, B). By measuring the intensity of mCherry-fused protrudin in the cell body of 
cells expressing syn-mCh-WT (10 392 grey values), syn-mCh-MUT1 (8367 grey values) or syn-
mCh-MUT2 (8068 grey values), we found a significantly higher fluorescent signal than was 
detected in cells expressing the same constructs together with GFP control plasmid (2869, 
2366 and 3086 grey values respectively (p<0.0001) (Fig. 4.7C). 
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Figure 4.6 Quantification of Axon Regeneration (with GFP). A. Bar graph to show the percentage of regenerating 
axons (n=3). Syn-mCh-MUT1 protrudin increased the proportion of regenerating axons compared to control 
(p=0.005) B. No differences were observed in the regeneration time between conditions (p=0.2644). C. Box plot 
to show that syn-mCh-WT and syn-mCh-MUT2 protrudin-expressing cells regenerated further distances than the 
control (p=0.0130, Kruskal-Wallis statistic=10.78). D., E., F. Box plots that there are no significant differences 
between conditions in the regeneration distance after 2 hours of regeneration (p=0.2811, one-way ANOVA), in 
the retraction distance (p=0.7416, Kruskal-Wallis statistic=1.247) or the maximum growth cone area (p=0.1878, 
Kruskal-Wallis statistic=4.791). G., H. Bar graphs to show the percentage of regenerating neurons which also 
show branching and ectopic growth. Syn-mCh-MUT1 and syn-mCh-MUT2 showed more branching (p=0.0006 
and p=0.0018 respectively) compared to control. No differences were observed in the percentage of neurons 
growing ectopically (p=0.7762). All percentage comparisons were calculated using Fisher’s exact test with 
Bonferroni-Dunn pairwise comparison. Values in box plots represent n numbers.  All values show mean ± SEM. 
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Figure 4.7 Protrudin Intensity in the Soma. A., B.  Immunofluorescence images of cells expressing either syn-
mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 protrudin expressed on its own or in combination with GFP 
control plasmid. Images are taken at 40x. Scale bars are 20 µm. C. Bar graph to show the difference in mCherry-
fused protrudin intensity in the soma. Cells overexpressing the three protrudin constructs on their own showed 
significantly higher intensity in the soma compared to cells expressing the protrudin constructs in combination 





 During the in vitro axotomy experiments expressing mCherry-fused protrudin 
constructs without GFP co-expression (Fig. 4.3 and 4.4), protrudin was observed to localise to 
the tip of regenerating axons (Fig. 4.8A). All three forms of protrudin (WT, MUT1 and MUT2) 
accumulated in the area proximal to the injury soon after axotomy (1-2 hours) (Fig. 4.8A). All 
forms of protrudin were also observed to accumulate in the retraction bulb that forms after 
injury as well as in the growth cone of regenerating axons and at branch points in axons (Fig. 
4.8A). Protrudin, however appeared to be at the base of the growth cone rather than in the 
dynamic edge. This observation was later confirmed by co-expression of a GFP control 
plasmid together with the protrudin constructs (Fig. 4.8B). GFP readily fills up the whole 
growth cone so it allows for visualisation of the full size of the growth cone. In control 
neurons, co-expressing syn-mCh together with GFP, both proteins are observed filling the 
whole growth cone in uninjured as well as in regenerating axons (Fig. 4.8B). In uninjured 
neurons expressing syn-mCh-protrudin (this was observed for all forms of protrudin) together 
with GFP, unlike the GFP protein which readily fills the growth cone, protrudin was mostly 
found at the base of growth cone in small amounts (Fig. 4.8B). In newly formed growth cones 
after injury, protrudin seems to invade most of the base of the growth cone but it is still not 
observed at the dynamic edge. These findings are not surprising as protrudin associates with 
kinesin 1 (Matsuzaki et al., 2011) which is a motor protein engaging with the microtubule 
(MT) cytoskeleton. The shaft of the growth cone contains bundles of stable MTs along which 
axon transport of protrudin is possible, whereas the dynamic edge contains unstable and 
dynamic MT and actin polymers (Blanquie and Bradke, 2018). These observations hint at a 
localised role for protrudin at the site of growth cone redevelopment, and is in keeping with 










Figure 4.8 Protrudin Localisation in Regenerating axons.  A. A series of images showing a regenerating axon of 
a cell overexpressing syn-mCh-MUT2 protrudin without GFP co-expression at different time points in the 
regenerative process. White arrows indicate the location of the laser injury. B. Series of images showing GFP and 
mCh-fused protrudin at the growth cone in neurons co-expressing both constructs. Growth cones from 
uninjured axons or from laser injured axons which have formed a new growth cone and initiated the 
regenerative process are shown here. Red outlines represent the full area of the growth cone as measured by 







2.3 Overexpression of protrudin enhances axon regeneration of 
retinal ganglion cell axons in vivo after optic nerve crush 
 
Based on the regeneration data obtained above (Fig. 4.4) wild-type and mutant 2 
protrudin (as the mutant which had the highest effect on regeneration) were inserted into 
AAV2-CAG vectors for viral production as described in Methods, Section 3.2.3 with the aim to 
test regeneration of CNS neurons in vivo. The newly designed viral DNA plasmids were first 
transfected into 10 DIV cortical neurons in order to assess the extent of protrudin 
overexpression from these vectors in cultured cortical neurons at 14 DIV. Neurons 
overexpressing either CAG-GFP-WT (3087 grey values) or CAG-GFP-MUT2 (3071 grey values) 
protrudin, showed dramatically increased staining intensity for the protrudin protein 
compared to control neurons only expressing CAG-GFP (204 grey values) or negative control 
where primary antibody is not used (10 grey values) (Fig. 4.9). 
 
 After validating that the DNA viral plasmid resulted in high expression of the protrudin 
protein in vitro, AAV2 viruses were produced by Raymond Fields at the NINDS Viral Production 
Core at the National Institutes of Health. Viruses containing CAG-GFP, CAG-GFP-WT protrudin 
and CAG-GFP-MUT2 protrudin were named AAV2-CAG-GFP, AAV2-CAG-WT and AAV2-CAG-
MUT2 respectively. These viruses were injected in mouse retinas and their transduction 
efficiency of retinal ganglion cells (RGCs) was examined. All three viruses were widely 
expressed throughout the retina (Fig. 4.10A). As there were axons observed in the retinal 
wholemounts, it was assumed that most transduced cells are of neuronal phenotype. To 
validate this, RGCs were immunostained for RGC marker – RBPMS (Rodriguez, de Sevilla 
Müller and Brecha, 2014) and the % of RBPMS-positive and GFP-positive neurons upon viral 
expression was calculated – 27% of control AAV-CAG-GFP, 20% of AAV2-CAG-WT and 14% 
AAV2-CAG-MUT2 expressing cells were also RGCs (Fig. 4.10B, C). Some of the cells were, 
however expressing at relative low levels so a refined experiment with higher n number and 
improved microscopy settings is currently carried out in order to obtain more reliable results. 
Lastly, GFP signal from the GFP only virus or from GFP-fused protrudin, was reliably detected 




Figure 4.9 Overexpression of CAG-protrudin plasmid constructs resulted in increased protein levels of 
protrudin in primary cortical neurons. A. Immunofluorescent images of endogenous GFP signal from CAG-GFP 
only, CAG-GFP-WT and CAG-GFP-MUT2 protrudin (green). Protrudin amount is detected by anti-protrudin 
immunostaining (red). Images were taken at 40x magnification. Scale bars are 20 µm. B. When imaging settings 
are altered to overexpose neurons expressing protrudin, the endogenous protrudin in cells not overexpressing 
plasmids could be observed. C. Bar graph to show the average staining intensity of the protrudin in cells 
expressing the plasmid constructs. Protrudin’s staining intensity is significantly higher in cells overexpressing 
CAG-GFP-WT and CAG-GFP-MUT2 protrudin compared to cell expressing control CAG-GFP only vector 




Figure 4.10 Protrudin viral constructs are expressed in RGCs throughout the retina and the optic nerve. A. 
Retinal wholemounts showing GFP-positive cells which have been transduced with one of three viruses: AAV2-
CAG-GFP, AAV2-CAG-GFP-WT or AAV2-CAG-GFP-MUT2 protrudin.  B. Immunostained images with RBPMS retinal 
ganglion cell marker (red) showing co-localisation between the virally infected cells (GFP) and RGCs. C. A bar 
graph showing robust viral expression in RGC-positive cells. For all three viruses, between 14-27% of all RGCs 
are also GFP-positive. (n=2 per condition). D. Immunofluorescent images showing robust GFP expression in 





After expression of the viral constructs was tested in the retina, all three viruses - AAV2-
CAG-GFP (n=8), AAV2-CAG-GFP-WT protrudin (n=8) and AAV2-CAG-GFP-MUT2 protrudin 
(n=9) were injected intravitreally in three groups of adult mice to specifically target the RGCs 
(see Methods, Section 7.2) (Fig. 4.11A). Two weeks following injection, optic nerve crush was 
performed as described in Methods, Section 7.3 to injure the RGC axons, and after an 
additional two weeks, the anterograde axon tracer – cholera toxin ß (CTB) was injected to 
visualise regenerating axons as described in previous studies (Park et al., 2008; de Lima et al., 
2012; Bray et al., 2017; Yao et al., 2018). 
 A significant increase was observed in the number of axons that regenerated beyond the 
crush lesion in mice whose RGCs expressed either the mutant or wild-type protrudin when 
compared with mice transduced with the GFP control – at 0.25 mm distal to the lesion there 
were 629±213, 379±101 and 44±18 axons respectively (p<0.0001), at 0.50 mm distal to the 
lesion site there were 433±180, 234±73 and 8±4 axons respectively (p<0.0001, p=0.01) (Fig. 
4.11B, 4.11C). There were also more regenerating axons expressing mutant protrudin 
(221±120 axons) compared to those expressing GFP control (6±3 axons) at 0.75mm distal to 
the injury site (p=0.01) (Fig. 4.11C). In addition, mice injected with mutant protrudin showed 
increased RGC regeneration after injury compared to those injected with wild-type protrudin 
at 0.25 mm (p=0.0027) and at 0.50 mm (p=0.022) from the crush site (Fig. 4.11C). 
Regenerating axons were found at the furthest distance of 0.75 mm for control CAG-GFP 
transduced animals, of 2.75 mm for CAG-GFP-WT protrudin transduced animals and of 3.5 
mm for CAG-GFP-MUT2 protrudin transduced animals. These results suggest that mutant 
protrudin induced the most robust regeneration, to a substantial distance past the injury site 
after only 2 weeks post crush. 
In order to confirm that the axons observed are indeed regenerating rather than spared 
axons, a CTB anterograde tracer was injected one day before the tissue was collected. In 
addition, the optic nerves were also stained for GAP43 – a developmentally downregulated 
protein which is re-expressed upon injury in regenerating neurons (Tetzlaff et al., 1989, 1991; 
Meyer, Miotke and Benowitz, 1994). A reliable co-localisation between CTB and GAP43 was 
found throughout the nerve in all conditions (Fig. 4.12). Interestingly, AAV2 control GFP-
expressing axons were much brighter than those expressing AAV wild-type or mutant 
protrudin. Additionally, the GFP detection pattern for protrudin was irregular. These 
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observations could suggest that there are still debris from degenerating axons around or that 
protrudin is less readily transported into the distal axon after crush as the GFP signal is visible 
on the proximal side of the crush. Further analysis is needed in order to characterise protrudin 
transport in the optic nerve, and these are being undertaken by other members of our group 
as part of on-going projects. 
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Figure 4.11 Protrudin enhances regeneration of RGC axons. A. Experiment timeline. B. Micrographs showing 
CTB-labelled axons in the optic nerves of mice treated with viruses carrying the mutant (MUT2) or wildtype (WT) 
protrudin or the GFP control. Arrows indicate lesion site. Insets (iv-vi) show regenerating axons in the distal optic 
nerve. Scale bar = 200 µm, insets = 20 µm (n=8-9 animals/group). C. Graph showing the number of regenerating 
axons at distances distal to the lesion site, displayed as mean ± SEM. Statistical significance was determined by 




Figure 4.12 Regenerating axons are GAP43-positive and CTB positive. A. Immunolabelled optic nerve sections 
for GAP-43, CTB and GFP. Dotted yellow rectangles indicate insets shown in panel B. B. Zoomed in insets from 
optic nerves expressing either AAV2-CAG-GFP control, AAV2-CAG-GFP-WT and AAV2-CAG-GFP-MUT2 protrudin. 




2.4 Constitutively phosphorylated protrudin has a modest effect on 
retinal ganglion cell neuroprotection in a model of glaucoma 
 
In the experiments above, it was observed that in optic nerves transduced with wild-
type or mutant protrudin virus, there appeared to be some remnants of degenerating axons 
2 weeks post injury to the nerve. These did not label for CTB or GAP43 and were not evident 
in control nerves expressing GFP alone. Additionally, some mutant forms of protrudin (see 
Chapter 5) seemed to have an effect on cell survival so it was hypothesised that in addition to 
protrudin’s effect on neuroregeneration, the protein might play a role in neuroprotection too.  
 
To test this hypothesis, a laser model of glaucoma was used to examine the effect of 
protrudin overexpression on RGC survival in the retina but also on integrin transport in vivo 
in both healthy and injured RGC axons. Glaucoma is a condition associated with increased 
intraocular pressure (IOP) that in severe cases leads to optic nerve axon degeneration, RGC 
loss and ultimately blindness. In rats, a rise in intraocular pressure is observed after laser 
treatment which disrupts the trabecular meshwork (the drainage system of the eye). Sprague 
Dawley rats were injected with AAV2-CAG-GFP (n=8), AAV2-CAG-GFP-WT-protrudin (n=9) or 
AAV2-CAG-GFP-MUT-protrudin (n=9) together in combination with AAV2-CAG-IntegrinA9-V5 
(Fig. 4.13A). 2 weeks post-injection a laser was applied to the left eye to cause a rise in IOP. 
24 hours later, elevation of IOP was confirmed (as described in Methods, Section 7.4) (Fig. 
4.13C). Because IOP returns back to normal levels after several days (around 20 mmHg), the 
same procedure was repeated a week later where a second laser insult was applied to the 
same eye in order to maintain elevated IOP. IOP elevation was again confirmed 24 hours later 
(Fig. 4.13C). All animals were sacrificed 4 weeks after the second laser injury. 
 
In previous experiments from our lab (data not shown), the increase in IOP resulted in 
a significant decrease in the number of surviving RGC cells in the retina of the injured eye. In 
this experiment, the number of RGC in the retina (quantified as described in Methods, Section 
5.3.2) significantly decreased after injury in animals injected with AAV2-CAG-GFP-WT 
protrudin (2031 RGCs/mm2) but not in those injected with AAV2-CAG-GFP-MUT2 protrudin 
(2305 RGCs/mm2) or AAV2-CAG-GFP control (2351 RGCs/mm2) compared to uninjured 




Figure 4.13 Constitutively phosphorylated protrudin enhances RGC survival after glaucoma injury. A. 
Experiment timeline. B. Wholemount retinas were prepared from injured and uninjured eyes and stained for 
Brn3a (RGC marker). 24 representative images were taken per retina – 6 per retinal quadrant (2 from the centre, 
2 from the middle and 2 from the periphery) and RGC density was calculated. C. Intraocular pressure profiles of 
the three treatment groups during the experiment. D. The density of RGC in the WT protrudin injected animals 
which received injury was lower than uninjured eyes, displayed as mean ± SEM (p=0.0138). Statistical 




Interestingly, rats injected with GFP control virus together with integrin alpha 9 did 
not show the reduced number of RGCs that was predicted from previous studies (around 50% 
RGC loss). This could have been a result of inadequate raise in IOP after the second laser 
treatment in the control group (10 mmHg lower) compared to the other two groups (Fig. 
4.13C). Furthermore, the Brn3a staining which was used as a marker of RGCs seemed to be of 
variable quality across the different retinas. Optic nerve resin embedding and axon counts by 
ultrathin sectioning are currently being performed as described previously (Marina, Bull and 
Martin, 2010) in order to confirm these results by examining axonal neuroprotection too. 
Nonetheless, the current findings show that MUT2 protrudin has a modest neuroprotective 
effect compared to WT protrudin on RGC survival in the retina after glaucoma. However, our 
overall interpretation of these results is inconclusive due to the data from the control group.  
 
In addition to RGC survival, the transport of anterograde axon tracer CTB from the 
injured eye to the contralateral side of the brain (particularly, in the superior colliculus area) 
was measured (Fig. 4.14A). In previous studies in our lab (data not shown), this transport was 
shown to be compromised in glaucoma-induced eyes possibly due to the high amount of cell 
death but also through some effects on axon transport itself. It was, therefore, hypothesised 
that the fluorescent intensity, area and volume of CTB-positive signal in the right superior 
colliculus (where the left, injured eye axons project) will be smaller than that of the left 
superior colliculus. The area and intensity of the CTB tracer in the superior colliculus as well 
as volumetric analysis were carried out as described in Methods, Section 5.3.1. In this 
experiment, no significant differences were observed in the CTB-positive area multiplied by 
the average intensity between the different conditions (p=0.3411). Although the CTB area x 
intensity showed a trend towards being lower in the right (injured) superior colliculus 
compared to the left (uninjured) superior colliculus within each condition, the trend did not 
reach significance (Fig. 4.14B).  Furthermore, volumetric analysis was performed as described 
in Chiasseu and colleagues (2017). No significant differences were observed in the volume of 
CTB-positive signal across the brains of animals of each condition (p=0.5961) (Fig. 4.14C). 
Again, despite there being a trend towards decreased CTB volume in injured animals 




Figure 4.14 CTB-positive area in the superior colliculus. A. Immunofluorescent images of CTB-positive area and 
GFP detected by anti-GFP antibody in the left (uninjured) and the right (injured) superior colliculus. Images are 
taken at 20x. Scale bars are 1mm. B. No significant changes are observed in the area of CTB signal multiplied by 
its intensity across the different conditions (p=0.3411, one-way ANOVA, n=8 in each condition). C. No significant 
changes were observed in the volume of CTB-positive area across the superior colliculus (p=0.5961, one-way 










Initially, the GFP signal in the superior colliculus was going to be measured in order to 
calculate the transport of the GFP-tagged protrudin to the brain along RGC axons. The 
detected GFP pattern, however appeared irregular across different animals so the experiment 
needs to be repeated in order to carry out those analyses.  
 
In this experiment, integrin-alpha9 virus was injected in conjunction with the 
protrudin viruses in order to assess the effect of overexpressing protrudin on integrin 
transport in vivo. The integrin virus contained V5 tag which was detected in vivo using anti-
V5 tag antibody. Several antibodies were utilised in order to visualise the V5-tagged integrin. 
In the retina, anti-V5 antibody (Bioss Inc, 1:250) showed reliable staining and cells stained for 
V5-tagged integrin co-localised with GFP-tagged protrudin and CTB-positive cells (Fig. 4.15A). 
In optic nerve sections and in the superior colliculus, however, reliable staining with anti-V5 
antibody could not be achieved (Fig. 4.15B, C). Even though there seems to be positive 
staining in the optic nerve compared to negative control, the staining appears irregular and 
not the correct pattern for integrin receptor vesicles moving along axons. A similar problem 
was observed with the anti-V5 tag staining in the superior colliculus. Furthermore, as the brain 
sections were much thicker (50 µm) than the retinal and optic nerve sections (14 µm), the 



















Figure 4.15 Integrin detection in the retina, the optic nerve and the brain A. Immunofluorescent images of 
retinal sections transduced with AAV2-CAG-GFP-MUT2 protrudin and AAV2-CAG-IntegrinA9-V5. Sections were 
stained for DAPI (dark blue), CTB (red), GFP (green) and V5 (turquoise). Images were taken at 20x magnification. 
Scale bars are 100 µm. White arrows represent cells co-expressing all three CTB, GFP and V5 simultaneously. B. 
Optic nerve sections from different conditions – viral injection and injury, no viral injection and injury and no 
primary antibody with an anti-V5 antibody. C. Superior colliculus sections from different conditions – viral 





In this chapter, protrudin’s ability to promote axon regeneration and neuroprotection was 
examined in several cellular and animal models. Overexpression of wild-type and two forms 
of constitutively phosphorylated protrudin were firstly found to promote axon regeneration 
in primary cortical neurons after laser axotomy in vitro. Additionally, viral expression of wild-
type and constitutively phosphorylated protrudin enhanced axon regeneration in the optic 
nerve after an optic nerve crush injury in mice. Lastly, constitutively phosphorylated protrudin 
showed mild neuroprotective properties in improving retinal ganglion cell survival in a rat 
laser model of glaucoma.  
 
 The initial hypothesis of this thesis stated that constitutive phosphorylation of protrudin 
could result in enhanced axon transport of growth-promoting molecules which could result 
in enhanced axon regeneration of CNS neurons which seem to have low levels of growth 
machinery in their axons. In vitro regeneration data showed that both phosphomimetic forms 
of protrudin but also wild-type protrudin enhanced axon regeneration after injury (Fig. 4.4). 
The percentage of regenerating axons especially in the mutant 2 condition (70%) was found 
to be higher than some of the best treatments utilised in our lab in this model system such as 
depletion of EFA6 – an ARF6 activator in the axon (59%) (Eva et al., 2017), dominant negative 
Rab11 (38%) (Koseki et al., 2017) and hyperactive PI3K alpha (69%) (Barber, Evans, 
Nieuwenhuis and Eva, unpublished data). Furthermore, this experiment showed that this 
system provides a reliable platform to test the extent of axon regeneration after different 
genetic manipulations. The percentage of regenerating control neurons is reasonably 
consistent (20-30%) when axotomy was performed by different researchers who cultured 
their own primary cortical neurons and used various control plasmids (CAG-mCherry, CMV-
mCherry, Syn-mCherry, CAG-GFP, dual promoter GFP, turbo RFP and scrambled shRNA 
control). One limitation of our in vitro laser axotomy system might be that there is a cap of 
the percentage of regenerating neurons as more than 86% successful regeneration in a single 




Interestingly, it was observed that overexpression of wild-type protrudin was on its own 
capable of enhancing axon regeneration despite to a lesser extent than the phosphomimetic 
mutants (Fig. 4.4, 4.6). This result was not predicted by the hypothesis. This observation could 
be due to the fact that protrudin on its own is scarce in the axon and when overexpressed, it 
allows for axonal functions that are normally supressed in mature CNS neurons. Our RNA 
sequencing data in the same primary cortical neurons shows that indeed protrudin is not 
expressed at very high levels in neurons throughout development and into adulthood (Koseki 
et al., 2017, see Chapter 3). Another explanation could be that the wild-type protrudin protein 
becomes phosphorylated by endogenous kinases when overexpressed, therefore producing 
effects similar to mutants 1 and 2. More experiments on the function of the two different 
mutants need to be carried out in order to elucidate this mechanism. For example, various 
kinase inhibitors could be added to our neuronal cultures once transfected with wild-type or 
phosphomimetic mutants before axotomy, in order to test whether the wild-type protein is 
indeed being phosphorylated inside the cell. It may also be that we chose to do axotomy at 
an intermediate time point when some regenerative capacity remains. At this time there may 
be more active signalling through the pathways that phosphorylate protrudin than say at 21 
DIV. In the past we have found negligible regenerative capacity at this time point. 
 
Several other interesting observations were made during the laser axotomy experiments. 
For example, overexpressed protrudin was mostly observed in the shaft but not at the 
dynamic tips of the growth cones of regenerating axons (Fig. 4.8). This effect could be due to 
the fact that protrudin associated with KIF5 for long-range transport along microtubules and 
once it reaches the actin-filled periphery of the growth cone (Dent, Gupton and Gertler, 
2011), it stops being transported into the tip of the growth cone. This is further supported by 
the observation that protrudin also does not fill dendritic spines which are also rich in F-actin 
(Penzes and Rafalovich, 2012) (see Chapter 3, Section 2.3). Future work is needed in order to 
study protrudin’s interaction with the actin cytoskeleton, if any. Another interesting 
observation was that a small percentage (10-25%) of the regenerating axons overexpressing 
wild-type, mutant 1 or mutant 2 protrudin seem to divert from the classic axon regeneration 
where the axon grows from the retraction bulb of the severed process, but instead result in 
the formation of multiple branches (Fig. 4.4G, 4.6G). Interestingly, protrudin was visualised 
at branch points in the axon in healthy and injured axons. This might suggest that protrudin 
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could promote reorganisation of the cytoskeleton in order to induce branching and therefore, 
growth in multiple different directions (Kalil and Dent, 2014). Furthermore, a recent paper 
points towards the endoplasmic reticulum (ER) serving as a microtubule-organising platform 
(Farías et al., 2019) and protrudin as a ER-resident protein interacting with MT cytoskeleton 
could allow for MT branching at the ER.  
 
We also performed the same in vitro laser axotomy but co-expressing GFP with the 
different protrudin constructs (Fig. 4.6). The GFP construct that was used as a control 
expresses GFP under SFFV promoter and emerald green under the ubiquitin promoter. This 
dual promoter construct results in really high expression pattern which possibly engages a 
large amount of intracellular transcription and translation machinery for the production of 
the GFP protein. This could be one reason why reduced amount of protrudin expression was 
observed than when protrudin is expressed on its own (Fig. 4.7). Nevertheless, neurons co-
expressing protrudin and GFP follow the same pattern of percentage of regenerating axons, 
with the two phosphomimetic mutants performing better than wild-type protrudin but all 
exceeding the regeneration seen in control (Fig. 4.6). Despite that, the extent of regeneration 
was much reduced (40-45% with GFP compared to 60-70% without GFP) which suggests that 
protrudin’s action on axon regeneration might be dose-dependent. In summary, the in vitro 
laser axotomy experiments when protrudin is expressed on its own or in combination with 
GFP, show three overriding characteristics of overexpressing the protrudin protein – 
enhancement of the percentage of regenerating cells, increased total distance of re-growth 
in regenerating neurons and increased axon branching.  
 
In order to validate the in vitro regeneration results, the optic nerve crush model was 
chosen as an in vivo model of axon regeneration. Some of the most effective treatments in 
promoting regeneration in this model target intracellular signalling pathways and are 
performed in transgenic animals carrying mutations in these genes since birth. For example, 
one of the most potent interventions up to date is a conditional deletion of the PTEN in adult 
RGCs resulting in improved regeneration and neuronal survival after optic nerve crush which 
was attributed to upregulation of the mTOR signalling pathway (Park et al., 2008). Since this 
discovery many studies focused on blocking the effects of PTEN using short-hairpin RNAs, 
CRISPR and pharmacological agents or on using combinational therapies with other 
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molecules, and have achieved various degrees of success in promoting axon growth after 
injury in the CNS (Ohtake, Hayat and Li, 2015). PTEN however, acts as a tumour suppressor 
gene and knocking it down has shown to cause tumour formation in several animal models 
so its wide use as an axon regeneration promoter is very limited. Many interventions that 
promote regeneration in the optic nerve have subsequently been demonstrated to have 
relevance in the spinal cord but have not yet been able to stimulate robust regeneration of 
the CST. Ultimately, our aim is to restore CNS regeneration both in the optic nerve and in the 
spinal cord. Better and more translatable therapies are needed, and our experiments with 
protrudin in the optic nerve are a starting point to testing protrudin as a pro-regenerative 
molecule, but also as a means for enabling integrin transport. Currently, the ability of wild-
type and mutant protrudin to enhance axon regeneration in the spinal cord after a dorsal 
transection is being tested in our laboratory.  
In the current study, adult mice were treated by delivering a virus directly to the eye only 
for 2 weeks before an optic nerve crush. It was shown that expressing wild-type and also 
phosphorylated mutant protrudin results in dramatically increased axon regeneration in the 
optic nerve, only 2 weeks after optic nerve crush (Fig. 4.11). One of the previous studies 
showing most potent regenerative effect in the optic nerve and which highly resembles the 
current experimental setup and timeline, used viral delivery of super-agonist to the CNTF 
receptor (ciliary neurotrophic factor) to Muller glial cells (Pernet et al., 2013). In their study, 
Pernet and colleagues achieved the regeneration of 500-600 neuronal fibres 0.5 mm past the 
injury site.  This study, however focused on manipulating the glial cells to enhance RGC 
regeneration. In one of the most successful studies targeting RGCs to improve regeneration 
with a similar experimental design to ours, an activator of the mTOR pathway was injected 
intravitreally and 2 weeks later an optic nerve crush was performed (Lim et al., 2016). Three 
weeks post-injury, less than 100 axons were observed at 0.5 mm and when combined with 
visual stimulation, the number of regenerating axons dramatically increased to 250-300 at 0.5 
mm away from the injury (Lim et al., 2016). These axons showed target-specific regeneration 
to the correct brain areas and formed functional synapses to improve visual acuity (Lim et al., 
2016). Expression of mutant protrudin allowed for 400-500 neuronal fibres to reach the 0.5 
mm mark by 2 weeks after injury suggesting that this intervention is comparable to some of 
the most potent interventions reported to date. Perhaps more importantly, the other work 
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presented in this thesis also demonstrates a number of mechanisms that are involved in 
mediating protrudin’s regenerative effects. These will be further examined by other members 
of the group and may even lead to the identification of other regenerative interventions 
which could be translated to clinical treatments. 
 Unfortunately, the retinal wholemounts from the optic nerve crush experiments were 
unsuccessfully stained for RGC markers and subsequently mounted, so the effects of 
protrudin overexpression on neuronal survival after optic nerve crush could not be analysed 
in this experiment but will be the subject of future experiments. Another interesting 
suggestion for future experiments is to explore the identity of the cells transduced with the 
protrudin virus. So far most regenerative RGCs have been shown to be alpha-type (Duan et 
al., 2015; Daniel, Clark and McDowell, 2018) but it is not improbable that the protrudin virus 
is enabling regeneration from other RGC cell types, not implicated as regenerative before or 
that have not previously been induced to regenerate by genetic manipulations. It will also be 
important to include a longer time point after the optic nerve crush (4 or 8 weeks) in order to 
observe whether the regenerating axons cross the optic chiasm and reach the brain to form 
the correct connections to allow for functional repair. This is an important question as 
stimulation of axon growth after injury is often disorganised and very few treatments result 
in long-range, targeted regrowth. Another future possibility is to use combinatorial 
approaches to further stimulate and direct axon growth. One such possibility is combining the 
protrudin treatment with extracellular matrix modifications such as the use of chondroitinase 
ABC (ChABC) (which removes inhibitory CSPGs) – an approach which has been shown to be 
beneficial for axon regeneration after optic nerve crush (Pearson et al., 2018). 
Lastly, the role of protrudin on neuroprotection and axonal transport in a rat model 
of glaucoma, was also examined. Overexpression of constitutively phosphorylated protrudin 
was mildly neuroprotective by increasing the number of surviving RGCs after the elevation in 
IOP (Fig. 4.13). A major caveat to this experiment was that the IOP in control rats injected 
with GFP virus only did not increase as high as in the other two groups after the second laser 
injury. This could have been the reason why no significant RGC loss in the retina in the control 
group was observed. Alternatively, maybe overexpression of integrin alpha 9 together with 
the control virus could be sufficient to induce neuroprotection. The effects of the integrin 
alpha 9 receptor on neuroprotection have not been examined yet in this model. If this is the 
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case, however, that could suggest that wild-type protrudin and integrin alpha 9 interaction is 
not beneficial for neuroprotection as there is still a reduction in the number of surviving RGCs 
in that condition (Fig. 4.13). Further experiments where the increase in IOP in control rats is 
sufficient enough to cause neuronal cell death and to examine the effects of integrin alpha 9 
on neuroprotection of RGCs are still needed.  As the model utilised is extremely variable 
between animals even of the same group, increasing the n number for each group could also 
prove to be an improvement in order to detect any small differences.  
The transport of CTB tracer along RGC axons to the superior colliculus in the brain was 
previously used as an indicator of the health and functionally of RGCs after an injury (Chiasseu 
et al., 2017). In this experiment, there was no significant difference in the area, intensity or 
the volume of the CTB-positive signal in the superior colliculus between the different groups 
(Fig. 4.14). The transport of CTB to the right side of the superior colliculus where injured axons 
from the left eye synapse, does indeed seem to be more compromised to that of the left 
superior colliculus – none of the differences observed are, however, significant. 
Finally, the main reason for injecting the integrin alpha 9 virus together with the other 
conditions, was to examine the normal transport of integrins in the optic nerve and whether 
this transport is affected by protrudin overexpression. Previously, the same integrin virus was 
shown to be transported into a small number of axons in the optic nerve (Andrews et al., 
2016), but this transport was not extensively studied. In the current study, although the 
integrin virus expression was reliably detected in the retina by using anti-V5 tag antibody, its 
detection in the optic nerve or in the superior colliculus in the brain was not optimal (Fig. 
4.15). Further experiments are needed in order to identify antibodies to reliably detect the 
integrin virus in the optic nerve and the brain, so its long-range transport could be reliably 
studied. To this end we have recently had useful suggestions from Melissa Andrews, who 
previously performed the in vivo integrin transport studies (Andrews et al., 2016). It will also 
be interesting to study the transport of endogenous or overexpressed TrkB receptor and to 
examine whether enhanced TrkB receptor trafficking along the axon could explain 
phosphorylated protrudin’s neuroprotective effects. There are currently projects in the lab to 
examine in detail the transport of integrin alpha 9, TrkB and Rab11 into RGC axons in the optic 
nerve. It will be important to determine what percentage of axons allow for their transport 
normally, and whether this can be altered through protrudin manipulation. 
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CHAPTER V: MECHANISMS OF PROTRUDIN ACTION 











 In this chapter, the mechanisms by which protrudin functions to promote axon 
regeneration are examined. Firstly, we aimed at suppressing the expression of endogenous 
rat protrudin in primary cortical neurons with the use of shRNA or CRISPR-Cas9 constructs in 
order to study its involvement in axon regeneration. The original selection of protrudin for 
regeneration studies was due to its potential as a facilitator of Rab11 axonal transport. Here, 
the transport of Rab11 and integrins in the axons of mature cortical neurons was studied upon 
protrudin overexpression using immunocytochemistry and live-cell imaging. In addition to its 
ability to bind Rab11, protrudin has several other significant molecular properties. Protrudin’s 
regenerative mechanism of action was therefore further tested by mutagenesis of its key 




Wild-type and phosphomimetic protrudin promote axon regeneration in vitro after laser 
axotomy and in vivo after optic nerve crush as described in Chapter 4. This chapter explores 
whether this increase in regenerative potential is due to an increased interaction with Rab11 
resulting in enhanced transport of integrins into the axon. It also sets out to investigate 
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whether further properties of protrudin are also involved in mediating its regenerative 
effects, by dissecting protrudin’s various molecular domains.  
 
1.1 Protrudin’s role in axonal transport of integrins and Rab11 
 
Integrins are essential growth-associated receptors which during development are 
involved in axon growth and guidance and in adulthood support synaptic function 
(Nieuwenhuis et al., 2018). Integrins have previously been shown to be excluded from mature 
axons (Bi et al., 2001; Mortillo et al., 2012; Franssen et al., 2015; Andrews et al., 2016). This 
developmental redistribution contributes to the regenerative failure of mature CNS neurons 
(Franssen et al., 2015; Eva et al., 2017). Interestingly, overexpressing integrin and/or its 
activator kindlin can enhance sensory, PNS axon regeneration in CNS environment in vitro and 
in vivo (Andrews et al., 2009; Tan et al., 2012; Cheah et al., 2016). Our group is currently 
working towards using this integrin strategy to enhance axon regeneration of corticospinal 
tract axons descending from the brain into the spinal cord, however overexpressed integrins 
are not readily transported into CNS axons (Andrews et al., 2016). Therefore, other methods 
to improve the transport of integrins into the axon need to be considered.  
 
One such strategy of enhancing the amount of integrins in CNS axons has been to modify 
the expression or the activation state of two small GTPases involved in axonal integrin 
transport – Rab11 and ARF6 (Eva et al., 2010). For example, overexpression of Rab11 into 
primary cortical neurons in vitro resulted in enhanced integrin amount in axons and improved 
axon regeneration after laser axotomy (Koseki et al., 2017). Furthermore, inactivation of ARF6 
by suppressing EFA6 (an ARF6 activator, located within the AIS) allows transport of integrins 
into the axon and improves axon regeneration after laser axotomy (Eva et al., 2017). These 
studies were the first two reports to suggest that manipulations of the internal axonal 
transport machinery of CNS axons can improve their regenerative potential. As protrudin is 
an adaptor protein involved in axonal transport which links Rab11-bound endosomes and the 
motor protein kinesin, its overexpression might have similar effects to Rab11 overexpression 




This chapter aims to establish a reliable knockdown system of endogenous protrudin by 
using shRNA and CRISPR constructs in vitro in order to study the contribution of the 
endogenous rat protein to axon regeneration. Furthermore, co-immunoprecipitation 
experiments are carried out to examine whether constitutively phosphorylated protrudin 
associates more readily with Rab11 as hypothesised. Finally, two different methods 
(immunocytochemistry and live-cell imaging) are used to assess whether Rab11 and integrin 
vesicles are more readily transported into CNS axons overexpressing protrudin or 
phosphomimetic protrudin.  
 
1.2 Protrudin protein domains  
 
Overexpression of both wild-type and phosphomimetic protrudin were shown to enhance 
axon regeneration both in vitro and in vivo, with constitutively phosphorylated protrudin 
exerting the most robust regenerative effect (see Chapter 4). This prompted us to examine 
the mechanisms by which protrudin facilitates axon regeneration. As protrudin contains 
multiple protein interaction domains that mediate diverse molecular functions, examining the 
contribution of each of these domains to aiding axon regeneration might shed light on novel 
mechanisms that are required for successful CNS regeneration. Protrudin contains a Rab11-
binding domain (RBD), 3 hydrophobic domains which principally target to the ER membrane 
(TM-1, TM-2 and TM-3), an FFAT motif which mediates interaction with the ER contact site 
protein – VAP-A, a coiled-coiled domain (CC) and a FYVE domain (a phosphoinositide-binding 
domain). In addition, the protein interacts with a microtubule-severing protein – spastin at its 
N-terminus and motor proteins from the kinesin-1 family such as kinesin 5 (KIF5). In order to 
examine which of these interactions of the protrudin protein are important for its role on 
axon regeneration – six domain mutants (∆FYVE, ∆FFAT, ∆KIF5, ∆Spastin, ∆RBD (Rab11-
binding domain), ∆ER were created as described in Methods, Section 3 (Fig. 5.1). These 
mutants were transfected into cortical neurons and their ability to enhance axon 
regeneration was compared to a positive control – constitutively phosphorylated mutant 2 












Figure 5.1 Schematic diagram of protrudin domain mutants. ∆FYVE and ∆FFAT domain mutants were created 
by substitution of lysine (367) and arginine (369) for alanine and aspartic acid (294) for alanine respectively (Saita 
et al., 2009; Gil et al., 2012). Rab11-binding domain mutant (∆RBD) was created by deleting amino acids 50-64 
(Shirane and Nakayama, 2006). KIF5-binding mutant (∆KIF5) lacked amino acids 274-361 (Matsuzaki et al., 2011), 
spastin mutant protrudin (∆Spastin) had amino acids 151 to 220 removed (Zhang et al., 2012) and ER mutant 
protrudin where the three transmembrane domains (TM1 (67–87a), TM2 (89–109aa) and TM3 (180–214aa) are 
removed so protrudin cannot associate with membranes (Chang, Lee and Blackstone, 2013). 
 
Most of these mutants have been examined in different paradigms before. For 
example, ∆ER protrudin mutant (missing the three hydrophobic regions) results in 
translocation of the protrudin protein from the ER structures to the cytoplasm and is unable 
to rescue changes in ER morphology induced by siRNA treatment against protrudin (Chang, 
Lee and Blackstone, 2013). The ∆FFAT domain mutant was shown to be essential for 
protrudin’s interaction with ER-resident protein – VAP-A (Saita et al., 2009). The FFAT motif 
is also found in other proteins which play a role in the transfer of lipids between the ER and 
other organelles such as the Golgi apparatus (Kawano et al., 2006). When the ∆FFAT mutant 
protrudin is overexpressed in HeLa cells, the percentage of cells extending neurites is 
significantly reduced compared to those overexpressing the wild-type (Saita et al., 2009). In 
addition, ∆FYVE protrudin results in decreased affinity for lipids, which subsequently prevents 
the enhancement of neurite outgrowth normally seen with wild-type protrudin in primary 
hippocampal neurons (Gil et al., 2012). The effects of these mutants are described in detail in 





2.1 No sufficient endogenous protrudin knockdown was achieved using 
shRNAs constructs in primary cortical neurons 
 
In order to understand whether endogenous protrudin plays a role in the regenerative 
enhancement observed in in vitro axotomy (Chapter 4) after human protrudin overexpression 
in rat primary cortical neurons, rat-specific shRNAs and CRISPR constructs were designed to 
silence the endogenous rat protrudin (see Methods). 
 
Firstly, PC12 cells and rat primary cortical neurons were transfected with 4 shRNA 
constructs (shRNA_A, shRNA_B, shRNA_C and shRNA_D from OriGene, see Methods). Cells 
were fixed either 4 or 7 days post transfection and stained with anti-protrudin antibody and 
the amount of protrudin fluorescence in the cell body was measured (Fig. 5.2A). In PC12s, 
overexpression of shRNAs for 4 days does not result in a reduced protrudin staining intensity 
in any of the conditions compared to cells overexpressing scrambled shRNA control (Fig. 
5.2B). On the contrary, in one of the conditions – in PC12s overexpressing shRNA_B (61 grey 
values), the intensity of protrudin in the cell body increased rather than decreased compared 
to scrambled control (49 grey values) (p<0.0001). In order to validate these results, cells 
overexpressing each shRNA construct were lysed 4 days post transfection and ran on a 
Western Blot to examine the amount of protrudin in lysate (Fig. 5.2C) When the amount of 
protrudin was calculated as a ratio of loading control – beta-actin, there were no significant 
differences across the conditions and control (p=0.776) (Fig. 5.2D) which confirms the 
immunocytochemistry results from above. One caveat of these experiments was that the 
transfection efficiency varied considerably between conditions. In order to bypass this 
problem, the two shRNAs which showed the highest decrease in protrudin intensity after 
immunocytochemistry – shRNA_A and shRNA_D were transfected in PC12s. Cells were then 
treated with puromycin antibiotic in order to select for the cells expressing the constructs and 
grown until they formed colonies. Individual colonies were selected and expanded to create 
cell lines stably expressing either scrambled RNA, shRNA_A or shRNA_D. In these cells, no 
significant changes were observed in the protrudin protein amount after Western blot or in 
the protrudin mRNA amount after RNA analysis (data not shown).   
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Figure 5.2 shRNAs against rat protrudin do not result in sufficient protrudin knockdown. A. 
Immunofluorescence images of PC12s expressing shRNA_A, shRNA_B, shRNA_C, shRNA_D or a combination of 
all four (green) and stained for protrudin (red). Images are taken at 63x. Scale bars are 20 µm. B. Overexpressing 
each shRNA does not result in significant decrease of protrudin staining compared to scrambled control. On the 
contrary shRNA_B causes increased amount of protrudin staining (p<0.0001, Kruskal-Wallis=34.12, n=2) C. 
Example Western blots of PC12 cells lysates. D. Quantification of the amount of protrudin staining on Western 
blots as a ratio of beta-actin staining as a loading control. There are no significant differences between any of 
the conditions (p=0.7762, Kruskal-Wallis statistic=2.568, n=5). E. Immunofluorescence images of primary cortical 
neurons expressing each construct. Images are taken at 40x. Scale bars are 20 µm. F. Bar graph to show that 
there are no significant changes were observed in protrudin staining intensity when overexpressing each 
construct (p=0.101, Kruskal-Wallis statistic=9.182, n=2). G. Bar graph to show the percentage of regenerating 
axons after laser axotomy of neurons overexpression scrambled control and 2 shRNAs - shRNA_A and shRNA_D.  
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The shRNA constructs were also validated in rat primary cortical neurons. 10 DIV neurons 
were transfected with each shRNA construct - shRNA_A, shRNA_B, shRNA_C or shRNA_D or 
a combination of all four and fixed at 14 DIV. They were then immunostained for the protrudin 
protein (Fig. 5.2E). Again, no significant changes were observed in the expression of the 
protrudin protein with either shRNA construct compared to scrambled control after 4 days of 
expression (p=0.101) (Fig. 5.2F). There were generally three types of protrudin staining 
observed in cells expressing shRNA constructs – either the protrudin staining did not differ 
majorly from non-transfected surrounding cells (highest proportion of cells), or the protrudin 
staining was very bright in the nucleus suggesting that the antibody has some non-specific 
staining or the intensity of protrudin staining was highly reduced indicating that the 
knockdown is working (lowest proportion of cells). Another approach was used where 
neurons were transfected for a total of 7-10 days in case the turnover of the protrudin protein 
was longer. Expressing the shRNA constructs in neurons for more than 4 days, however, 
resulted in substantial cell death and toxicity (data not shown). Due to these variable 
observations, shRNAs were not taken forward for regeneration experiments. While the 
validation experiments were taking place, however, small number of laser axotomies were 
carried out in neurons expressing either scrambled, shRNA_A or shRNA_D and very low 
regeneration rates were observed (11%, 5% and 0% respectively) (Fig. 5.2G). These results 
suggested that the neurons transfected with the shRNA constructs had poor overall health 
and that the shRNA construct might be toxic to some extent.  
 
 
2.2 Partial protrudin knockdown was achieved using CRISPR-Cas9 
constructs in primary cortical neurons 
 
As the shRNA constructs were shown to be toxic in neurons, another approach was used 
to knockdown endogenous rat protrudin. Three different rat-specific sgRNA sequences, 
targeting different regions of the protrudin gene, were designed and cloned into CRISPR-Cas9 
constructs (see Methods). A control non-targeting RNA (nsgCRISPR) was used as a control. 
These constructs were then transfected into primary cortical neurons either at 3 DIV or at 10 
DIV and neurons were fixed at 15 DIV and stained for HA-tag to detect the CRISPR-Cas9 




Figure 5.3 CRISPR constructs against rat protrudin result in partial protrudin knockdown. A. 
Immunofluorescence images of primary cortical neurons expressing GFP alone, nsgCRISPR control, CRISPR_1 or 
CRISPR_3 (green) and stained for protrudin (red). Images are taken at 40x. Scale bars are 20 µm. B. Example 
images of a cell transfected with CRISPR_1 which shows complete knockdown as there is no protrudin staining. 
Images were taken at 40x. Scale bars are 20 µm. C. Bar graph to show that rat primary cortical neurons 
overexpressing CRISPR_1 and CRISPR_3 constructs show reduced amount of protrudin staining intensity in the 
cell body compared to nsgCRISPR control or GFP only control (p<0.0001, one-way ANOVA, n=2). Error bars 









By four days after transfection there were no significant changes in protrudin intensity 
in cells expressing CRISPR_1 or CRISPR_3 compared to CRISPR control (data not shown). By 
twelve days after transfection, however there was a decrease in protrudin intensity in cells 
expressing CRISPR_1 (783 grey values) or CRISPR_3 (691 grey values) compared to nsgCRISPR 
control (1161 grey values) or GFP only control (1447 grey values) (p<0.0001) (Fig. 5.3C). This 
difference was, however, mostly attributed to a small proportion of cells expressing CRISPR_1 
and CRISPR3 constructs which had no or very little protrudin staining (Fig. 5.3B). The rest of 
the cells had similar amount of protrudin compared to the two controls. It was difficult to 
study whether the cells showing vigorous knockdown of protrudin, are healthy and protrudin 
is reliably knocked down or if they have simply undergone apoptosis as the CRISPR constructs 
only localised to the cell body. In order to test the viability of these cells, a further stain for 
cell death markers should be added to the staining procedure. Also, due to the variability 
observed in each condition, more rigorous analysis of what proportion of all transfected cells 
show a knockdown and whether the percentage is high enough to use these cells in in vitro 
regeneration experiments, is needed.  
 
In summary, the CRISPR method of protrudin knockdown seems to be more effective 
in knocking down the protein in primary cortical neurons while keeping the neurons alive. 
However, further analyses are needed in order to validate its value in studying axon 
regeneration in rat primary cortical neurons.  
 
The original intention of the protrudin silencing approach was three-fold. Firstly, to be 
able to determine an endogenous role for protrudin in the regulation of axon growth or 
regeneration. Secondly, to be able to express protrudin deletion mutants on a background of 
depleted protrudin (all protrudin mutants are human and would not be targeted by the shRNA 
or CRISPR constructs, thereby acting as resistant constructs). Thirdly, our hypothesis was that 
phosphomimetic protrudin would mimic phosphorylation by enzymes functioning 
downstream from growth factors (Shirane and Nakayama, 2006). We reasoned that this 
would be necessary due to diminished signalling in more mature neurons. Our finding that 
wild-type protrudin stimulated regeneration to a similar degree as the phosphomutants 
suggested that the endogenous protein was perhaps also phosphorylated at the stage when 
axotomy was performed. Depleting endogenous protrudin may have allowed for a detectable 
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difference between expression of wild-type protrudin compared to the phosphomimetics. 
The problems encountered in trying to deplete endogenous protrudin led to the focus on the 
experiments described below. 
 
 
2.3 Wild-type and constitutively phosphorylated protrudin bind to all forms 
of the Rab11 protein  
 
In this section, we address the interaction between protrudin constructs and Rab11. In 
previous reports, wild-type protrudin was shown to bind to small GTPase Rab11 (Shirane and 
Nakayama, 2006). In their experiments, Shirane and colleagues showed that wild-type 
protrudin binds to Rab11 and that this interaction is strengthened by addition of NGF which 
activates the ERK-MAPK pathways and increases protrudin phosphorylation. Protrudin was 
also shown to bind preferentially to a GTP-deficient form of Rab11 (S25N) but not to a GTP-
bound form lacking GTPase activity (Q70L) (Shirane and Nakayama, 2006). Furthermore, this 
interaction between Rab11-GDP and protrudin was shown to be required for neurite 
outgrowth in PC12 cells upon NGF treatment. 
 
In this thesis, phosphomimetic mutants were created in order to enhance the interaction 
between protrudin and Rab11-GDP without having to activate intracellular pathways such as 
the ERK/MAPK pathway. In order to examine whether the phosphomimetic mutants have an 
enhanced affinity for Rab11, co-immunoprecipitation studies were carried out in HeLa cells 
where GFP only, GFP-WT protrudin or GFP-MUT2 protrudin were co-transfected with either 
mCherry-Rab11-WT, a dominant negative form of Rab11 – RFP-Rab11-DN (GDP-bound, S25N) 
and a constitutively active form of Rab11 – RFP-Rab11-CA (GTP-bound, Q70L). Cells were 
lysed 48 hours post transfection and co-immunoprecipitation was carried out on an anti-GFP 
magnetic bead column as described in Methods (Fig. 5.4A). Once the proteins that were 
bound to the column were eluted, they were next analysed by SDS-PAGE (Fig. 5.4B). 
 
The experiment showed that both forms of protrudin – GFP-WT protrudin and GFP-MUT2 
protrudin bound to all three forms of Rab11 including the constitutively active form of Rab11 
(GTP-bound) in contradiction with previous studies (Fig. 5.4B) (Shirane and Nakayama, 2006). 
From the initial hypothesis that constitutively active protrudin will bind more Rab11-GDP 
156 
 
(S25N), a thicker band was expected when RFP-Rab11-DN is co-precipitated with GFP-MUT2 
protrudin compared to when co-precipitated with GFP-WT protrudin. Wild-type and 
phosphomimetic protrudin appeared, however to be binding to similar extent to all forms of 
Rab11 after multiple experiments (Fig. 5.4B). There were no significant differences between 
wild-type and constitutively phosphorylated protrudin in their binding to wild-type Rab11 






Figure 5.4 Co-Immunoprecipitation of protrudin and Rab11. A. A schematic diagram to describe the co-
immunoprecipitation methodology. B. Immunoblots from IP and input to show that wild-type and also 
constitutively phosphorylated protrudin bind to all forms of Rab11. GFP only does not bind to any forms of 
Rab11. C. Quantification of the band density of Rab11 in IP after immunoblotting with anti-Rab11 antibody from 
several different experiments (n=3-4). There were no differences observed between the binding of wild-type 






2.4 The axon-to-dendrite ratio of Rab11 or integrin does not change 
majorly after protrudin overexpression using immunohistochemistry 
 
 
After observing such robust effects of protrudin overexpression on axon regeneration 
both in vitro and in vivo (see Chapter 4), the next question was whether this effect is a result 
of increased transport of growth-promoting molecules into the axon. Immunocytochemistry 
for Rab11 and integrin was carried out on cortical neurons overexpressing control or 
protrudin constructs (Fig. 5.5A). The amount of endogenous Rab11 and integrins in the 
proximal and distal part of the axon was measured as described in Methods.  
The average axon/dendrite ratio of Rab11 was higher in neurons expressing syn-mCh-
MUT2 (ratio=1.1) compared to that in neurons expressing syn-mCh control (ratio=0.67) 
(p=0.006) (Fig. 5.5B). This change in the axon/dendrite ratio seems to be caused by a trend 
towards less Rab11 in dendrites (17 grey values) and a trend towards more Rab11 in the axons 
(14 grey values) of neurons expressing syn-mCh-MUT2 despite that no significant changes 
were observed in these parameters compared to control (25 grey values in dendrites and 11 
grey values) (Fig. 5.5C, 5.5D). Neurons expressing syn-mCh-MUT1 showed a decreased 
amount of Rab11 in dendrites (15 grey values) compared to syn-mCh control (25 grey values) 
(p=0.019) and a decreased amount in the axon (9.7 grey values) compared to neurons 
expressing syn-mCh-MUT2 (14 grey values) (p=0.011) (Fig. 5.5C, 5.5D). No significant changes 
were observed in the axon/dendrite ratio of Rab11 in neurons expressing syn-mCh-WT 
(p>0.999) or syn-mCh-MUT1 (p=0.7835) compared to neurons expressing control (Fig. 5.5B).  
Cortical neurons were further stained for 2 different integrins – integrin beta-1 and 
integrin alpha-5. The α5β1 integrin receptor has previously been detected extensively in the 
CNS and has been proposed to play a role after injury in the fibronectin-rich scar (Nieuwenhuis 
et al., 2018). Endogenous integrin alpha 5 is also one of the few integrins which has previously 
been detected axonally in rat tissue using immunohistochemical analysis (King, McBride and 
Priestley, 2001). In this study, the integrin beta-1 staining was unreliable and unquantifiable, 
so no further experiments were carried out with this antibody (data not shown). When 
neurons were stained for integrin alpha-5, there were no significant changes in the axon-to 
dendrite ratio or of the amount of integrin in dendrites of cells expressing syn-mCh control,  
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Figure 5.5 Immunocytochemical analysis of Rab11 in primary cortical neurons. A. Immunofluorescent images 
of endogenous mCherry signal from syn-mCh control, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 
constructs (red), Rab11 detected by immune staining (green) and neurofascin as an axon initial segment marker 
(blue). Images were taken at 40x magnification. Scale bars are 20 µm. B. Bar graph to show that the axon-to-
dendrite ratio of Rab11 in cells expressing syn-mCh-MUT2 is higher than that in cells expressing syn-mCh control 
(p=0.0113, Kruskal-Wallis statistic=11.09, n=5). C. Bar graph to show that cells expressing syn-mCh-MUT1 show 
decreased intensity of Rab11 in their dendrites compared to control (p=0.0273, Kruskal-Wallis statistic=9.157, 
n=5). D. Bar graph to show that the Rab11 intensity in the axons of cells expressing syn-mCh-MUT2 is higher 
than that of cells expressing syn-mCh-MUT1 (p=0.0208, Kruskal-Wallis statistic=9.755, n=5). Error bars represent 




syn-mCh-WT, syn-mCh-MUT1 or syn-mCh-MUT2 protrudin (p=0.259 and p=0.0919 
respectively, n=3) (Fig. 5.6A, B, D). There were some small changes observed in the amount 
of integrin alpha 5 in the axons – neurons expressing syn-mCh-WT (22 grey values) had higher 
intensity of integrin staining compared to syn-mCh control (11 grey values, p=0.016) or syn-
mCh-MUT1 (10 grey values) (p=0.011) (Fig. 5.6C). 
 
Both antibodies (against Rab11 and against integrin alpha 5), however, produced high 
background staining which was difficult to analyse, especially in the case of integrin. 
Furthermore, both integrins and Rab11 were previously shown to be excluded from mature 
axons of primary neurons (Franssen et al., 2015; Koseki et al., 2017) so subtle differences in 
their expression level and transport along the axons, are very unlikely to be detected by 
immunocytochemistry which presents a single time-point to detect highly dynamic vesicles 
along the axon. Therefore, further testing was needed in order to validate these results - live-
cell imaging experiments were carried out as a more reliable source to measure integrin and 
Rab11 amount in axons in real time and allows for visualisation of the distal axon which was 


















Figure 5.6 Immunocytochemical analysis of integrin alpha 5 in primary cortical neurons. A. Immunofluorescent 
images of endogenous mCherry signal from syn-mCh control, syn-mCh-WT, syn-mCh-MUT1 and syn-mCh-MUT2 
constructs (red) and integrin alpha 5 detected by immune staining (green). Images were taken at 40x 
magnification. Scale bars are 20 µm. B. Bar graph to show that there are no significant changes in the axon-to-
dendrite ratio of integrin alpha 5 across the different conditions (p=0.259, Kruskal-Wallis statistic=4.017, n=3). 
C. Bar graph to show that cells expressing syn-mCh-WT show increased intensity of integrin alpha 5 in the axon 
compared to control or syn-mCh-MUT1-expressing neurons (p=0.0048, Kruskal-Wallis statistic=12.95, n=3). D. 
Bar graph to show that there are no differences in the intensity of integrin alpha 5 in dendrites of neurons 









2.5 Axonal transport of Rab11 and integrin vesicles increases in the distal 
axon upon protrudin overexpression as observed by live-cell imaging 
 
In order to study whether overexpression of protrudin resulted in an increased amount of 
Rab11- or integrin alpha9-positive endosomes in the axon, live-cell imaging experiments were 
performed as described in Methods, Section 5.2. Syn-GFP-integrinα9 and syn-GFP-Rab11 
constructs were co-expressed with syn-mCh control, syn-mCh-WT or syn-mCh-MUT2 
protrudin constructs in 10 DIV primary cortical neurons. Axonal transport of Rab11 and 
integrin vesicles was imaged live using a spinning-disc confocal microscope at 13-17 DIV. The 
number of vesicles and their direction of transport was measured in the proximal part of the 
axon (within 100-200 µm of the cell body), in the distal part of the axon (beyond 600 µm) and 
at the growth cone where possible. Four types of transport were observed and measured in 
these axons – anterograde (towards the tip of the axon), retrograde (towards the cell body), 
bidirectional (vesicles moving in both directions but with net movement of less than 2 µm) 
and static (vesicles with a total movement of less than 2 µm during their visible lifetime) 
(described in detail in Eva et al., 2010, 2012). At least 40 different axons were analysed in 
each condition.  
When examining Rab11 transport (Fig. 5.7A) in the proximal and distal axon, the 
length of axonal segment in which transport was measured did not differ significantly across 
the conditions (Fig. 5.7B). Our results showed that there were more Rab11-positive vesicles 
in neurons overexpressing syn-mCh-WT protrudin (26 vesicles) compared to control in the 
proximal axon (21 vesicles, p=0.008). In addition, neurons overexpressing syn-mCh-WT 
protrudin (21 vesicles) or syn-mCh-MUT2 protrudin (19 vesicles) also showed increased 
number of Rab11-positive vesicles in the distal axon compared to control (14 vesicles, 
p<0.0001 and p=0.0008 respectively) (Fig. 5.7C). These findings suggest that overexpression 
of either form of protrudin results in increased number of Rab11 endosomes in distal axons. 
When examining the different types of transport, there were no significant changes observed 
in anterograde (p=0.293, one-way ANOVA), retrograde (p=0.844, one-way ANOVA) or 
bidirectional (p=0.169, one-way ANOVA) transport, proximally (Fig. 5.7D). There was an 
increased number of static vesicles in neurons overexpressing WT protrudin compared to 
control in the proximal axon (p=0.006, Kruskal-Wallis statistic=10.10) (Fig. 5.7D). Distally, 
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there were more particles moving retrogradely in axons expressing WT protrudin compared 
to control (p=0.016, Kruskal-Wallis statistic=8.197) and more particles moving bidirectionally 
in axons expressing WT and MUT2 protrudin compared to control (p=0.0002, Kruskal-Wallis 
statistic=16.60) (Fig. 5.7D). There were no significant changes observed in the anterograde 
(p=0.136, one-way ANOVA) or static vesicle transport (p=0.105, Kruskal-Wallis 
Statistic=4.499) in the distal axon across conditions (Fig. 5.7D). 
Although there is a small increase in the number of Rab11 vesicles in the growth cones 
of neurons expressing MUT2 protrudin compared to control, no significant changes were 
observed across the different conditions (Fig. 5.7C). There were also no significant changes in 
the number of vesicles moving anterogradely (p=0.108, Kruskal-Wallis statistic=4.441), 
retrogradely (p=0.113, Krukal-Wallis statistic=4.368), bidirectionally (p=0.747, Kruskal-Wallis 
statistic=0.584) or being static (p=0.197, Kruskal-Wallis statistic=3.243) in the growth cones 
of different conditions (Fig. 5.7D). As the length of the axon segment analysed in the growth 
cone was significantly longer in MUT2-expressing neurons compared to control (p=0.032) 
(Fig. 5.7B), all measurements for transport in growth cones were calculated as number of 






Figure 5.7 Transport of Rab11 endosomes along axons of mature cortical neurons. A. Kymographs showing the 
dynamics of syn-GFP-Rab11 in the proximal and distal axon as well as in growth cones of neurons expressing 
syn-mCh control, syn-mCh-WT or syn-mCh-MUT2 protrudin. B. The length of the segments measured for the 
analysis was not significantly different between the conditions in the proximal (p=0.634, one-way ANOVA) or 
distal (p=0.617, one-way ANOVA) axon but differed in growth cones (p=0.0383, Kruskal-Wallis statistic=6.527). 
C. Quantification of the number of Rab11 vesicles (n=4). There were more Rab11 vesicles in axons expressing 
WT protrudin compared to control in the proximal (p=0.008, one-way ANOVA) and in the distal axon (p=0.0001, 
one-way ANOVA) as well as in axons expressing MUT2 compared to control in the distal axon (p=0.0008, one-
way ANOVA). There were no differences in growth cones (p=0.07, one-way ANOVA). D. Bar graphs representing 
the number of vesicles being transported anterogradely, retrogradely, bidirectionally or being static across 
conditions. Proximally, neurons expressing WT protrudin had more static vesicles than control neurons 
(p=0.005). Distally, there was more retrograde transport in cells expressing WT protrudin (p=0.015) as well as 
more bidirectional transport in cells expressing WT (p=0.0002) and MUT2 (p=0.02) protrudin compared to 
control. There were no changes in the different transports in growth cones. Error bars represent mean ± SEM. 
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Similar results were obtained when observing the transport of integrin alpha 9-
containing vesicles in axons overexpressing either syn-mCh control, syn-mCh-WT or syn-mCh-
MUT2 protrudin (Fig. 5.8A). As hypothesised, there were more integrin-positive vesicles in 
neurons overexpressing syn-mCh-WT protrudin (14 vesicles) or syn-mCh-MUT2 (13 vesicles) 
compared to control neurons (9 vesicles) in the distal axon (p<0.0001 and p=0.0005 
respectively) (Fig. 5.8C). No significant changes were observed in the number of integrin 
vesicles in the proximal axons or in the grown cones of neurons expressing a control plasmid 
(21 and 5 vesicles respectively), WT (24 and 8 vesicles respectively) or MUT2 protrudin (23 
vesicles and 10 vesicles respectively) (Fig. 5.8C).    
When examining the different types of transport, proximally there were no significant 
changes observed in anterograde (p=0.578, one-way ANOVA), retrograde (p=0.641, one-way 
ANOVA), bidirectional (p=0.559, one-way ANOVA) or static (p=0.111, one-way ANOVA) 
transport (Fig. 5.8D). Distally, there were more particles moving anterogradely in axons 
expressing WT protrudin (p=0.006) or MUT2 protrudin (p=0.007) compared to control and 
more particles moving retrogradely in axons expressing MUT2 protrudin compared to control 
(p=0.0002) (Fig. 5.8D). There were no significant changes observed in the bidirectional 
(p=0.136, one-way ANOVA) or static vesicle transport (p=0.051, Kruskal-Wallis 
Statistic=5.951) in the distal axon across conditions (Fig. 5.8D).  
There were also no significant changes in the number of vesicles moving anterogradely 
(p=0.644, Kruskal-Wallis statistic=0.875), retrogradely (p=0.202, Kruskal-Wallis 
statistic=3.191), bidirectionally (p=0.535, Kruskal-Wallis statistic=1.251) or being static 
(p=0.811, Kruskal-Wallis statistic=0.4191) in the growth cones of different conditions (Fig. 
5.8D). As the average length of the axon segments analysed was significantly longer in WT 
and MUT2-expressing neurons compared to control (p=0.02) (Fig. 5.8B), all measurements for 
transport in growth cones were calculated as number of vesicles per a specific distance (in 
this case, 50 µm). Even though no significant changes were observed in growth cones, the 
number of growth cones (approximately 10-15 growth cones per condition) in which 
transport was examined was significantly lower than the number of proximal or distal axons 
(approximately 40-50 axonal sections per condition). There are several reasons for this 
discrepancy – firstly, some distal axons were difficult to trace beyond 800 microns from the  
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Figure 5.8 Transport of integrin alpha 9 vesicles along axons of mature cortical neurons. A. Kymographs 
showing the dynamics of syn-GFP-integrinα9 in the proximal and distal axon as well as in growth cones of 
neurons expressing syn-mCh control, syn-mCh-WT or syn-mCh-MUT2 protrudin. B. The length of the segments 
measured for the analysis was not significantly different between the conditions in the proximal (p=0.218, one-
way ANOVA) or distal (p=0.271, Kruskal-Wallis statistic=2.609) axon but differed in growth cones (p=0.0076, one-
way ANOVA) C. Quantification of the number of integrin vesicles (n=5). There were more integrin vesicles in 
axons expressing WT or MUT2 protrudin compared to control in distal axons (p<0.0001, Kruskal-Wallis 
statistic=21.81).  There were no differences in the proximal axon (p=0.149, Kruskal-Wallis statistic=3.797) or in 
growth cones (p=0.559, one-way ANOVA). D. Bar graphs representing the number of vesicles being transported 
anterogradely, retrogradely, bidirectionally or being static across conditions. There were no significant 
differences in transport in the proximal axon or growth cones. In the distal axon, there were more vesicles 
moving anterogradely in neurons expressing WT and MUT2 protrudin compared to control (p=0.0019, Kruskal-
Wallis statistic=12.57) and there were more vesicles moving retrogradely in neurons expressing MUT2 protrudin 
compared to control (p=0.0003, Kruskal-Wallis statistic=16.46). Error bars represent mean ± SEM. 
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cell body (as described in Chapter 3); and secondly, protrudin does not fill growth cones 
completely as it is only visible at the base, so growth cones are difficult to find in the dish (as 
described in Chapter 4). Further analysis of the transport in growth cones is needed in order 
to confirm these results. 
 Co-localisation between Rab11 and integrin vesicles with control plasmid, WT or 
MUT2 protrudin (Fig. 5.9A) was also measured during live image acquisition and was 
expressed as a percentage of total vesicles observed (Fig. 5.9B). Rab11 vesicles co-localised 
more readily with WT (29%) and MUT2 (29%) protrudin vesicles compared to control (18%) 
(p<0.0001, one-way ANOVA) (Fig. 5.9C). Similarly, integrin vesicles showed increased co-
localisation with WT (17%) and MUT2 (21%) protrudin compared to control (13%) (p<0.0001, 
Kruskal-Wallis statistic=24.15) (Fig. 5.9D). Although there was no statistical difference 
between WT and MUT2 co-localisation with Rab11 or integrin alpha9, in both conditions 
MUT2 protrudin showed higher co-localisation than WT protrudin as predicted by our 
hypothesis that constitutive phosphorylation will result in increased association.  
In summary, overexpression of either wild-type or mutant protrudin results in 
increased number of Rab11 and integrin alpha9-containing vesicles in the distal axon. In 
addition, there is an increased amount of active (anterograde and retrograde) transport of 
these vesicles in the distal axons of neurons expressing WT or MUT2 protrudin. These 
observations are important as the distal axon is the most usual site of axonal injury and this 
is where the most pronounced absence of Rab11 and integrins is evident. Therefore, being 
able to improve Rab11 and integrin transport in this part of the axon might explain the 
increased regenerative ability of neurons overexpressing protrudin. Lastly, both WT and 
MUT2 protrudin vesicles co-localised more with Rab11 and integrin confirming previous 
results that protrudin associates with Rab11-positive endosomes.  Furthermore, this is the 
first evidence to show that a proportion of integrin-containing vesicles in the axon is 






Figure 5.9 Rab11 and integrin alpha9 colocalise with wild-type and MUT2 protrudin in the axon. A. 
Representative kymographs for MUT2 protrudin (red) and Rab11 (green) or Integrin alpha 9 (green) and a 
merged image from which the number of vesicles containing both proteins (yellow) was measured. B. 
Quantification of the total percentage of co-localisation between Rab11 vesicles and control or protrudin 
plasmids as a function of the total number of Rab11 vesicles observed per axon segment. There were more 
Rab11 vesicles which also contained WT or MUT2 protrudin compared to control (One-way ANOVA, p<0.0001). 
C. Bar graph to show that there are more integrin vesicles containing WT (17%) or MUT2 (21%) protrudin 




2.6 Protrudin aids axon regeneration via multiple molecular pathways 
 
The results obtained during the regeneration experiments described in Chapter 4, 
showed that overexpressing wild-type protrudin on its own, promotes regeneration after 
laser injury in cultured cells and after optic nerve crush. The transport data above suggest 
that this is associated with an increase in both Rab11 and integrin transport into the distal 
axon. Protrudin is, however, a complex protein with numerous cellular functions as described 
in Introduction, therefore we hypothesised that there might be other molecular pathways 
through which protrudin is promoting axon regeneration, beyond the transport of growth-
promoting molecules.  
To test this, five more mutant forms of the protrudin protein were created – each 
disrupting a specific region of the protein important for its involvement in various molecular 
pathways (endoplasmic reticulum shaping, axonal transport, phospholipid interactions, 
microtubule severing, etc.) (Fig. 5.1). Rat primary cortical neurons were then grown in culture 
for 10 days and were transfected with each of the constructs described (control, ∆FYVE, 
∆FFAT, ∆KIF5, ∆Spastin, ∆RBD, ∆ER and MUT2 protrudin as positive control). Their 
regenerative abilities were tested in the in vitro axotomy model described in Chapter 4 for 
their effects on axon regeneration.  
Strikingly, expression of either ∆Spastin or ∆RBD protrudin mutants in primary cortical 
neurons at 10 DIV, resulted in cell death (Fig. 5.10A) in the majority of the transfected cells. 
This effect seemed to be cortical-neuron-specific and dose-dependent because the two 
constructs had no adverse effects when transfected in PC12 cells or when co-expressed with 
a GFP control vector where some neurons in which the expression of the mutant was 
dampened down, survived (data not shown). Due to the adverse effects these two mutants 
had on primary cortical neurons, their effect on regenerative ability could not be examined. 
These results suggested that the overexpression of ∆Spastin and ∆RBD protrudin interfered 
with endogenous protrudin function and that the interactions of protrudin with spastin and 
Rab11 might be essential for neuronal health and survival. 
 The rest of the mutants did not result in any immediately obvious morphological or 
functional changes so their effect on regenerative ability could be tested. Overexpression of 
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all four mutants of protrudin - ∆FYVE (43%, n=4), ∆FFAT (48%, n=4), ∆KIF5 (46%, n=4) and ∆ER 
(35%, n=2) resulted in decreased percentage of regenerating axons compared to neurons 
overexpressing positive control – syn-mCh-MUT2 protrudin (86%, n=1) which was previously 
described to promote axon regeneration (see Chapter 4) (Fig. 5.10C). Furthermore, the 
percentage of regenerating axons in all four mutant conditions, did not significantly differ 
from syn-mCh control only (33%, n=6). More axotomies are currently being carried out with 
∆ER and syn-mCh-MUT2 positive control in order to increase the n number of experiments. 
These results suggest that mutating any of the domains described above results in reduced 
ability of protrudin to promote axon regeneration. There were no significant differences in 
other parameters measured during axotomy such as the time of regeneration (Fig. 5.10E), the 
total regenerative distance (Fig. 5.10D), the regeneration distance after 2 hours (Fig. 5.10H), 
the retraction distance (Fig. 5.10F) or the maximum growth cone area (Fig. 5.10G).  
From these experiments we concluded that protrudin promotes regeneration through 
multiple mechanisms, some of which, such as endoplasmic reticulum (ER) involvement have 
not previously been well-studied with regards to the process of axon regeneration. These 
findings prompted us to hypothesise that protrudin acts as a scaffold molecule bringing 
multiple molecules, organelles and cellular components together at the tip of growing axons 








Figure 5.10 Overexpression of protrudin mutants suppresses protrudin’s effect on axon regeneration. A. 
Immunofluorescent images of endogenous mCherry signal from different protrudin mutants. The ∆Spastin and 
∆RBD mutants resulted in cell death when overexpressed in neurons at 10 DIV and suppressed neurite 
outgrowth at 3 DIV (B.) Images are taken at 40x magnification. Scale bars are 20 µm. C. The percentage of 
regenerating axons in neurons overexpressing syn-mCh-MUT2 protrudin is significantly higher than neurons 
overexpressing syn-mCh control or any of the functional domain mutants (p=0.0015, Fisher’s exact test with 
Bonferroni-Dunn pairwise comparison). D., E., F., G., H. There were no significant differences between the time 
of regeneration after injury (p=0.6107, Kruskal-Wallis statistic=3.584), the total distance regenerated (p=0.3454, 
Kruskal-Wallis statistic=5.616), the regeneration distance 2 hours after regeneration initiation (p=0.1778, 
Kruskal-Wallis statistic=7.630), the maximum growth cone area (p=0.6619, Kruskal-Wallis statistic=3.248) or the 
retraction distance (p=0.5887, Kruskal-Wallis statistic=3.732) between any of the conditions.  
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2.7 Constitutively phosphorylated protrudin colocalises better with Rab7 in 
the cell body and REEP5 in growth cones compared to wild-type 
protrudin 
 
Recently, protrudin’s co-localisation with another Rab protein – Rab7 (a marker of late 
endosomes) was also examined, initially in the cell body. Syn-mCh-WT and syn-mCh-MUT2 
protrudin was overexpressed in 10 DIV primary cortical neurons which were fixed at 14 DIV 
and stained for endogenous Rab7 (Fig. 5.11A). Mutant protrudin showed more co-localisation 
with Rab7 in the cell body of mature neurons (41%) compared to wild-type protrudin (22%) 
(p=0.002, Man-Whitney test) (Fig. 5.11B). Furthermore, protrudin’s co-localisation with a 
resident smooth endoplasmic reticulum protein – REEP5 was also tested. It was observed that 
mutant protrudin co-localised more with REEP5 in the distal axon and in growth cones (Fig. 
5.11C). The Rab7 co-localisation experiment was carried out twice and the REEP5 experiment 
once so further repetitions are needed in order to confirm these results and observations. 
Rab7 is difficult to trace in the axon so in order to perform these experiments, we are 
currently co-transfecting wild-type or mutant protrudin with Rab7-GFP construct in order to 
observe the effects in the axon. Furthermore, the specificity of REEP5 and another smooth ER 
marker – reticulon-4 antibodies (Farías et al., 2019) is currently being tested against ER lumen 





Figure 5.11 Protrudin co-localises with Rab7 in the cell body and REEP5 in the growth cone. A. 
Immunofluorescent images of endogenous mCherry signal from wild-type and mutant 2 protrudin (red) in cells 
stained for Rab7 (green). Images are taken at 63x magnification. Scale bars are 10 µm. White arrows point at 
protrudin-filled vesicular structures in the cell body. B.  Bar graph to show that syn-mCh-MUT2 protrudin co-
localises better with Rab7 in the cell body compared to syn-mCh-WT protrudin (p=0.002, Man-Whitney test). 
Error bars represent mean ± SEM. C. Immunofluorescent images representing endogenous mCherry signal from 
WT and MUT2 protrudin constructs (red) and stained ER marker REEP5 (green). Images are taken at 40x. Scale 








In this chapter, the mechanisms behind protrudin’s action on axon regeneration are 
explored. Overexpression of wild-type and mutant protrudin resulted in increased axonal 
transport of Rab11 and integrins into the distal part of the axon. This increase could in part 
explain the regenerative properties of protrudin, given the mounting evidence that increased 
transport of these molecules can facilitate CNS regeneration (Eva et al., 2017; Koseki et al., 
2017). Protrudin’s involvement in ER shaping and function, lipid transfer, lysosomal transport 
and axonal transport were all implicated in the process of axon regeneration by studying 
protrudin’s functional mutants.  
 
Overexpression of wild-type and constitutively active protrudin resulted in enhanced axon 
regeneration in vitro as described in Chapter 4. In this system, however the human protrudin 
was overexpressed on top of the endogenous rat protein and the interaction between the 
two proteins or their individual involvement in boosting axon regeneration was difficult to 
study. A system where the endogenous protein is knocked down could be valuable for 
studying whether protrudin is required and necessary for basal levels of axon regeneration in 
mature neurons. Previously, successful knockdown of protrudin was performed using siRNA 
constructs in RPE-1 cells (human retinal pigmented epithelial cells) and in HEK293 (from 
human embryonic kidney) after 48 hours (Hong et al., 2017) as well as in HeLa cells (Connell 
et al., unpublished data). Protrudin has also been previously knocked down in zebrafish using 
morpholinos and this resulted in developmental impairments (Zhang et al., 2012) as well as 
in human monocytes using siRNA where it resulted in compromised phagocytosis and toll-like 
receptor expression (Lindholm et al., unpublished data). These studies, however, showed a 
reliable knockdown in human protrudin protein. Knockdown of endogenous rat protrudin in 
PC12s or rat primary neurons has not been documented so far.  
 
In order to distinguish between the effects of endogenous rat protrudin and the 
overexpressed human protrudin, endogenous protrudin knockdown was attempted by two 
methods. Firstly, rat-specific protrudin shRNA constructs (OriGene) were transfected 
transiently in PC12 cells for 4 days with the aim to reduce the protrudin protein expression. 
175 
 
There were, however, no significant changes in the intensity of protrudin staining in the cell 
body analysed by immunocytochemistry or in the amount of protrudin protein in the lysate 
analysed by SDS-PAGE compared to scrambled shRNA control (Fig. 5.2A-D). Furthermore, 
PC12 cells expressing two of the four shRNAs in stable lines, showed no differences in the 
amount of the protrudin protein as analysed by SDS-PAGE (data not shown). There were also 
no differences when shRNAs were expressed in primary cortical neurons for 4 days in the 
amount of the protrudin protein in the soma as analysed by immunofluorescence (Fig. 5.2E-
G). It was observed that when transfected for longer periods of times – 7 or 10 days, primary 
cortical neurons started to show some changes in the amount of protrudin, but this also 
resulted in increased toxicity and in compromised cell survival.  
 
There are several reasons why no robust knockdown is observed using the shRNAs. Firstly, 
as discussed in Chapter 3, there is very little protrudin during the development of rat primary 
cortical neurons in vitro to begin with - knocking down the already sparse protein and reliably 
detecting it could be a challenge. Furthermore, the protrudin protein turnover has not been 
previously documented in neurons so a substantial knockdown might require longer 
expression of shRNAs which in our case resulted in toxicity. Lastly, protrudin antibody used in 
all experiments produced high amount of background especially in more mature cultures, so 
detecting a small difference in protrudin expression might prove a challenging task.  
 
These could explain why robust expression was not detected in primary cortical neurons, 
but in PC12s, the protein is expressed at high levels and the antibody works reliably. One 
reason for the failure to detect differences in protrudin levels in PC12 cells, could be that low 
and variable transfection rates were achieved for Western blot analysis (data not shown). In 
order to bypass these obstacles, lines of PC12 cells stably expressing two shRNAs which 
showed promising results after immunocytochemistry – shRNA_A and shRNA_D, were 
generated. These, however also did not show significant changes in protrudin levels after SDS-
PAGE analysis which could be attributed to the long period of time needed to create and 
expand the stable lines (approximately 2-3 weeks) during which time the cells may have 
compensated by protrudin upregulation. In summary, no reliable knockdown was achieved in 




Another approach was using the CRISPR-Cas9 system to knockdown endogenous rat 
protrudin. In this experiment, shorter version of the Cas9 protein from Staphylococcus aureus 
(saCas9) was used in order to fit all components into a single plasmid (Friedland et al., 2015).  
Three different sgRNA sequences against rat protrudin were designed to target different 
regions of the protrudin gene (see Methods). There were difficulties in sequencing and 
obtaining a pure sample of the plasmid containing the CRISPR_2 sequence, so this plasmid 
was not used for initial experiments. CRISPR constructs 1 and 3 showed promising results in 
knocking down protrudin when overexpressed in primary cortical neurons for more than 10 
days. They appeared less toxic and a percentage of cells showed substantial knockdown of 
protrudin as analysed by immunocytochemistry (Fig. 5.3). As described in Results above, 
however, the viability of these cells needs to be tested in further experiments in order to 
validate these constructs and their use for future experiments. Unfortunately, as neuronal 
transfection only results in 1% of neurons being transfected in primary cortical cultures, no 
reliable SDS-PAGE analysis could be carried in neurons to validate the reduced amount of 
protrudin protein.  
 
In summary, the CRISPR-saCas9 constructs showed more promising results in knocking 
down endogenous rat protrudin than using shRNAs in terms of efficiency and viability. 
However, due to the variability in the knockdown achieved and the fact that there is very little 
detectable protrudin in these cells in the first place, the rest of the experiments were carried 
out as initially described by overexpressing human protrudin in addition to the rat 
endogenous protein.  
 
Our initial hypothesis was that creating constitutively phosphorylated protrudin will 
increase the interaction between protrudin and Rab11-GDP. Firstly, immunoprecipitation (IP) 
was carried out by overexpressing wild-type and mutant protrudin and blotting for 
endogenous Rab11. In these experiments, however, no band was detected for endogenous 
Rab11 in the IP immunoblotting (data not shown). Therefore, a new experiment was designed 
where wild-type or mutant protrudin (fused to GFP) was co-expressed together with either 
one of three forms of Rab11 (WT, GTP-bound form and GDP-bound form, fused to RFP or 
mCherry) in HeLa cells which were then lysed. The lysate was then passed through a magnetic 
anti-GFP column where protrudin-GFP and its binding partners attached and after several 
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washes to remove unbound proteins, the final eluate was analysed by SDS-PAGE and blotted 
for Rab11 (Fig. 5.4A). It was anticipated that increased interaction between mutant protrudin 
and the GDP-bound form of Rab11 (RFP-Rab11-DN) will produce visibly thicker band on the 
IP blot. The overexpression of both protrudin and Rab11 was reliably detected in the input 
blots with staining for protrudin, GFP, Rab11 and mCherry (Fig. 5.4). Protrudin was also 
successfully pulled down in the GFP column as the overexpressed protein was reliably 
detected in the IP blot (Fig. 5.4) The overexpressed protrudin in the pull down showed 
monomeric (at 75 kDa) and oligomeric forms (at 150 kDa, data not shown) as previously 
described suggesting that the protein has retained its normal binding properties (Pantakani 
et al., 2011). There were, however no obvious differences in the amount of wild-type or 
mutant protrudin binding any more to a particular form of Rab11. Although our experiment 
was designed in a similar fashion to the experiments performed by Shirane and Nakayama 
(2006), we found that both forms of protrudin associated with all forms of Rab11 which is 
contradictory to their findings that protrudin preferentially binds Rab11-GDP (Shirane and 
Nakayama, 2006). One caveat of this study might be that the two proteins were 
overexpressed, and this might result in some unusual interactions which are not characteristic 
of the physiological situation. Furthermore, co-immunoprecipitation is a semi-quantitative 
method to detect protein-protein interactions and could be highly dependent on the 
transfection rate of the cell lines, the levels of protein expression in each condition, the 
capacity of the column and so on. This makes the method better suited for qualitative rather 
than quantitative analysis. In order to improve this experiment in the future, achieving 
detection of endogenous Rab11 is desired as well as the use of a quantitative method such as 
GST pull down, for example.  
 
 It was then anticipated that if mutant protrudin does indeed interact more readily 
with Rab11-GDP and the whole complex moves anterogradely, then more Rab11 as well as 
some of its cargo – integrins, will be detected in the axons of neurons overexpressing mutant 
protrudin. This hypothesis was first tested utilising immunocytochemistry in primary cortical 
neurons. There were minimal changes in the amount of Rab11 and no changes detected in 
integrin staining in the axons of cells expressing wild-type or mutant protrudin (Fig. 5.5, 5.6). 
These results could be due to the fact that Rab11-recycling endosomes carrying integrins and 
other growth receptors could be stationary or highly dynamic structures moving up and down 
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the axons at speeds ranging between 0.2-0.5 µm/s (Prekeris, Foletti and Scheller, 1999). Using 
immunocytochemistry which relies on a single time point might not be reliable. Furthermore, 
the antibodies against Rab11 and integrin alpha 5 produced inconsistent results and high 
background staining, which could make the detection of subtle changes very challenging. 
Therefore, live-cell imaging of Rab11 and integrin endosomes in the proximal and distal axon 
as well as in the growth cone was carried out using spinning-disc confocal microscopy.  
 
 Similar to previous studies, our live-cell imaging experiments confirmed that the 
majority of Rab11-positive vesicles traffic bidirectionally (Eva et al., 2010) whereas the bulk 
of integrin-containing endosomes undergoes retrograde movement (Franssen et al., 2015). 
In this study, overexpression of wild-type and constitutively phosphorylated mutant protrudin 
resulted in increased retrograde and bidirectional transport of Rab11 and in enhanced 
anterograde and retrograde transport of integrins in the distal axon (Fig. 5.7, 5.8). There were 
also more Rab11 and integrin-positive vesicles present in the distal axon and these vesicles 
colocalised more readily with protrudin (especially mutant protrudin) compared to control 
(Fig. 5.7, 5.8, 5.9). Even though no statistical differences were observed, constitutively 
phosphorylated protrudin seem to have increased co-localisation with integrin vesicles than 
wild-type protrudin and to have a larger effect on their active transport in the distal axon. In 
this study, only one integrin (alpha 9) was examined. After injury, one of the most highly 
upregulated components of the extracellular matrix is tenascin-C, which is a substrate for 
integrin alpha 9 (Fawcett and Asher, 1999). We chose to focus on integrin alpha 9 receptor as 
this subunit is absent in adult neurons which prevents them from regenerating or growing 
through tenascin-rich areas such as the glial scar after injury. Integrin alpha 9 upregulation in 
adult DRGs has been shown to improve axon growth and regeneration in vivo and in vitro on 
the otherwise inhibitory tenascin-C (Andrews et al., 2009). In addition, different forms of the 
integrin receptor have previously been shown to co-localise with Rab11-positive vesicles (Eva 
et al., 2010). Rab11 has also been shown to transport many other growth molecules along the 
axon such as the transferrin receptor, insulin growth-factor receptor (Romanelli et al., 2007) 
and tyrosine-kinase B receptor (Hollis et al., 2009b). Therefore, we cannot conclude that the 
regenerative effect we observe with protrudin overexpression is solely due to increased 
amount of integrin in the axons. It will be interesting to examine other forms of integrin 
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receptor as well as other growth-associated receptors and their trafficking in mature axons 
upon protrudin overexpression. 
 
 The fact that wild-type protrudin enhanced axon regeneration in vitro after laser 
axotomy and in vivo after optic nerve crush, suggest that additional cellular processes other 
than axon transport of growth-molecules could also be involved in mediating protrudin’s 
action on axon growth. Therefore, a battery of mutants was created in order to test which 
interactions of protrudin are necessary for its growth-promoting effect. Each mutant was 
overexpressed in 10 DIV primary cortical neurons and laser axotomy was carried out between 
13-17 DIV. It was hypothesised all mutants will act to suppress neurite outgrowth in culture 
and that some mutants will have a predominant effect on suppressing axon regeneration 
compared to others. Interestingly, overexpression of mutants which attenuate protrudin’s 
interaction with spastin (microtubule-severing protein) or with Rab11, resulted in cortical 
neuron but not PC12 cell death (Fig. 5.10A). This finding suggests that protrudin’s interaction 
with these molecules is necessary for basic neuron function, and therefore neuronal survival. 
Due to the toxic effects of these two mutant forms, their effects on axon regeneration could 
not be tested.  
 
The effects of all mutants on neurite outgrowth were tested in 2 DIV neurons which 
were fixed and imaged using Cellomics (as described in Methods). Only ∆Spastin and ∆RBD 
mutants showed to have significant effect in reducing neurite outgrowth from this assay (Fig. 
5.10B). Some of the other mutants have also been previously shown to reduced neurite 
outgrowth in different cell types (see Introduction) – this effect, however was not replicated 
here. There were many caveats with this experiment. The main one was that the cortical 
neurons were imaged at 10x in order to obtained images for the whole wells of a 24-well 
plate. However, as the mCherry constructs express at quite low levels, in some cases the 
software could not distinguish between an axon and the background resulting in 
underestimating the length of some exceptionally long axons. Further experiments conducted 
at higher magnification or with a brighter marker are desired in order to validate these results.  
Interestingly, in younger cells overexpression of ∆Spastin and ∆RBD showed a larger 




When testing the protrudin mutants in our paradigm of laser axotomy, all four 
mutants (∆FYVE, ∆FFAT, ∆KIF5, ∆ER) resulted in decreased proportion of regenerating axons 
down to control levels compared to positive control neurons expressing a phosphomimetic 
form of protrudin (Fig. 5.10C). The mutants had no effect on any of the other parameters 
measured during axotomy such as the time of regeneration, the distance regenerated, the 
size of the growth cone or the retraction distance (Fig. 5.10D-H). Interestingly, neurons 
overexpressing syn-mCh-MUT2 previously showed decreased time of regeneration and 
increased total regeneration distance compared to control (see Chapter 4). This result was 
not replicated in the current study – the discrepancy seems to be due to the fact that in this 
study a different control plasmid was used (syn-mCh only) which seems to regenerate faster 
and further than our previous GFP dual control plasmid. These findings suggest that 
overexpression of dual GFP control plasmid could have some toxic effects on the cell and 
decrease regenerative potential (also discussed in Chapter 4). The percentage of regenerating 
axons, however did not differ between the two controls suggesting that these cells still have 
decreased regenerative potential to begin with and that overexpression of constitutively 
active protrudin results in dramatic enhancement of regeneration. Furthermore, only one 
positive control experiment and two ∆ER mutant experiments were carried out to date so 
further testing is performed at the moment in order to complete the data set.  
  
 The data presented here indicate that the association between protrudin and the ER 
is essential for its ability to enable axon regeneration. Importantly, the ∆ER protrudin mutant 
has the most prominent effect of all mutants tested, with its expression completely failing to 
stimulate axon regeneration (Fig. 5.10C). This mutant has previously been shown to result in 
dissociation of protrudin from membranous structures and its accumulation in cytoplasm 
(Chang, Lee and Blackstone, 2013). An important part of the regenerative mechanism acting 
within the ER is indicated by the effect of deleting the FFAT domain. This domain is required 
for protrudin’s interaction with the ER-resident protein VAP-A and its removal also sharply 
reduces protrudin’s ability to stimulate growth. These combined data indicate that the ER and 
ER contact sites are key players in protrudin-mediated regeneration and suggest an important 




The involvement of the ER in axon regeneration has not been tested in mammalian 
CNS neurons before. One previous study has presented correlative evidence implicating not 
only the ER but also the protrudin-binding protein-spastin in axon but not dendrite 
regeneration due to their accumulation at the tips of regenerating axons after axonal injury 
in Drosophila (Rao et al., 2016). In some preliminary experiments, we found that there is more 
ER (shown by REEP5 marker) in the growth-cones of neurons expressing mutant 2 protrudin 
but not wild-type or control plasmids (Fig. 5.11). Speculatively, protrudin’s interaction with 
the ER, endosomal organelles and kinesin could be important for trafficking ER into the axon 
towards the site of growth/injury because the ER itself is reported to hitchhike on motile 
organelles (Guo et al., 2018). An increased ER presence here could, provide the necessary 
lipids and membrane components required for axon elongation. Smooth ER was previously 
found to form a continuous network throughout the whole axon – a network referred to as a 
“neuron within a neuron” (Berridge, 1998) which is held in place by ER-resident proteins such 
as reticulons and REEPs (Yalçın et al., 2017). Mutations in these proteins have previously been 
shown to cause hereditary spastic paraplegia (HSP). In animal models, defective reticulons 
and REEP proteins lead to disruption of the continuous ER network where fewer but larger 
tubules as well as breaks in the ER are observed, specifically in the distal axon (O’Sullivan et 
al., 2012; Yalçın et al., 2017). As axonal ER normally plays important functions such as calcium 
buffering, lipid biosynthesis and membrane trafficking, these mutations resulted in an 
increased ER stress, changes in the microtubule cytoskeleton and mitochondria (O’Sullivan et 
al., 2012). These changes support a model where disruption of ER structure and function 
within the distal axon could be the basis for the distal neurodegeneration observed in HSP. In 
this sense, enrichment of smooth ER at the growth cone as seen when constitutively 
phosphorylated protrudin is overexpressed can aid axonal functions of other organelles and 
components and therefore, improve axon regeneration. Currently, high-resolution structured 
illumination microscopy (SIM) is being performed in our laboratory in collaboration with Dr 
Evan Reid’s laboratory in order to examine the precise structure and amount of ER in the 
distal axon and in the growth cone upon protrudin overexpression.  
 
One possible mechanism through which ER, enriched at growing processes could 
support axon regeneration is by rapid plasma membrane (PM) expansion and lipid synthesis 
and transfer. The interface between the ER and PM has previously been shown to play a key 
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role in calcium buffering, lipid shuttling and cell signalling (Gallo, Vannier and Galli, 2016). 
During developmental growth, secretory vesicles fuse with the plasma membrane – a process 
mediated by SNARE proteins (Martinez-Arca et al., 2000; Alberts et al., 2003). Interestingly, 
blockade of vesicular trafficking have little effect on the transport of lipids, which suggests 
that other non-vesicular processes of lipid transfer might play a role in membrane expansion 
during growth (Voelker, 2009). For example, lipid transport proteins were shown to be able 
to directly influence the trafficking of lipids from the ER to the PM (Lalanne and Ponsin, 2000; 
Levine, 2004). In a recent study, a vesicle-independent lipid transfer from the ER to the PM 
was demonstrated where Sec22b – an ER-resident SNARE interacted directly with syntaxin 1 
on the PM to create pockets through which a large amount of lipids could be transported 
without a requirement for membrane fusion (Petkovic et al., 2014). This process allows for 
bulk transfer of lipids form the ER to the membrane and is essential for developmental axon 
growth. In our study, similar mechanisms could be working whereby protrudin drags more ER 
into the tip of injured processes and positions it in close apposition to the PM which in turn 
could facilitate more efficient transfer of already synthetised lipids from ER to PM and allow 
for rapid expansion of the plasma membrane at the growth cone – a requirement for 
successful axon regeneration.  
 
Interestingly, the ∆KIF5 protrudin mutant was expected to reduce the amount of 
protrudin in the axon due to decreased anterograde movement. However, protrudin was still 
visible in the axon allowing for laser axotomy to be performed. This could be due to the large 
overexpression of the protein which allows it to freely diffuse in the axon or there is a 
possibility that protrudin interacts with other families of KIF proteins, not just kinesin 1. 
Nonetheless, the mutant still resulted in decreased regenerative potential suggesting that 
anterograde axonal transport of protrudin is indeed required for its effects on axon 
regeneration.  
 
Lastly, a mutation in the FYVE domain of protrudin which is important for its binding 
to phosphoinositides is also required for axon regeneration. Recently, novel techniques 
requiring the introduction of unnatural amino acids to the protrudin protein were used to 
covalently trap transient interactors of the protein in vivo. These identified numerous 
protrudin interactors, including molecules involved in DNA repair, ubiquitination, translation 
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and vesicle-related proteins (Zhang et al., 2017). One particularly interesting interactor of 
protrudin was fatty acid synthase (FASN) (Zhang et al., 2017). Fatty acid synthase is an enzyme 
involved in the synthesis of lipids which is transported in Rab18-endosomes. Interestingly, 
adding a FASN inhibitor to HeLa cells overexpressing protrudin, results not only in decreased 
protrudin levels, lower amounts of free fatty acids but also to impaired process formation 
suggesting that FASN interaction with protrudin is a likely source of lipid material for 
membrane expansion during neurite outgrowth (Zhang et al., 2017). A model was proposed 
where protrudin recruits FASN for lipid biosynthesis within the tubular ER which in turn 
facilitates membrane expansion and increases membrane fluidity during the process of 
neurite outgrowth. The role of lipid biosynthesis and transfer upon protrudin overexpression 
and the enhancement of regenerative potential was not studied in detail in this thesis but 
would be an interesting avenue to explore in future studies.  
 
Another interesting observation was that overexpressed phosphorylated protrudin 
resulted in an increased number of Rab7-positive endosomes in the cell bodies of mature 
cortical neurons (Fig. 5.11). As the phosphorylation mutation of protrudin was introduced in 
the Rab11-binding domain, it is not unlikely, that this mutation could also influence the 
binding of other Rab proteins (such as Rab7). In a recent study, the role of the protrudin-Rab7 
interaction was studied in the light of forming membrane contact sites between the ER and 
recycling endosomes (Raiborg et al., 2015). ER-endosome contact sites are quite unique – 
these sites cover 3-5% of the endosomal surface and 99% of endosomes remain in contact 
with the ER while trafficking (Raiborg et al., 2015). Protrudin was shown to colocalise with 
LAMP1-positive late endosomes and lysosomes in HeLa cells upon overexpression (Raiborg et 
al., 2015). Interestingly, ER-resident protrudin was shown to be recruited to late endosomes 
by binding to Rab7-GTP (a late endosomal marker but also a protein involved in long-range 
retrograde signalling) and this interaction resulted in the formation of multiple ER-endosome 
contact sites (Raiborg et al., 2015). This process was shown to be facilitated by protrudin 
loading kinesin 1 motors onto FYCO1 – a protein found on late endosomes which results in 
their displacement along microtubules towards the tip of growing processes. Accumulation of 
late endosomes at the growing tip then results in fusion with the plasma membrane and 
release of contents. This process seems to be imperative for the aiding of neurite outgrowth 
as when FYCO1 or Rab7 are depleted in HeLa cells, protrudin-mediated process formation is 
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compromised. The significance of these results lies in the fact that this could be a potential 
mechanism for providing lipids and proteins to the protrusion tip membrane that are 
favourable for protrusion extension. However, an important caveat is that our RNA sequencing 
data of cortical neurons developing in vitro (Koseki et al., 2017) indicate that FYCO1 is 
expressed at very low levels throughout cortical neuron development and into adulthood.  
Further analysis of the levels of protein expression are therefore required in these neurons.  
Interestingly, in a recent study, protrudin-FYCO1-Kinesin-Rab7-dependent displacement of 
late endosomes to the plasma membrane has been shown to result in activation of the mTOR 
pathway and suppression of autophagy (Hong et al., 2017), both of which have previously 
been identified in the process of axon regeneration (Park et al., 2008; Ban et al., 2013). Here, 
we showed that protrudin has an effect on the amount and distribution of Rab7-positive late 
endosomes and therefore could influence the autophagosome-lysosomal pathways in the cell. 
Several other organelles (e.g. mitochondria, proteasomes and autophagosomes) and their 
distribution have been associated with reduced regenerative ability in adult CNS axons (see 
Introduction), therefore studying the transport of those along axons overexpressing protrudin 
is an interesting suggestion for future experiments.  
Lastly, one further possible mechanism of protrudin enhancing axon regeneration 
could be through its interaction with the microtubule-severing protein - spastin. Microtubule 
(MT) dynamics play a critical role an important player in successful growth cone formation 
and axon regeneration (Blanquie and Bradke, 2018). For example, disorganised MTs in 
retraction bulbs were shown to be indicative of regenerative failure (Erturk et al., 2007) 
whereas the addition of low doses of MT-stabilising drug – taxol, resulted in organised MT 
bundles, enhanced axon growth and improved outcome after injury (Erturk et al., 2007; Witte, 
Neukirchen and Bradke, 2008). Recent studies showed that spastin, similarly to protrudin, 
localises to ER-endosome contact sites and is involved in receptor trafficking and ER shaping 
(Allison et al., 2013, 2017). Our collaborators in Dr Evan Reid’s laboratory showed that spastin 
regulated protrudin-dependent neurite outgrowth. When an HSP-associated mutant form of 
spastin which lacks its MT-severing properties was introduced, enhanced neurite outgrowth 
was observed in cultured neurons (Connell et al., unpublished data). Spastin might act as an 
inhibitor of protrudin-induced neurite outgrowth either by introducing physical breakage of 
the MT tracks which prevents long-range protrudin transport to the tip of growing neurites or 
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by preferential loading of dyneins at new MT ends resulting in enhanced minus-end directed 
transport. These results are further supported by a recent study where knockdown of fidgetin 
– another spastin-like MT-severing protein resulted in enhanced regeneration by increasing 
the mass of the liable microtubules in the axon – recapitulating the situation during 
development (Matamoros et al., 2019). In our study, the interaction between spastin and 
protrudin was difficult to study due to the reduced viability of mature cortical neurons 
expressing ∆Spastin protrudin. Further experiments involving spastin knockdown in our 
system could provide valuable insight into this interaction’s involvement in axon 
regeneration. Furthermore, studying the MT dynamics in protrudin-expressing neurons is 
another future avenue. In the current experiments, live-cell imaging of EB3 – a MT-plus end 
binding protein was attempted (data not shown); however, no reliable results were obtained.   
In summary, we propose a model where protrudin acts from within the ER as a 
scaffolding molecule bringing together multiple molecules, organelles and cellular 
components (Fig. 5.12) at the tip of growing axons/site of injury and that its reduced levels in 















Figure 5.12 Schematic of protrudin’s action at the growth cone. A model where protrudin is transported along 
MTs, acts from within the ER and interacts with spastin and FASN in order to deliver membrane and the correct 
components and receptors for axon growth. 
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CHAPTER VI: TRANSCRIPTION FACTORS AS A TOOL 
TO REVERSE MATURATION AND REGENERATIVE 








1. Introduction  
 
1.1 Developmental Transcriptional Programs 
 
During development neurons extend long processes to reach their final target cells. 
More than 100 billion axons extend their way through the brain using guidance cues to create 
a complex network of 100 trillion synapses (O’Donnell, Chance and Bashaw, 2009). This 
process is tightly regulated by turning on specific transcription factor programmes as a result 
of signals from the growth cone to the nucleus which in turn activate genes important for 
growth (da Silva and Wang, 2011). In addition to these internal changes, the extracellular 
environment around the growing axons also changes in order to guide them to the correct 
targets and to prevent the formation of faulty synapses (Sheppard, Hamilton and Pearlman, 
1991).  
Once CNS neurons have formed synapses, their genetic expression milieu dramatically 
changes driving the post-mitotic neuron to switch from a growth-competent to a growth-
incompetent state. Some of the changes that occur are decreased expression in many growth 
components such as cytoskeletal elements (e.g. actin and growth-associated tubulin 
elements), in transcription factors driving growth associated-gene expression and in signalling 
molecules (Smith and Skene, 1997; Hoffman, 2010; Tedeschi and Bradke, 2017). In addition, 
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redistribution of some growth-associated receptors such as TrkB and integrins from the axon 
to the somatodendritic compartment, also occurs (Hollis et al., 2009b; Franssen et al., 2015; 
Andrews et al., 2016). Furthermore, some synaptic proteins which start being expressed at 
the time, have the ability to instruct the expression of growth inhibiting molecules (Tedeschi 
et al., 2016). This decline in neuronal growth capacity likely occur as an evolutionary control 
mechanism to prevent aberrant growth and excessive synapse formation and acts as a critical 
period during which the expression of growth-promoting genes is restricted. These changes 
have been postulated to be responsible for the decline in the regenerative ability of adult CNS 
neurons (Smith and Skene, 1997). It is well characterised that mature CNS axon regenerate 
poorly compared to immature CNS axons (Bregman et al., 1989; Nicholls and Saunders, 1996). 
The decline in regenerative ability of CNS neurons with maturation as well as the 
intrinsic and extrinsic processes accompanying this change are reviewed in detail in 
Introduction. 
 
1.2 Regeneration-associated Transcriptional Programs 
 
Interestingly, not all neurons lose their regenerative ability with maturation. Some 
regenerative types of neurons such as PNS neurons continue to express growth-related 
proteins even during maturation suggesting that there are gene expression and 
transcriptional changes affecting the regenerative state of a neuron (Smith and Skene, 1997; 
Plunet, Kwon and Tetzlaff, 2002). For example, after an injury to the PNS, a robust 
regenerative response is generated by increasing the growth ability but also by decreasing 
the inhibitory effects of the extracellular environment of the PNS axons. This response is 
referred to as regeneration-associated growth (RAG) response (Abe and Cavalli, 2008; van 
Kesteren et al., 2011) and is mediated through transcriptional changes affecting gene 
expression and axon transport (Smith and Skene, 1997; Mason et al., 2002; Starkey et al., 
2009; Geeven et al., 2011; Petrova and Eva, 2018).  
In addition, some CNS axons also regenerate when provided with a growth-permissive 
environment of a peripheral graft (Aguayo, David and Bray, 1981). These regeneration-
capable CNS axons have also been shown to upregulate the RAG programme (Mason et al., 
2002; Murray et al., 2011). In fact, the rapid induction of a RAG response in the PNS has been 
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shown to be necessary and sufficient for successful regeneration because when RNA 
polymerase inhibitors are applied, the regenerative response is blocked (Smith and Skene, 
1997; Cai et al., 2002). 
What does a RAG transcriptional program include? The RAG transcriptional program 
involves the activation or suppression of numerous transcription factors and transcriptional 
elements which in turn either upregulate or downregulate specific genes involved in axon 
growth (Ma and Willis, 2015). Some of the genes with altered expression during the induction 
of the RAG program include cytoskeletal and growth cone elements (e.g. GAP43), 
transcription factors (e.g. ATF3), cell adhesion molecules (e.g. integrins) and neuropeptides 
(e.g. NPY and CGRP). At first glance, many of these regenerative genes which are upregulated 
during PNS or CNS regeneration through peripheral nerve grafts resemble genes involved in 
early axon growth and development but whose expression dramatically declines with age 
(Doster et al., 1991; Tetzlaff et al., 1994; Mason et al., 2002; Hoffman, 2010) In fact, it has 
been proposed that successful regeneration require the re-expression of genetic profiles 
normally important in developmental growth (Bendotti, Servadio and Samanin, 1991; 
Mearow et al., 1994) 
In the non-regenerating CNS, however, many of these developmental and RAG 
programs fail to be elicited which could be one of the main reasons for the regenerative 
failure of these neurons (Tetzlaff et al., 1994).  
Interestingly, many of the studies mentioned above show that many aspects 
of neuroregeneration recapitulate development and that both processes share similar 
molecular players (reviewed in Harel and Strittmatter, 2006 and Hilton and Bradke, 2017). In 
this sense, understanding the transition from early to late neuronal development might be 
essential to identifying factors contributing to the regenerative failure of mature neurons. 
Recapitulation of these transcriptional programs in mature CNS axons could offer a reliable 
new method to boost CNS neurons’ otherwise poor regenerative potential by stimulating 
developmental-like axon growth even after the process of maturation has ceased. 





                Many studies so far focused on studying effector genes which seem to change their 
expression during development when CNS neurons transit from regenerative to non-
regenerative state. For example, manipulating signalling pathways downregulated with 
development such as the ERK-MAPK (Hollis et al., 2009b) and mTOR (Park et al., 2008; Liu et 
al., 2010) pathway have been shown to improve CNS regeneration in the optic nerve and to 
some extent in the corticospinal tract. Another approach was to restore axonal integrins 
which are preferentially re-distributed to the somatodenritic compartment with maturation 
– an approach which also yielded relative success in promoting axon regeneration of the 
central branch of DRG neurons (Franssen et al., 2015; Andrews et al., 2016; Cheah et al., 
2016). 
 
             Recently, studying the regenerative response after injury in regenerating neurons 
allowed for the identification of numerous regeneration-associated genes (RAGs) such as 
ATF3, Jun and GAP43. These genes have been shown to be upregulated after injury in the PNS 
but fail to be expressed after a CNS lesion (Jenkins and Hunt, 1991; Tetzlaff et al., 1991; 
Schwaiger et al., 2000; Tsujino et al., 2000). As a result, several studies examined whether 
overexpression of these molecules in the CNS could increase the intrinsic capacity of mature 
CNS axons to grow. For example, overexpression of cytoskeletal protein GAP-43 could, in fact, 
boost spontaneous axon sprouting in DRG axons or CNS axons (Aigner et al., 1995) but does 
not promote long-range axon regeneration after spinal cord injury (Neumann and Woolf, 
1999; Bomze et al., 2001). Furthermore, overexpression of GAP-43 in cerebellar Purkinje cells 
increased the level of sprouting after axotomy but did not result in enhanced axon growth in 
a growth-permitting embryonic grafts (Buffo et al., 1997). 
 
Another example of a RAG upregulation is via overexpression of cyclic adenosine 
monophosphate (cAMP) which results in multiple molecular cascades resulting in altered 
gene expression and modest increase in axon regeneration in vivo after CNS injury (Neumann 
et al., 2002; Qiu et al., 2002). Developmentally “younger” neurons have been shown to have 
higher levels of cAMP and therefore regenerate better (Cai et al., 2001). The overexpression 
of cAMP itself, however, is not sufficient to produce sustained long-range regeneration as 




These studies suggested that expressing individual components of regenerative 
response which are important for growth, could improve the regenerative response to some 
extent but it is not sufficient to promote long-range axon regeneration in the CNS. This 
observation makes sense when the scope of the regenerative response is considered – 
thousands of genes were shown to be differentially expressed after injury in numerous 
studies (summarised in Ma and Willis, 2015). It is only predictable, that manipulating a single 
gene, or a combination of effector genes will not be sufficient to initiate and sustain long-
range regeneration.  
Recently more efforts have been concentrated on identifying networks of 
transcription factors which regulate large sets of pro-regenerative genes. For example, 
deletion of the target effector RAG - integrin a7 (normally elevated in PNS but not CNS injury), 
results in a small decrease or delay in reinnervation and functional recovery after peripheral 
nerve injury (Werner et al., 2000). However, if a transcription factor upstream of this RAG 
effector such as c-Jun is manipulated, the effects are much more profound. Deletion of c-Jun 
caused a 4-fold decrease in reinnervation after facial motoneuron axotomy (Raivich et al., 
2004). This example highlights the need to identify transcription factors involved in 
developmental growth and in the regenerative response in order to design manipulations 
targeting a large set of genes important for axon growth rather than individual genes and 
pathways. 
 
1.4 Boosting CNS regeneration with Transcription Factors 
 
1.4.1 Identifying Networks of Transcription Factors 
 
As described above, the regenerative abilities of PNS and CNS neurons as well 
immature and mature neurons are very different with PNS and young neurons being able to 
sustain a robust regenerative response whereas mature CNS neurons fail to self-repair and 
re-grow after injury (Ramon y Cajal, 1928). Numerous studies have utilised these differences 
in order to create differential genome-wide expression and transcriptional profiles of 
regenerating vs. non-regenerating and immature vs. mature neurons in order to identify 
molecules and pathways which are active during developmental growth and regeneration.  
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Some studies, for example, examined differentially active transcription factors (TFs) in 
mature PNS (dorsal root ganglion) vs CNS (cerebellar granule) neurons (Smith et al., 2011). 
They found 32 TFs enriched in the DRG in comparison to the CNS. Overexpression of one of 
the identified transcription factors – STAT3, in CNS cerebellar granule cells resulted in 
increased neurite outgrowth (Smith et al., 2011). The most comprehensive study up to date 
examines the genome-wide transcriptional changes in regenerating PNS neurons after injury 
by exploring multiple time points after injury, comparing five injury models from different 
laboratories and cross-referencing to existing literature (Chandran et al., 2016). They 
identified 16 RAG transcription factors which provide cross-talk between multiple pathways 
involved in axon growth and are differentially expressed in regenerating peripheral neurons 
after injury. Of these RAG TFs, 10 promoted neurite outgrowth in an in vitro DRG culture 
assay. Remarkably, this study identified networks of gene expression changes which could be 
targeted pharmacologically with an FDA-approved drug – ambroxol. Treatment with 
ambroxol increased the expression of several components of the PNS transcriptional network, 
promotes neurite outgrowth in vitro and had a modest effect on CNS regeneration in vivo 
after optic nerve crush (Chandran et al., 2016). These results confirm that identifying key 
transcription factors in development and regeneration could bring new light to the 
regenerative processes and with that, new treatable drug targets to boost regeneration.  
 
1.4.2 Manipulating Single Transcription Factors for 
Regeneration  
 
Large sequencing and microarray studies like the ones described above have identified 
numerous transcription factors which are not only developmentally regulated but also play a 
role in axon growth after injury. As a result, a myriad of studies where genetic manipulation 
of single transcription factors was used as a strategy to boost CNS axon growth and 
regeneration, followed.  
Several members of the KLF family of transcription factors are developmentally 
regulated. For example, growth-incompetent mature retinal ganglion cells (RGCs) express 
lower levels of growth-promoting factors (KLF6 and KLF7) and higher levels of growth-
restricting factors (KLF4 and KLF9) (Moore et al., 2009). Indeed, transgenic knockdown of KLF4 
resulted in improved axon growth in vitro and in vivo after optic nerve crush without affecting 
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survival suggesting that this improvement is due to increased regenerative capacity (Moore 
et al., 2009). Interestingly, KLF7 is upregulated in the PNS but not in the CNS after injury (Zou 
et al., 2009). When overexpressed in postnatal cortical neurons or cortical slices, KLF7 
promoted axon growth (Blackmore et al., 2010, 2012a) as well as it significantly enhanced 
axon regeneration in the adult CST, albeit with no functional improvement (Blackmore et al., 
2012a).  
Another transcription factor commonly used as a single TF manipulation to promote 
axon growth after injury is ATF3. ATF3 is upregulated in regenerating PNS neurons and also in 
regenerating thalamic neurons in the presence of peripheral nerve grafts but not in the CNS 
(Tsujino et al., 2000; Campbell et al., 2005). ATF3 promotes neurite outgrowth when 
introduced into various different cell types (Nakagomi et al., 2003; Pearson et al., 2003; 
Seijffers, Allchorne and Woolf, 2006). Furthermore, ATF3-mutant mice show reduced ability 
for axon regeneration after peripheral nerve injury and suppressed neurite outgrowth in 
cultured DRG neurons again supporting the role of ATF3 in axon growth and elongation after 
injury (Gey et al., 2016). Interestingly, overexpression of ATF3 improved the regeneration 
capacity of the DRG peripheral branch axons similar to a conditioning lesion (Seijffers, Mills 
and Woolf, 2007). This treatment, however, could not overcome the myelin inhibition when 
DRG neurons are cultures on myelin substrate or after dorsal column injury. ATF3 
overexpression elevated some but not all regeneration-associated genes needed for 
successful regeneration in the PNS - an increase in c-Jun, Hsp27, and SPRR1A but not of GAP-
43, CAP-23, integrin a7, or STAT3 was observed (Seijffers, Mills and Woolf, 2007). Despite the 
promising results, however ATF3 overexpression could not recapitulated the effects of a 
conditioning lesion where injury to the peripheral axon enables its central branch to 
regenerate faster beyond the lesion site (Richardson and Issa, no date; Neumann and Woolf, 
1999). These findings do not mean, however, that ATF3 is not involved in CNS growth and 
regeneration. On the contrary, they point out that ATF3 might act in a coordinated network 
with other transcription factors as it activates a specific branch of the regenerative response.  
Sox11 and STAT3 are two other transcription factors which are downregulated with 
development but upregulated after PNS (not after CNS) injury. Overexpression of Sox11 in 
adult RGCs changed their genetic profile to more “immature-like” one and improved axon 
regeneration after optic nerve crush (Norsworthy et al., 2017). Surprisingly, Sox11 was toxic 
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to alpha-RGCs (the most common cell type to regenerate after optic nerve crush 
manipulations) but promoted outgrowth from other RGC cell types, highlighting the 
importance of targeting the right manipulations to the right cell types and brain areas. 
Moreover, overexpression of Sox11 in the CST improved sprouting and axon growth but 
resulted in worsening of the functional outcome (Wang et al., 2015) suggesting that 
promoting directed, functionally relevant axon growth should be the major goal in the field 
of axon regeneration. Lastly, a constitutively active form of STAT3 (STAT3-CA) resulted in axon 
regeneration of RGCs 2 weeks post optic nerve crush (Mehta et al., 2016). In addition, STAT3A 
that was overexpressed in DRGs, allowed for sprouting and axon outgrowth of the central 
branch of the DRG but did not aid elongation (Bareyre et al., 2011). This study highlighted the 
importance of making sure that transcription factors which are overexpressed become active 
and that different TFs might play different roles at different stages in the regenerative 
process.  
Not only transcriptional activators but transcriptional repressors suppressing the 
expression of RAGs in maturation could play an important role in the regenerative decline 
with age. For example, repressor element-1 silencing transcription factor (REST) is widely 
expressed during embryogenesis but its downregulation in later stages of neuronal 
differentiation is essential for the acquisition of the neuronal phenotype (Noh et al., 2012). In 
mature neurons, REST is found at basal levels and acts to repress the expression of RAGs. In 
a recent paper, Oh and colleagues (2018) show that REST is epigenetically repressed upon 
injury in order to allow for axon regeneration (Oh et al., 2018). In a follow-up study, REST was 
deleted in DRGs and CST which increased activation of pro-regenerative intracellular 
pathways and promoted growth after T10 spinal cord injury with more axons growing towards 
the injury site but not past it (Cheng et al., unpublished data, personal communication).  
All the studies described in this section target individual transcription factors 
implicated in neuronal developmental axon growth or axon regeneration, or both. They 
mostly show enhanced neurite outgrowth in vitro, attenuated PNS response after injury and 
modest effects on axon regeneration in the CNS. None of them, however, result in complete 
initiation and maintenance of the RAG program and axon regeneration. The functional 
improvement in many of them is negligent if not non-existent and they all point towards the 
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need for using combinational therapies of multiple transcription factors or identifying 
pharmacological agents which alter effector genes broadly. 
 
1.4.3 Manipulating Multiple Transcription Factors for 
Regeneration 
 
Only recently, several laboratories have attempted combinational transcription factors 
approach to improve axon growth and regeneration. In the study described above, Chandran 
and others (2016) identified several TFs involved in the PNS regenerative response after 
injury. They show that a combination between ATF3 and c-Jun acts in synergy to improve 
neurite outgrowth more than each transcription factor individually. In a different study, 
however, where four transcription factors (ATF3, c-Jun, Smad1 and STAT3) were virally 
delivered to DRGs, the combinatorial effect on axon regeneration after injury was comparable 
to the effect of ATF3 overexpression alone (Fagoe et al., 2015). One reason why there is a 
discrepancy in the two studies described above could be that each TF is expressed to a 
different extent such that in one of the studies optimal levels are achieved to affect 
transcription but not in the other. These studies underline the need to achieve more subtle 
control of expression levels and stress the importance of temporal expression of each 
transcription factor. Timing is another factor to be considered when using multiple 
transcription factors. For example, Sox3 and Sox11 have both been shown to be important 
for axon growth and regeneration. However, in order for them to exhibit these effects Sox3 
expression has to precede that of Sox11 transiently (Bergsland et al., 2011). Therefore, 
prolonged overexpression which is typical of many treatments will be insufficient in this case 
(Venkatesh and Blackmore, 2017).  
 
There are more than 1000 TF in the genome with several already identified by multiple 
studies to be involved in axon regeneration in vivo, giving rise to countless possibilities of 
combinatorial treatments (Venkatesh and Blackmore, 2017). When designing improved 
strategies for multiple transcription factors expression, it is important to consider how their 
activity is regulated and whether their expression levels depend on one another. For example, 
STAT3 drives SOCS3 expression which in turn acts as a negative regulator to suppress STAT3 
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activity. In that case, SOC3 deletion is the most effective way to enhance STAT3 activity as 
overexpression of STAT3 will only exacerbate the negative feedback loop (Venkatesh and 
Blackmore, 2017).  Lastly, the effects of TFs on chromatin remodelling should also be 
considered. Some TFs, for example, have the ability to access closed chromatin and to open 
it up to allow other TFs to bind. Furthermore, developmental changes in the chromatin 
structure have recently been shown to contribute to restricted axon growth (Venkatesh et al., 
2018). It is, therefore important that mechanisms for opening chromatin are employed, as 
overexpression of TFs that cannot access the DNA will likely not yield positive results. 
1.5 Epigenetic modifications in development and regeneration 
 
 In order to design effective strategies to boost CNS axon regeneration via the 
application of combinations of transcription factors, additional epigenetic modifications 
should also be considered in order to allow the TFs to access the DNA and induce a large 
repertoire of developmentally silenced regeneration-associated genes.  
One epigenetic mechanism is DNA methylation. DNA methylation patterns and 
epigenetic changes in general are established during early development in order to suppress 
the expression of genes involved in axon outgrowth once neurons have matured (Ma et al., 
2010; Venkatesh et al., 2016). Interestingly the DNA methylation pattern changes upon PNS 
but not CNS injury to allow for rapid outgrowth and functional recovery (Lindner et al., 2014). 
In a recent study, Weng et al. (2017) showed that demethylation of RAGs by Tet3 was elevated 
after sciatic nerve injury and was required for the re-expression of regeneration-associated 
genes to drive the PNS regenerative response. This upregulation of demethylation have also 
previously been described in another study (Loh et al., 2017) where differential 
demethylation was observed after peripheral and central injury which might confer the 
differential regenerative response in those two systems. These studies challenged the 
standing dogma that the methylation pattern of the genome is fixed after development is 
complete which allowed for the identification of new targets to improve regeneration by 
targeting DNA methylation.  
Another mechanism of epigenetic regulation is histone acetylation. Histones are 
acetylated by enzymes called histone acetyltransferases (HATs). PCAF, for example, is 
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HAT which associates with the promoters of known pro-regenerative genes and drives their 
expression after peripheral injury (Puttagunta et al., 2014). The importance of acetylation was 
first highlighted in a study where PCAF upregulation is shown to improve axonal outgrowth 
not only through the acetylation of RAGs but also by acetylation of regeneration-associated 
transcription factors such as p53. P53 is in turn more active and can affect a wider array of 
effector molecules (Gaub et al., 2010). These findings were further supported by observations 
that PCAF overexpression in the optic nerve and spinal cord enhances the regenerative 
response of these CNS components (Tedeschi et al., 2009; Puttagunta et al., 2014). On the 
other hand, inhibition of the deacetylase – HDAC1 also results in increased acetylation of 
regeneration-associated SMAD1, which in turn drives the regeneration response and allows 
for sensory axon regeneration (Finelli et al., 2013; Finelli, Wong and Zou, 2013) although 
without some classical RAG upregulation.  
All of these studies highlight the importance of epigenetic changes but much like the 
use of single transcription factors underline the need to combining multiple treatments as 
single manipulations do increase growth and regeneration but fail to induce the full 
regenerative response which leads to functional recovery after injury.  
 
1.6 Rejuvenation of mature neurons – approach 
 
One of the most remarkable studies of the last few centuries showed that cell fate can 
actually be altered by the addition of a combination of transcription factors (Oct3/4, Sox2, 
Klf4, and c-Myc) to fibroblasts resulting in their de-differentiation into pluripotent stem cells 
(Takahashi and Yamanaka, 2006), confirming the possibility of altering cell fate and function 
by delivering a cocktail of TFs. For regeneration, this has implications that multiple TFs need 
to be delivered to convert a neuron from a mature, growth-incapable cell to more immature 
like growth state. Interestingly, fully differentiated post-mitotic cortical neurons have recently 
been reprogrammed from one neuronal subtype to another by the forced expression of 
transcription factor Fezf2 in vivo (Rouaux and Arlotta, 2013).  These studies reveal the 
enormous potential that delivery of the correct combination of activated transcription factors 
can regulate and influence not only the molecular milieu but also the fate of post-mitotic CNS 
neurons not only in development but also after injury resulting in functional recovery. 
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2. Aims and Hypothesis 
Most studies described above either consider developmental or regeneration-
associated changes of transcription factors in order to design genetic manipulations to boost 
CNS regenerative ability. Our study here is the first of its kind where bioinformatic analysis 
was performed on several sets of data from injury models as well as from developmental 
changes in mature cortical neurons in vitro. The data was compared across 12 species and a 
comprehensive list of TFs involved in neuronal development and regeneration was 
established. What differentiates our study from others in the field is the establishment of an 
in vitro injury system where multiple different combinations of transcription factors could be 
tested for reversing maturational state and therefore improving growth and regeneration 
before animal models are utilised. Furthermore, as a comprehensive RNA sequencing analysis 
was performed in our system, maturity markers at different developmental stages could be 
identified and used as a quick screening mechanism to identify transcription factors 
combinations that alter developmental state and improve regeneration.  
2.1 Hypothesis 
 
Our hypothesis is that the application of a combination of transcription factors 
involved in axon growth during development and after regeneration to mature primary 
cortical neurons will result in altering their developmental stage to an earlier time point which 










Aim 1: To identify maturity markers at different stages of neuronal maturation in primary 
cortical cultures 
 
Aim 2: To test the ability of several candidate transcription factors to bring cortical neurons 
to an earlier developmental stage with the aid of the maturity markers 
 
Aim 3: To test whether a change in developmental status can serve to improve axon 


























3.1 Plasmid Constructs and Antibodies  
 
3.1.1 Plasmid Constructs  
Transcription factor constructs were kindly provided by Prof. Joost Verhaagen, The 
Netherlands Institute for Neuroscience (ATF3, CEBP, Sox11, Egr constructs), Dr Lawrence 
Moon, King’s College London (pCMV-SPORT6-sox4 construct) and Prof. Vance Lemmon and 
Prof. John Bixby, University of Miami (STAT3ACA constructs). REST transcription factor 
construct (pHR’-NRSF-CITE-GFP construct) was obtained from AddGene (plasmid #21310). 
Pou6f1 construct was obtained (Myc-DDK-tagged) was purchased from OriGene. 
3.1.2 Primary Antibodies  
Rabbit polyclonal anti-tropomyosin-1 (Abcam, ab55915, 1:100); chicken polyclonal 
anti-68kDa-neurofilament (Abcam; ab134460, 1:1000); rabbit polyclonal anti-MAP1A 
(Abcam, ab89648, 5 mg/µL), rabbit polyclonal anti-doublecortin (Abcam, ab18723, 5 mg/µL); 
rabbit monoclonal anti-TUBA4A (Abcam, ab177479, 1:100); rabbit polyclonal anti-
tropomyosin 4 (EMD Millipore, AB5449, 1:500); mouse monoclonal anti-CGRP (Abcam, 
ab81887, 1:100); rabbit polyclonal anti-OMgP (Abcam, ab101567, 1:1000); rabbit polyclonal 
anti-Vangl2 (Merck, ABN373, 1:500); rabbit polyclonal anti-ATF3 (SantaCruz, Sc-188, 1:500). 
3.2 Candidate Maturity Markers and Transcription Factor Selection 
A collaborative study between the following laboratories - Lemmon/Bixby, Bradke, 
Verhaagen, Moon and Fawcett, was set up in order to create a list of candidate transcription 
factors whose expression might be important for neuronal growth during development and 
in regeneration (Table 6.1).Initial molecular targets were obtained after RNA sequencing 
studies and molecular profiling in PNS neurons after successful regeneration carried out by 
Prof. Joost Verhaagen and Valleria Cavalli. Further RNA sequencing experiments on primary 
cortical cultures during different developmental stages (at 1, 4, 8, 16, 24 DIV) were carried 
out by Hiroaki Koseki to identify molecules which might be relevant to axon growth in 
development. The molecules which showed the greatest change in mRNA transcript 
expression in development and in regeneration were identified. Promoter analysis of the 
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selected genes was then applied by Matt Mason to map common transcription factors. The 
list of candidate transcription factors was refined by comparing the promoter for the same 
gene in 12 different species in order to ensure that the candidate transcription factors have 
the potential to regulate growth and regeneration genes across multiple species via common 
pathways. The list was finally narrowed down by literature studies. Several candidate markers 
of maturity in vitro were also identified using the same strategy (Table 6.1). An additional 
criterion of selecting maturity markers was that a reliable antibody exists in the marker and 




Figure 6.1 Table with the final list of candidate maturity markers and transcription factors which was obtained 
after the results of several RNA sequencing studies were analysed using bioinformatics. Their mRNA expression 
levels and fold difference in primary cortical cultures at 1, 4, 8, 16, 24 DIV in primary cortical cultures are also 
shown. The values in each box represent average values from at least 4 independent experiments. 
Candidate Maturity Markers DIV1 DIV4 DIV8 DIV16 DIV24 
Fold 
Difference 
Doublecortin (DCX) 265.5 282.9 211.7 76.7 13.3 ↓ 20x 
Tropomyosin 4 (TPM4) 308.5 196.4 119.9 51.1 75.7 ↓ 4x 
Planar Cell Polarity Protein 2 
(Vangl2) 
34.6 19.5 12.5 6.0 2.2 ↓ 17x 
Microtubule-associated 
protein 1A (MAP1A) 
11.3 21.5 49.0 80.0 78.3 ↑ 7x 
Tubulin 4A (TUBA4A) 1.2 7.2 22.9 140.7 210.3 ↑ 175x 
68kDa Neurofilament (NEFL) 4.4 24.6 81.9 258.1 522.9 ↑ 130x 
Tropomyosin 1 (TPM1) 38.6 72 112.4 167.3 232.4 ↑ 6x 
Calcitonin gene-related 
peptide (CGRP) 
0.2 1.1 5.6 116.5 326.4 ↑ 1630x 
Oligodendrocyte Myelin 
Glycoprotein (OMgP) 
2.5 4.4 20.5 47.0 82.9 ↑ 32x 
Candidate Transcription 
Factors 
DIV1 DIV4 DIV8 DIV16 DIV24 
Fold 
Difference 
REST 13.7 6.5 2.4 1.9 1.4 ↓10x 
Sox11 214.5 126.9 35.7 13.5 7.9 ↓27x 
CEBP  24.8 16.2 8.7 9.7 8.0 ↓3x 
Pou6f1 23.6 16.7 12.2 9.4 10.9 ↓2x 
ATF3 5.0 0.6 0.3 0.6 1.2 ↓4x 
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3.3 Cell Culture and Transfections  
Cortical neurons were dissected from E18 Sprague Dawley rat embryos and plated on 
acid washed coverslips in a 24-well plate at density of 8x104cells/coverslip. All surfaces were 
coated with poly-D-lysine. The cells were grown in serum-free MACS Neurobasal Media 
supplemented with 2% GS21 and 1% GlutaMAX supplements at 37°C in 7% CO2 incubator. 
Cortical neurons (1 DIV) on coverslips were transfected using lipofectamine 2000 reagent 
(ThermoFisher Scientific) as follows: 3.6μg of DNA plasmid were mixed with 400μL NB media 
and 6.6μL lipofectamine 2000. The reaction was kept for 30 minutes at room temperature 
and then added to a 1 mL of freshly warmed-up NB media supplemented with GlutaMAX for 
1 hour at 37°C. The transfection media was then removed, and the original media was 
transferred back to the imaging dishes. Plasmid reporter gene expression was observed 48 
hours post-transfection. 
3.4 Immunocytochemistry 
Cortical neurons were fixed in 3% PFA for 15 minutes and then thoroughly washed 
and kept in PBS at 4°C. Cells were permeabilised in 3% BSA in PBS and 0.1% Triton for 5 
minutes and then blocking solution was added (3% BSA in PBS) for 1 hour at room 
temperature. Primary antibodies (listed in 2.1.2) were added at the correct concentration and 
kept overnight at 4°C. On the next day antibodies were washed 3 times in PBS for 5 minutes. 
Secondary antibodies (listed in Methods, 1.2.2) were applied at the correct concentration for 
1 hour at room temperature in a dark chamber. The cells were then washed twice in 1xPBS 
and twice in 1xTNS (5-minute washes) and the coverslips were removed from the 24-well 
plate and mounted using Diamond anti-fade mounting agent with DAPI (Molecular Probes) or 
FluorSave mounting reagent (Calbiochem) onto glass slides. 
 
3.5 Microscopy  
Images of immunostained cells were taken with a confocal microscope (Leica DMI 
4000 B) using LAS-AF software (Leica Systems). For maturity marker identification, staining 
intensity for each developmental stage for a particular marker were initially tested. The 
settings to visualise the brightest maturational state were used as standard settings to 
examine all maturational states for the particular maturity marker for a particular staining 
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experiment. A z-stack of images was obtained through each cell by taking an image at every 
0.5μm thickness and an average intensity z-projection was created. On average 15-20 cells 
were examined per condition per staining experiment, so in cases were n=3 45-60 cells were 
examined per condition. Immunofluorescent intensity was measured in the LAS-AF software 
by outlining the cell body using the polygon tool (Fig. 6.2A) The exact same shape which 
measured a single cell body was placed immediately next to the cell body where no obvious 
staining or other cells were present in order to measure background (Fig. 6.2B). The final 
measurements were obtained by subtracting the background for each cell from its 
measurement in the cell body.  
Figure 6.2 Figure to represent measuring strategy for maturity markers protein expression. A. Using the 
polygon tool an area around a single cell was outlined (yellow) and the intensity was measured. B. Using the 
exact same region of interest, the intensity of an area which is in proximity of the measured cell but does not 
contain any recognisable cell bodies or process, was also measured as a background (red). Scale bars are 10 µm. 
 
3.6 Statistics  
Statistical analysis was performed using GraphPad Prism 7.0 (GraphPad Software, La 
Jolla, CA). Each data set was individually tested for normal distribution using the D'Agostino-
Pearson normality test. When data was normally distributed one-way ANOVA with multiple 
comparisons was used to test statistical significance between the experimental groups with 
Tukey’s post hoc test. Data from different staining experiments for a particular experimental 
group were tested for statistical difference using Kruskal-Wallis test in order to determine 
203 
 
whether values could be combined together. When the sets were not significantly different 
from each other, the means from each procedure were used when making comparisons 
between the groups. In cases where the sets were significantly different from each other, the 
data was normalised to 2-3 DIV intensity and the means of the normalised values were 
compared. All statistics were carried out at 95% confidence intervals, therefore a significant 




















4. Results  
 
4.1 Doublecortin, 68 kDa Neurofilament, Calcitonin Gene-related 
Peptide and Tubulin 4a Were Identified as Reliable Maturity 
Markers 
 
Using the data and the analysis available from our collaborative project and from the 
RNA sequencing studies carried out in our primary cortical cultures during different ages, 
several candidate markers of maturity in vitro were identified as described in Methods. 
Maturity marker selection was essential at this stage in order to ensure that the effects on 
the maturational state of the neurons, which any future transcription factors manipulations 
might have, could be reliably detected. Immunocytochemistry for all the candidate maturity 
markers was carried out in order to validate whether the changes in mRNA transcript could 
be recapitulated by the protein levels at each different stage. 
 
 After at least three independent stainings, four maturity markers were selected for 
future studies – 68 kDa Neurofilament (NEFL) and calcitonin gene-related peptide (CGRP) 
were selected as potential late maturity markers, doublecortin (DCX) as a potential early 
maturity marker and tubulin 4a (TUBA4A) as a good 7 DIV marker (Fig. 6.3A). All of these 
molecules showed significant changes in fluorescent intensity levels across the different ages 
which are consistent with our RNA sequencing results. 
 
NEFL staining intensity was significantly higher at 13-14 DIV (101 grey values) 
compared to 2-3 DIV (55 grey values) (p=0.0263, n=4). CGRP staining showed higher intensity 
levels at 13-14 DIV (72 grey values) compared to 2-3 DIV (29 grey values, p=0.0052) and to 6-
7 DIV (43 grey values) (p=0.0341, n=3). DCX intensity was significantly lower at 13-14 DIV (102 
grey values) compared to 2-3 DIV (203 grey values, p=0.0001) and to 6-7 DIV (205 grey values, 
p=0.0001, n=4). TUBA4A staining intensity was significantly higher at 6-7 DIV (1945 grey 
values, p=0.0005) and at 13-14 DIV (1327 grey values, p=0.018) compared to 2-3 DIV (507 




Figure 6.3 DCX, CGRP, NEFL and TUBA4A are reliable maturity markers in primary cortical neurons. A.  
Immunofluorescent images of 68 kDa neurofilament, calcitonin gene-related peptide, doublecortin and tubulin 
4a in primary cortical neurons during different stages of development. Scale bar is 50 µm. Images were taken at 
40x. B Graphs showing the RNA expression levels on the right axis (line) and the staining intensity (bars) on the 




4.2 Tropomyosin 1 and Oligodendrocyte-myelin Glycoprotein (OMgP) 
were Identified as Potential Late Maturity Markers  
Two other molecules – tropomyosin 1 and oligodendrocyte-myelin glycoprotein 
(OMgP) were examined as potential late maturity markers. Tropomyosin 1 staining intensity 
varied between different experiments, so the values were normalised to 2-3 DIV values in 
each individual experiment. Tropomyosin 1 showed a trend towards high protein levels at 13-
14 DIV (2.6 normalised intensity ratio) compared to 2-3 DIV (1 normalised intensity ratio, 
p=0.08, n=3). OMgP staining also showed a trend towards higher amount of protein at 13-14 
DIV (2072 grey values) compared to 6-7 DIV (2108 grey values, p=0.1) and 2-3 DIV (1259 grey 
values, p=0.1, n=2). Despite that, these results did not reach statistical significance of <0.05 
(Fig. 6.4). 
Figure 6.4 Tropomyosin 1 and OMgP might act as late maturity markers. A. Immunofluorescent images of 
tropomyosin 1 and oligodendrocyte-myelin glycoprotein (OMgP) in primary cortical neurons during different 
stages of development. Scale bar is 50 µm. Images were taken at 40x. B Graphs showing the RNA expression 
levels on the right axis and the staining intensity on the left axis for both molecules. Error bars represent mean 
± SEM. One-way ANOVA was performed in all experiments. 
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4.3 Tropomyosin 4, Microtubule-associated protein 1A (MAP1A) and 
VANGL Planar Cell Polarity Protein 2 (VANGL2) did not Prove to be 
Reliable Maturity Markers 
 
Some tested markers did not follow the predicted RNA sequencing pattern of 
immunostaining. For example, microtubule-associated protein 1A (MAP1A) had increased 
RNA levels with maturation. However, the staining intensity of the protein did not change 
significantly between the three different timepoints of maturation – 2-3 DIV (1 normalised 
intensity ratio), 6-7 DIV (1.1 normalised intensity ratio) and 13-14 DIV (0.99 normalised 
intensity ratio) (p=0.96, n=2) (Fig. 6.5). Unlike the RNA sequencing data which shows a 
decrease in tropomyosin 4 RNA levels with maturation, the immunostaining showed the 
opposite trend towards an increase in the protein level from 2-3 DIV (1 normalised intensity 
ratio) to 6-7 DIV (1.5 normalised intensity ratio) and 13-14 DIV (2.4 normalised intensity ratio) 
(p=0.16, n=3) (Fig. 6.5). Again, contrary to the change in RNA levels with maturation, Vangl2 
shows an increase in immunostaining intensity with maturation from 2-3 DIV (1 normalised 
intensity ratio) to 6-7 DIV (1.9 normalised intensity ratio) and 13-14 DIV (1.7 normalised 
intensity ratio) (p=0.39, n=2) (Fig. 6.5). In all three cases, there was a significant variation 
between the staining intensity measured in individual experiments, so the data was 












Figure 6.5 MAP1A, tropomyosin 4 and VANGL2 showed staining intensity results different to RNA sequencing 
data. A. Immunofluorescent images of microtubule-associated protein 1A (MAP1A), tropomyosin 4 and Vangl2 
in primary cortical neurons during different stages of development. Scale bar is 50 µm. Images were taken at 
40x. B Graphs showing the RNA expression levels on the right axis and the staining intensity on the left axis for 
both molecules. Error bars represent mean ± SEM. One-way ANOVA was performed in all experiments. 
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4.4 ATF3 Could Potentially Act as a Positive Control of Rejuvenation  
ATF3 is a transcription factor involved in multiple developmental and regenerative 
processes. ATF3 was transfected into primary cortical neurons at 1 DIV and cells were fixed at 
3 DIV, 6 DIV and 14 DIV in development (Fig. 6.6A). The cells were then stained with two late 
maturity markers – CGRP and 68 kDa neurofilament which both show increased 
immunostaining intensity with maturation. We hypothesised that overexpressing ATF3 could 
reverse the maturational state of the neurons and therefore, influence the expression of the 
maturity markers. Contrary to our hypothesis, CGRP intensity was still higher with maturation 
at 14 DIV (996 grey values) compared to 3 DIV (349 grey values) (p=0.001) and 6 DIV (470 grey 
values) (p=0.04) (Fig. 6.6B). The intensity did not increase from 3 DIV to 6 DIV, however which 
differs from our findings above. 68 kDa neurofilament, on the other hand, had altered 
expression levels of expression with maturation upon ATF3 expression with it being equal at 
all stages of development – 3 DIV (1154 grey values), 6 DIV (1241 grey values) and 14 DIV 
(1179 grey values) (p=0.733) (Fig. 6.6C). These results suggest that ATF3 overexpression alters 







Figure 6.6 ATF3 overexpression results in altered maturity marker expression. A. Immunofluorescent images 
of primary cortical neurons transfected with ATF3 at 1 DIV and stained for two different maturity markers at 3 
DIV, 6 DIV and 14 DIV. Scale bars are 50 µm. Images are taken at 40x. B. A graph to quantify the immunostaining 
intensity of CGRP during different developmental stages. C. A graph to quantify the immunostaining intensity of 
68 kDa neurofilament during different developmental stages. Error bars represent mean ± SEM. One-way 













4.5 Combinations of Transcription Factors Could Potentially Bring 
Neurons to an Earlier Maturational State 
The main hypothesis of our study was to identify combinations of transcription factors 
involved in neuronal development and regeneration which could reverse the maturational 
state of adult primary cortical neurons in vitro. Preliminary testing showed that several 
combinations might have an effect (Fig. 6.7A). For example, co-expression of CEBP and ATF3 
at 1 DIV resulted in still elevated intensity of the CGRP protein at 8 DIV (17 grey values) 
compared to 2 DIV (11 grey values) (p=0.01) (Fig. 6.7B). Contrary to our previous findings that 
CGRP is expressed to a higher extent at 16 DIV neurons, there was no change in the staining 
intensity between 2 DIV (11 grey values) and 16 DIV (14 grey values) upon CEBP and ATF3 co-
transfection (Fig. 6.7B). These results suggest that an overexpression of a combination of two 
transcription factors whose expression goes down during development, could decrease the 
abundance of a late maturity marker - CGRP in mature cortical neurons.  
 
 
Figure 6.7 CEBP and ATF3 co-expression results in altered maturity marker expression. A. Immunofluorescent 
images of primary cortical neurons transfected with CEBP and ATF3 at 1 DIV and stained for late maturity marker 
CGRP at 2 DIV, 8 DIV and 16 DIV. Scale bars are 50 µm. Images are taken at 40x. B. A graph to quantify the 
immunostaining intensity of CGRP during different developmental stages. Error bars represent mean ± SEM. 




5. Discussion  
The current study is first of its kind to identify markers of maturation in an in vitro 
system which could be used to test the ability of combinations of transcription factors to 
rejuvenate adult neurons. This study will advance the knowledge in the field as it will show 
whether reversing the intrinsic maturational state of adult neurons is necessary and sufficient 
to improve regenerative ability. 
The current study aimed at testing candidate transcription factors identified in a large 
collaborative study on their ability to bring mature neurons back to an earlier developmental 
stage, and the potential effects this could have on regeneration. Our hypothesis relied on the 
premises that the candidate transcription factors show high expression levels early in 
development which gradually decline with maturation, so a forceful expression should mimic 
early developmental programmes. In order to do this, an essential step had to be taken where 
molecules at different stages of maturation had to be identified in our primary cortical 
cultures. All candidate markers of maturity were chosen not only on the basis of highest 
change in RNA transcript expression with age in our primary cortical cultures but also due to 
their relevance in development and regeneration in the literature.  Out of all nine (Fig. 6.3-
6.5) candidate maturity markers, four were taken forward based on the observation that 
staining for the protein showed pattern of intensity similar to the patterns observed in RNA 
transcript levels and were easy to detect – DCX, NEFL, CGRP and TUBA4A (Fig. 6.3). All four 
candidate maturity markers and their relevance in neuronal development and axon 
regeneration is discussed below. 
Doublecortin (DCX), for example, is a cytoskeletal protein which has been shown to 
serve as a new-born neuronal marker in young migrating neuroblasts in chicks due to its high 
expression levels early in development. Doublecortin-labelled cells are also present in 
regenerating chick spinal cord which is less mature and more plastic (Whalley et al., 2009). 
DCX is also expressed by newly born neurons and is then quickly downregulated in mature 
neurons (Gleeson et al., 1999). Mutations in doublecortin have been linked to several 
conditions where there is abnormal migration of neurons through the cortex early in 
development (des Portes et al., 1998).  This effect was for many years thought to be caused 
merely by changes in the cytoskeleton. Recent study, however, points towards a new 
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mechanism - a knockdown of doublecortin resulted in impaired KIF1-mediated transport of 
Vamp2, a cargo molecule of KIF1 suggesting that doublecortin might actually influence the 
transport of cargo along microtubule tracts (Liu et al., 2012). The authors proposed that 
doublecortin might regulate trafficking of signalling molecules to specific neuronal domains, 
and that cargo reaching these domains could be essential for proper function and migration 
(Liu et al., 2012). Recently, doublecortin-like kinase, a member of the DCX family has been 
shown to act through distinct mechanism in aiding neuronal survival and in promoting axon 
elongation and regeneration both in PNS and CNS axons after axotomy (Nawabi et al., 2015).  
Another selected marker is calcitonin gene-related peptide (CGRP). CGRP is highly 
expressed in various brain areas (in particular in the cortex and the spinal cord) during early 
development in the rat embryo (starting at E16) (Terrado et al., 1999). CGRP has been shown 
to be located at the tip of growing neurites upon sciatic nerve injury as well as upon peripheral 
axotomy (Li et al., 2004). CGRP levels increase with maturation in our primary cortical neurons 
(Fig. 6.1, Fig 6.3B). What is intriguing is that ATF3-labelled neurons with high expression of 
ATF3 after injury show low CGRP expression levels (Li et al., 2004). ATF3 is one of our 
candidate transcription factors and it is possible that the high levels of ATF3 observed after 
axotomy are due to recapitulation of early developmental transcriptional programmes. This 
activation in turn results in reverting neurons to an earlier maturation state, hence the 
reduced amount of CGRP.  
68 kDa neurofilament – a major intermediate filament of mature neurons was also 
chosen as a potential maturity marker. The expression levels of 68 kDa neurofilament have 
previously been reported to be low during development as well as during regeneration in rat 
sensory neurons (Hoffman and Cleveland, 1988). The authors proposed that the 
developmental program for cytoskeleton gene expression is recapitulated during axonal 
regeneration as 68 kDa neurofilament becomes downregulated upon an insult to the adult 
neuron which normally expresses high levels of the protein. 68 kDa neurofilament mRNA 
levels are particularly strongly expressed in regions which develop postnatally in the brain 
such as the cerebellum and cerebrum (Wang et al., 2012). It has also been proposed that this 
developmental expression pattern could be explained by retrograde transport of signal 
molecules so that once a neuron has reached its target cell and matured, retrograde signals 
are initiated to increase and maintain 68 kDa neurofilament expression. Interestingly another 
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cytoskeletal molecule – tubulin 4A (TUBA4A) showed promising results in our staining 
experiments as a 7 DIV marker (Fig. 6.3B). TUBA4A levels have been shown previously to 
dramatically increase with age (up to 50-fold) and to play an important part in human motor 
cortex development such that mutations in it result in familial amyotrophic lateral sclerosis, 
a rapidly progressing neurodegenerative disease (Smith et al., 2014).   
Once markers of maturation which could be used to predict the stage of maturity in 
the primary cortical cultures were identified, several experiments were carried out where 
different transcription factors were transfected in 1 DIV cultured neurons. The cells were then 
grown to 14 DIV, fixed and stained for doublecortin, 68 kDa neurofilament or CGRP to assess 
maturational state. 
Transcription factor ATF3 has previously been identified in numerous studies as 
essential for early neuronal development and regeneration after injury as summarised above. 
ATF3 levels decrease four-fold during the development of primary cortical neurons in vitro 
from 1 DIV to 24 DIV (Fig. 6.1). For these reasons, ATF3 was used as a positive control to test 
whether its forced overexpression in mature neurons can cause maturity marker expression 
to follow a different expression pattern resembling early neuronal states. In this study, ATF3 
showed promising results as a reliable positive control transcription factor as it induced slight 
changes in the expression of late marker CGRP at 7 DIV and more dramatic changes in 68 kDA 
neurofilament at 7 DIV and 14 DIV indicating a change in maturational state of these adult 
neurons (Fig. 6.6). However, only 2 independent experiments were performed using ATF3, so 
these results are not conclusive and further testing is needed. Testing other maturity markers 
which reliably showed a maturational change such as DCX and TUBA4A might also strengthen 
the current results. Furthermore, other transcription factors such as Klf7 and STAT3A-CA 
could also be reliable positive controls due to their well-studied effects on axon regeneration 
(Qiu et al., 2005; Blackmore et al., 2012b; He and Jin, 2016). These, however, have not been 
tested in our paradigm yet.  
Most of the DNA constructs that we obtained from different collaborators contained 
the GFP expression tag, so the first combination of TFs tested that might have relevance to 
one another was the combination – ATF3 (no tag) and CEBP (GFP-tagged). The role of ATF3 in 
development and regeneration is extensively reviewed the Introduction of this Chapter. CEBP 
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has previously been shown to be upregulated after axonal injury and to be involved in the 
regenerative response in C. elegans (Li, Hisamoto and Matsumoto, 2015). Knockdown of CEBP 
in the normally regenerating fresh water snail – L. stagnalis, delays axon regeneration and 
functional recovery (Aleksic and Feng, 2012). In the adult mouse, CEBP is upregulated after 
facial motoneuron injury and acts to aid regeneration by increasing the expression of RAGs 
such as tubulin a1 and GAP43 and its silencing disrupts the regenerative process (Nadeau et 
al., 2005; Lopez de Heredia and Magoulas, 2013). ATF3 and CEBP are transcription factors 
from the same bZIP (basic region/leucine zipper) transcription factor family. ATF3 and CEBP 
interact in a way that they form a heterodimer which binds to the ATF3 promoter and further 
regulates its expression upon various stresses such as nutrient depletion (Pan et al., 2007).  
Combination of these two transcription factors showed some changes in the 
expression of one of the selected maturity markers – CGRP (Fig. 6.7). This experiment, 
however was only performed once so further studies are needed. Other maturity markers 
should also be tested with this combination of transcription factors.  
The current study has several limitations. For example, our microscopy system 
permitted only the imaging of 4 fluorescent channels, one of which was always the DAPI 
channel. Therefore, should experiments are carried with a combination of two or three 
transcription factor, only one 1 maturity marker could be observed. Therefore, new 
constructs which do not have a fluorescent tag will be ideal for use. This approach might also 
be more biologically relevant as the tag might interfere with the activity of the transcription 
factor. Furthermore, extensive characterisation of the co-transfection rates and expression 
amounts between two, three or more transcription factors should be carried out.  
In addition, many of our transcription factor constructs contained the CMV promoter 
which as discussed in Methods, Section 3.2.1 was not very efficient in primary cortical 
neurons. Therefore, in order to obtain higher transfection rates and neuron-specific 
expression of the transcription factors, the CMV promoter should be exchanged with the 
synapsin promoter for future experiments.  
The role of vp16 and vp64 sequences in transcription factor activation has recently 
been extensively studied. vp16, for example is a DNA motif from Herpes Simplex virus which 
is widely used and clinically approved (Rajagopalan et al., 2007) to promote better expression 
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rates and strong transcriptional activation. It acts by recruiting co-factors and acetyl 
transferases to affect chromatin remodelling (Mehta et al., 2016). Fusion of vp16 to various 
transcription factors such as CREB and STAT3 enhances their activity majorly and results in 
improved regeneration compared to the transcription factor alone (Gao et al., 2004; Hirai, 
Tani and Kikyo, 2010; Blackmore et al., 2012b). The efficacy of adding the vp64 sequence is 
still being investigated in the process of axon regeneration. For future experiments, cloning 
these sequences into our candidate transcription factors could ensure that the transcription 
factors that are being overexpressed are actually activated and that a level of epigenetic 
control exists.  
This experiment highlighted the complexity of combining multiple transcription 
factors and the numerous consideration that have to be taken – in an ideal situation all TFs 
from our list will have no tags but will possess the activational motif vp16 and the synapsin 
promoter, the co-transfection efficiency will be above 90% and we will have reliable 
antibodies to detect each one as well as the maturity markers. The ultimate aim of this study 
is to test multiple combinations of transcription factors which are relevant for regeneration 
in mature cortical neurons for their ability to reverse maturational state of the neurons using 
maturity markers. For future studies, combinations which successfully alter the 
developmental stage of mature CNS neurons to a more developmentally immature one, will 
be tested for their ability to improved axon growth and regeneration in an in vitro laser 
axotomy system. For further functional effects, AIS markers will be used in order to study 










CONCLUSION AND FUTURE DIRECTIONS  
 
 In this thesis, two independent strategies to improve axon regeneration in the CNS by 
targeting intracellular mechanisms, were explored. One strategy involved expressing 
combinations of developmentally downregulated transcriptions factors which were identified 
from several large RNA sequencing databases (see Chapter 6). This approach relied on 
upregulating genes which are normally important for developmental growth in order to boost 
axon regeneration in the adult. Nine candidate maturity markers to help us predict the 
maturational state of our primary neuronal cultures were identified from previous RNA 
sequencing studies and tested in our model. Four markers – calcitonin gene-related peptide, 
68 kDa neurofilament, doublecortin and tubulin 4a showed reliable staining at different 
stages of development (Koseki et al., 2017). Some preliminary data suggested that 
overexpression of ATF3 on its own or in combination with another transcription factor – CEBP 
in primary cortical neurons, resulted in altered expression of some of our maturity markers. 
These findings highlighted the potential of our in vitro system as a valuable tool to identify 
combinations of transcription factors which could induce a change in the regenerative state 
of mature CNS neurons. This system could also help us inform future animal studies without 
having to test each combination in vivo. Much work, however is still needed in order to 
optimise this tool and to advance our knowledge of what transcription factor combinations 
could be beneficial for axon regeneration.  
Many studies to date, have focused on targeting individual molecular players in large 
intracellular pathways which normally produce an array of downstream effects. Some of 
these studies have been successful in improving sprouting and/or axon regeneration as well 
as achieving modest functional recovery (Park et al., 2008; Liu et al., 2010; Blackmore et al., 
2012b; de Lima et al., 2012). Despite that, the exact cellular and molecular mechanisms 
triggering this axon growth are still largely unknown. Recently, another approach emerged 
which not only boosted PNS axon regeneration through the non-permissive CNS environment 
but also provided some indication of the mechanisms required for targeted axon growth – 
this approach involved overexpression of integrins together with their activator - kindlin 
which allowed for their axonal transport into the axon (Cheah et al., 2016). It is well 
218 
 
documented now, that a developmental change occurs in CNS neurons where growth-
promoting receptors become removed from the fully developed axon and instead are 
concentrated in the somatodendritic compartment of the cell (Hollis et al., 2009; Franssen et 
al., 2015; Andrews et al., 2016). This re-distribution has also been named as one of the key 
factors that contribute to adult CNS decline in regenerative ability. Overexpressing activated 
integrins in the CNS, however, might not be a viable approach to improve axon regeneration 
as overexpressed integrins are actively removed from mature CNS axons. 
For these reasons, the second strategy used in this thesis to enhance axon 
regeneration after injury involved targeting one component of the transport machinery that 
traffics integrins into the axon – the adaptor protein protrudin (see Chapter 3-5). Protrudin is 
a membrane-bound protein which acts as a linker protein between Rab11-positive recycling 
endosomes containing integrins and kinesin 1 – a motor protein involved in anterograde axon 
transport (Shirane and Nakayama, 2006; Matsuzaki et al., 2011). Phosphorylated protrudin 
was, in particular shown to be essential for the anterograde movement of the whole complex 
to the tip of growing processes in PC12 cells. Our hypothesis, therefore stated that 
overexpressing a constitutively phosphorylated form of protrudin in adult CNS neurons could 
improve the anterograde transport of several growth receptors which are contained within 
Rab11-tagged endosomes and therefore, might be beneficial for axon growth after injury.  
We discovered that endogenous protrudin is found at low levels in mature CNS 
neurons and it is not upregulated after injury. Furthermore, there is less protrudin in axons 
compared to dendrites as primary cortical neurons mature in vitro, similar to other growth 
machinery and cargo. Overexpression of either wild-type or constitutively phosphorylated 
protrudin resulted in improved axon regeneration of rat primary cortical neurons after in vitro 
laser axotomy and in adult retinal ganglion cells after an optic nerve crush in vivo. This 
increase in regenerative potential was attributed to the increased amount of integrins and 
Rab11-positive vesicles in the distal axons of neurons overexpressing either form of protrudin. 
Interestingly, overexpression of wild-type protrudin improves regeneration both in vitro and 
in vivo, despite at a lesser extent compared to the phosphomimetic mutant. By creating 
several molecular domain mutants of protrudin, we were able to dissect the mechanisms that 
mediate protrudin-driven axon regeneration. For example, protrudin’s association with the 
ER, with KIF5 and ER-resident protein – VAP-A as well as its involvement in lipid transfer were 
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all shown to be essential for its effects on axon regeneration. In addition, protrudin binding 
to spastin and Rab11 seem to be important for overall neuronal health as mutations in these 
binding sites resulted in neuronal cell death.  From these results, we created a working model 
where protrudin acts as a scaffolding molecule bringing together multiple other molecules 
(growth factor receptors, motor proteins, late-endosomal proteins), organelles (ER, 
endosomes, lysosomes) and cellular components (lipids, membrane components) together at 
the tip of growing axons and that its reduced levels in mature axons could be contributing to 
the regenerative failure in mature neurons. In this model, we also hypothesised that protrudin 
functions from within the ER to target not only regenerative machinery but also ER itself into 
the distal part of the axon. After injury, the re-construction of new plasma membrane is key 
for axon growth. Therefore, the establishment of functional ER could play a crucial role in this 
process in order to supply the materials required for axon regeneration.  
Recently there have been tremendous advances in gene therapy targeting the eye 
with the first successful clinical trials in humans being reported over the past few years 
(Walsh, 2019; Xue et al., 2018). Our studies revealed that phosphomimetic protrudin has the 
potential to treat diseases in the eye that lead to loss of optic nerve axons, such as advanced 
glaucoma. Phosphorylated protrudin is currently being tested in our laboratory for its ability 
to improve regeneration in a spinal cord injury model and to grant neuroprotection in the eye 
following the induction of glaucoma. In addition to its potential suitability for gene therapy, 
protrudin’s properties of interaction with multiple proteins and its involvement in various 
cellular pathways, will also prove to be a valuable tool for identifying mechanisms required 
for successful axon regeneration. Investigating these may lead to the identification of new 
targets for either gene therapy or pharmacological intervention which could ultimately 
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